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ABSTRACT
The microinjection of noradrenaline (NA) into the hypothalamic 
paraventricular nucleus (PVN) of the rat results in feeding. 
This response was shown; contrary to previous reports; to be 
mediated through both a-1 and a-2 NA receptors. Selective 
blockade of these two receptor sub-types, in conjunction with 
re-uptake blockade was used to examine the individual 
contributions of each receptor type to the whole response. 
It is suggested that the previously reported a-2 receptor 
specificity of the response to microinjected NA is a result 
of the location of these receptors. The post-synaptic a-1 
receptor being located close to the pre-synaptic re-uptake 
mechanism, whilst the post-synaptic a-2 receptor is located 
outside the synapse and thus away from the re-uptake 
mechanism. The re-uptake mechanism acts to create a 
concentration difference of microinjected NA between the two 
receptor sub-types, resulting in a higher concentration and 
thus a preferential action at a-2 receptors. The involvement 
of the paraventricular NA system in stress induced eating was 
examined using a tail pinch procedure. Microinjection of NA 
antagonists into PVN prior to the onset of the pinch had no 
effect on the duration or latency of the eating response, thus 
there was no evidence for the involvement of this system in 
tail pinch elicited feeding. Further to the suggestion that 
the NA a-2 receptor is extra-synaptic whilst a-1 is intra- 
synaptic, the actions of NA were examined at a second site. 
NA microinjected into the ventral striatum elicited a vigorous 
locomotor response, although the origins of this showed a 
clear priming effect. However, this response was unaffected 
by prior microinjection of NA a- antagonists, preventing an 
analysis of receptor involvement comparable with that 
performed in PVN.
LIST OF ABBREVIATIONS.
ACTH adrenocorticotropic hormone
ADR adrenaline
AMB nucleus ambiguus
ANOVA analysis of variance
AVP arginine-vasopressin
CNS central nervous system
CRF corticotropin releasing factor
DA dopamine
DBH dopamine-B-hydroxylase
DMH dorsomedial hypothlamus
DMI de sme thy 1 - imipr amine
DMV dorsal motor nucleus of the vagus
DNAB dorsal noradrenergic bundle
EAA's excitatory amino acids
EDTA ethylene-diamine-tetra-acetic acid
ESB electrical stimulation of the brain
HPLC-ED high performance liquid chromatography with 
electrochemical detection 
IBO ibotenic acid
IML intermediolateral cell group
i.p. intra-peritoneal
LH lateral hypothalamus
LHA lateral hypothalamic area
MAOI monoamine-oxidase inhibitor
MFB medial forebrain bundle
NA noradrenaline
NMDA N-methyl-d-aspartatic acid
NST nucleus of the solitary tract
6-OHDA 6-hydroxydopamine
OXT oxytocin
PAG periaqueductal grey
PHA-L "phaseolus vulgaris^ leuco-agglutin
PMV premammi1lary nucleus
PNMT phenyletheanolamine-N-methyl-transferase
PVN paraventricular nucleus of the hypothalamus
TH tyrosine hydroxylase
TP tail pinch
VMH ventromedial hypothlamus
VMN ventromedial nucleus of the hypothalmus
VNAB ventral noradrenergic bundle
VTA ventral tegmental area
INTRODUCTION
THE REGULATION OF FOOD INTAKE
The study of the mechanisms and regulation of food intake is 
one of the most intensively researched aspects of behaviour. 
Feeding and feeding behaviour are ubiquitous in the animal 
kingdom and would appear to present a common link between all 
classes of organisms. What controls feeding behaviour and 
* metabolism? It is clearly more than a peripheral, 
physiological process and since 1849 when Claude Bernard 
observed an increase in blood sugar following puncture of the 
floor of the IV ventricle, systematic research has been 
undertaken to elucidate the control of feeding and metabolism 
by the brain.
Much research has indicated the involvement of the 
hypothalamus in the control of food intake. Hetherington and 
Ranson (1939, 1942) reported that bilateral electrolytic
lesions of the ventromedial hypothalamic area (VMH) resulted 
in a syndrome of hyperphagia and obesity, and further 
suggested that lesions of other hypothalamic sites did not 
result in weight gain. This latter statement was contradicted 
by the results published by Heinbecker et al. (1944) 
indicating the involvement of the paraventricular nucleus of
the hypothalamus (PVN), but for nearly 30 years the focus of 
research was the collection of metabolic and behavioural 
disturbances accompanying VMH lesion. This research led to 
the concept of a 'satiety' centre located in the VMH 
(Stellar 1954). Experiments performed by Anand and Brobeck 
(1951) further strengthened this concept. They discovered 
that lesions of the lateral hypothalamic area (LHA) resulted 
in a syndrome of aphagia, adipsia and dramatic weight loss. 
Thus it was proposed that food intake and metabolism were 
regulated by two reciprocally antagonistic centres in the 
hypothalamus, the VMH as 'satiety' centre and the LH as 
'feeding' centre. More support for this theory was derived 
from the electrical stimulation of these areas. Stimulation 
of the VMH in hungry rats inhibited food intake (Margules and 
Olds 1962; Hoebel and Teitelbaum 1962), whilst electrical 
stimulation of the LH resulted in feeding in satiated animals 
(Andersson and Wyrwicka 1957).
The appeal of such a clearly defined model of feeding 
regulation is apparent: it accommodated the great majority of 
the available data, fitted neatly with the role of the 
hypothalamus as regulatory centre and could be explained 
simply, in terms of excitation and inhibition of discrete 
neuronal populations. Indeed such has been the impact of 
this model that it still appears in current undergraduate 
texts in biology, despite many apparent difficulties and
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contradictions. Not all the experimental data could be 
explained and further research has exposed shortcomings in the 
two centre hypothesis. Richard Gold attempted to define 
exactly the area which, when lesioned, would give rise to the 
VMH syndrome. The central component of the VMH is the 
ventromedial nucleus (VMN) and Gold (1973) demonstrated that 
radio-frequency lesions of VMN which did not damage tissue 
outside this nucleus were ineffective in producing the VMH 
syndrome. Examination of those lesions which did produce the 
syndrome revealed that "the effective lesions overflow the 
bounds of the VMN, the largest lesions typically producing the 
fattest rats" (p. 488). Furthermore Gold observed that
lesions caudal or lateral to the VMN, parasagittal knife cuts 
rostrolateral to the VMN and even midbrain lesions could all 
produce obesity even though the VMN was left intact. Thus it 
appeared that some component of the VMH other than VMN was the 
primary contributor to the syndrome. Gold suggested that the 
syndrome might be due to damage of the ventral noradrenergic 
bundle (VNAB) and this hypothesis was supported by the lesion 
studies of Kapatos and Gold (1973), in which knife cuts of 
VNAB were shown to result in hyperphagia and obesity.
Another interesting observation concerning VMH syndrome 
animals had been made by Teitelbaum (1955). He observed that 
the palatability of the diet had a greater impact on VMH 
animals than controls. He described the VMH animals as
finicky, palatable diet being overconsumed compared to 
controls, and food adulterated with quinine (bitter) or bulked 
out with cellulose, underconsumed. Graff and Stellar (1962) 
suggested that it might be possible to dissociate the 
finickiness and hyperphagia components of the VMH syndrome 
with selective lesions. Ahlskog and Hoebel (1973) confirmed 
this using electrolytic lesions and the catecholamine specific 
neurotoxin 6-hydroxdopamine (6-OHDA). Lesions of the ventral 
noradrenergic bundle (VNAB) resulted in a hyperphagia leading 
to obesity, whether the lesion was electrolytic or made with 
6-OHDA. The hyperphagia appeared to result from a depletion 
of forebrain noradrenaline (NA) due to lesion of the VNAB. 
However lesions in the medial hypothalamus sufficient to 
induce the traditional VMH syndrome resulted in no detectable 
loss of forebrain NA, whereas the NA depleting VNAB lesion 
resulted in >90% depletion. Furthermore, the two procedures 
were additive, not substitutive, in their effects on eating 
(Ahlskog et al. 1975). These results indicated that the 
'classical' VMH syndrome was due to a combination of damage 
in the medial hypothalamus and damage to the VNAB caused by 
extensive lesions. The finickiness component described by 
Teitelbaum (1955) was demonstrated not to be a consequence of 
the obesity these lesions produced. Animals prevented from 
becoming obese after lesion did not show this syndrome 
(Franklin and Herberg 1974).
FIGURE 1. Diagram of the noradrenergic projections of the locus 
coeruleus complex viewed in the saggital plane. Abbreviations : 
AON, anterior olfactory nucleus; AP-VAB, ansa-peduncularis - 
ventral amygdaloid bundle systems; BS, brainstem nuclei; CC, corpus 
callosum; CTX, cerebral neocortex; H, hypothalamus ; HP, hippocampal 
formation; S, septal area; SOD, supra-optic decussation; T, tectum; 
TH, thalamus. The darkly shaded area is the dorsal noradrenergic 
bundle. (Redrawn from Moore and Bloom 1979.)

FIGURE 2. Representation, in horizontal view, of the location and 
projections of brainstem NA groups excluding the LCC. 
Abbreviations: BF, basal forebrain; BS, brainstem; DMV, dorsal
motor nucleus of the vagus ; LR, lateral reticular formation; MFB, 
medial forebrain bundle, SG, spinal cord grey; TH+HYP, thalamus and 
hypothalamus; ts, nucleus of the solitary tract. (Adapted from 
Moore and Bloom 1979.)
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More recently, evidence has begun to appear suggesting that 
the lesions made by Ahlskog and Hoebel were not selective for 
VNAB but in addition damaged the dorsal noradrenergic bundle 
(DNAB), which originates in and around the locus coeruleus 
(for details of the anatomy see below p.15 and figures 1 and
2). Experiments by Lorden et al. (1976) and Oltmans et al. 
(1977) found no significant difference in body weight gain 
between animals with 6-OHDA lesions of VNAB and controls 
despite the fact that these lesions damaged not only VNAB but 
also caused slight damage to DNAB. The deficit produced by 
lesion of ascending NA fibres was clearly complex in nature, 
affecting both body weight gain and sensory aspects of the 
diet. In order to establish which of the ascending NA fibre 
bundles were responsible for which of the observed deficits 
Sahakian et al. (1983) made selective lesions of either 
VNAB or DNAB and contrasted the results. The results of this 
study serve to indicate the complexity of the interactions 
between the lesions; DNAB lesions contrast with those of VNAB 
in that DNAB lesioned animals show no hyperphagia, weight gain 
or finickiness, all of which were apparent in the VNAB 
lesioned animals. However the results of the VNAB lesions 
bear only a superficial similarity to the results of 
electrolytic VMH lesions in that whilst rats with either 
lesion show hyperphagia, weight gain and finickiness, the 
magnitude of some of these effects is far greater in VMH 
lesioned animals. The finickiness appears to be identical
irrespective of lesion but the hyperphagia and weight gain are 
reduced in the VNAB lesioned animals when compared to those 
with a VMH lesion.
The above experiments have all been concerned with the 
regulation of food intake and metabolism as central processes 
and have taken little account of metabolic disturbances which 
may have resulted from the various central manipulations. 
Analyses of peripheral metabolism in conjunction with central 
manipulations helped to elucidate the nature of VMH obesity. 
Animals with VMH lesions become hyperinsulinaemic (Prohman and 
Bernardis 1968) and as daily administration of insulin in 
experimental rats results in obesity (MacKay et al. 1940), 
this is likely to be a component of VMH syndrome obesity. 
Furthermore Powley and Opsahl (1974) observed that vagotomy 
abolished the obesity from VMH lesions. However, Vilberg and 
Beatty (1975) demonstrated VMH obesity in diabetic rats 
receiving controlled levels of insulin, indicating that 
hyperinsulinaemia is only a contributory factor in the 
syndrome. In normal animals the liver and adipose tissue act 
as parts of an energy store, absorbing nutrients 
post-ingestionally and then slowly releasing them when food 
is not available. Friedman and Strieker (1976) suggested that 
the consequence of a VMH lesion is to affect metabolism in 
such a way that the animal is fixed in the absorptive phase. 
Thus instead of performing its normal function, adipose tissue
continuously absorbs nutrients leaving the animal in a state 
in which it must eat more often to maintain energy balance.
The data presented above demonstrates that far from being a 
uniform deficit resulting from damage at a specific locus, the 
VMH syndrome is a collection of deficits due to a variety of 
damage across several loci. Much of the interst in the VMH 
syndrome concerned the paradoxical dissociation between 
'hunger' and food intake. In an attempt to reconcile all of 
the VMH effects in one theory Powley (1977) proposed the 
"Cephalic Phase Hypothesis". This suggested that VMH lesions 
produced their major effects on feeding behaviour by **directly 
heightening the phasic, autonomic and endocrine responses 
triggered by oropharyngeal contact with food stimuli -  the 
cephalic reflexes of digestion*' (p. 89). Further, "by directly 
altering the visceral responses in the direction of positive 
energy balance, the lesion exaggerated cephalic reflexes have 
the effect of producing anabolic adjustments which in turn 
produce overeating and weight gain" (p. 90).
As an hypothesis the "Cephalic Phase" was excellent being both 
parsimonious and testable, however when tested problems were 
found :
(1). Experiments by Storlien (1985) showed an abolition of 
cephalic phase reflex in VMH lesioned rats.
(2). Duggan and Booth (1986) claim that the hyperinsulinaemia
(central to the cephalic phase hypothesis) is caused by 
changes in the rate of gastric emptying. Hyperinsulinaemia 
is therefore a secondary consequence. Thus Powley's 
hypothesis which provided a theory of VMH function could not 
be correct.
The finickiness produced by VMH lesion is also produced by 
VNAB lesion and may result from a loss of NA input to the 
amygdala, and the autonomic effects may result from damage to 
descending fibres from other medial hypothalamic sites.
As a result of the experiments performed to identify the exact 
locus mediating VMH obesity interest was revived in the 
paraventricular nucleus of the hypothalamus (PVN). This area 
had been implicated in hypothalamic obesity by Heinbecker in 
1944 but had been largely ignored by researchers until the 
knife cut studies of Gold and his colleagues (Gold, 1977; and 
Sclafani, 1971) . The PVN is a major target site for the VNAB 
and also receives a small (<20%) NA input from DNAB. The PVN 
is also the site most responsive to feeding elicited by the 
microinjection of exogenous NA (Booth 1968, Leibowitz 1978a), 
Further, the anatomical connections of the PVN, such as strong 
reciprocal connections with structures in the brainstem known 
to be involved in autonomic regulation, indicate a possible 
role in the control of visceral events. Finally, the 
demonstration that electrolytic lesions of the PVN produced
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increased levels of food intake and excessive weight gain in 
rats (Leibowitz et al. 1981; Aravich and Sclafani 1983; 
Sclafani and Aravich 1983) indicated that this site had a 
major role in the regulation of food intake.
The recognition of the importance of the PVN and the 
demonstrations of noradrenergic involvement in the functioning 
of this nucleus represented a significant advance in the 
understanding of hypothalamic regulation of food intake and 
metabolism. However, in order to appreciate fully the 
involvement and interaction of this nucleus with the 
ascending NA systems and the resulting effects on food intake 
and metabolism, it is necessary to examine the anatomical 
interactions and effects of NA manipulation in considerably 
more detail.
ANATOMY
Behavioural patterns, in particular those concerned with the 
survival of the organism, appear to be organised by the limbic 
system. The hypothalamus is a diencephalic component of this 
system and it is hard to overstate its importance in complex 
limbic integration. To quote from P.Luiten et al. (1987) 
"Speaking in general terms the hypothalamus guards a part of 
the channels of entry and the majority of the outflow of 
information to and from the internal environment of the 
mammalian body. It makes the first overall selection of
'4
certain inputs and a major selection of output to and from the 
^higher' integration centres of the limbic system. As such, 
the hypothalamus is not only a centre of relay of information, 
but acts as a centre of integration as well. Focusing such 
a large number of important functions in a structure of such 
moderate size leads to two easily discernable conclusions : its 
anatomy is complex and the effects of even minor damage are 
dramatic" (pp, 27-28),
PARAVENTRICULAR NUCLEUS
The PVN can be sub-divided into two basic divisions; the 
magnocellular portion and the parvocellular portion. These 
are illustrated in figures 3 and 4, A detailed analysis using 
both connectional and cytoarchitectonie criteria revealed the 
presence of eight possible sub-divisions within the nucleus 
(Swanson and Kuypers 1980). The magnocellular portion is 
composed of three parts, anterior, medial and posterior zones  ^
which all project predominantly to the posterior lobe of the 
pituitary gland. A projection of arginine-vasopressin (AVP) 
containing fibres arises from this region to the median 
eminence where terminals contact the hypophyseal portal 
capillaries (data from the guinea pig) (Sofroniew et al. 
1979). The parvocellular portion of PVN can be divided into 
five areas; anterior, medial, lateral, dorsal and 
periventricular. The parvocellular part of PVN contains small 
oxytocin (OXT) and AVP producing neurons and gives rise to a
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FIGURE 3. (A) Organisation of ascending, predominantly
noradrenergic projections (asterisks) to the PVN. Note that A1 
innervates both magnocellular and parvocellular divisions of PVN. 
(B) Organisation of efferents from PVN involved in central control 
of autonomic function. Abbreviations; Al, the noradrenergic cell 
group Al; DVC, dorsal vagal complex; ME, median eminence; IML, 
intermediolateral cell column of the spinal cord; IX, 
glossopharyngeal nerve; X, vagus nerve; LC, locus coeruleus; P, 
posterior pituitary; *, oxytocin and *, vasopressin-containing 
components of magnocellular PVN. (Adapted from Sawchenko and 
Swanson 1981.)

FIGURE 4. Representative summary of the major sub-divisions of the 
PVN. Abbreviations: ANS, autonomic nervous system; ME, median 
eminence; PP, posterior pituitary; dp, dorsal parvocellular part; 
Ip, lateral parvocellular part; mpl, dorsal and mp2, ventral 
subdivisions of the medial parvocellular part; pml, lateral and 
pm2, medial subdivisions of the posterior magnocellular part; pv, 
periventricular part (from Swanson and Sawchenko 1983).

descending projection which distributes fibres to the locus 
coeruleus, the parabrachial nuclei, the dorsal motor nucleus 
of the vagus, and the nucleus of the solitary tract (Swanson 
and Hartman 1980, Sawchenko and Swanson 1982). Some of these 
fibres enter the dorsal part of the lateral funiculus of the 
spinal cord. Within the spinal grey matter these fibres 
terminate in the central grey, the marginal zone of the dorsal 
horn and the intermediolateral column (Swanson and McKellar
1979).
The function of these AVP and OXT projections from PVN to the 
autonomic centres in the brain stem and spinal cord may be 
related to the regulation of the processes with which these 
peptides are involved in the periphery. A coupling of the 
central and peripheral actions of hypothalamic peptides has 
been suggested as a general principle (Swaab 1982).
Localisation studies of cells containing posterior pituitary 
hormones revealed that AVP stained cells were concentrated in 
the posterior zone of the magnocellular cell group whilst OXT 
containing cells were found predominantly in the anterior and 
medial zones.
Swanson et al. (1981) have interpreted the results of 
localisation studies of the catecholamine containing neurons 
in PVN, combined with the anatomy of peptidergic neurons
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within this nucleus. They conclude that adrenergic input to 
PVN may influence the cells projecting to preganglionic 
autonomic centres, whilst the NA projection influences 
predominantly AVP cells that project to the posterior lobe of 
the pituitary, as well as cells in the periventricular region 
that project to the median eminence. However, in the light 
of the data presented by Mefford (1987) which suggests that 
PNMT containing cells are not adrenergic neurons in the 
accepted sense (see p. 21) Swanson's interpretation must be 
considered oversimplified.
NORADRENERGIC INNERVATION OF PVN.
The neurons that synthesise NA appear restricted to the 
pontine and medullary regions. Dahlstrom and Fuxe (1964) 
described seven NA cell groups in rodents - designated A1-A7 
and most of these have been recognised in primates as well 
(see Nieuwenhuys, 1985 for review). As this thesis is 
concerned with the PVN only the cell groups and projections 
relevant to this nucleus will be considered.
The cells of groups Al and A2 are both situated in the lower 
portion of the medulla oblongata. The cells of Al surround 
the lateral funiculus and extend dorsomedially into the 
lateral part of the reticular formation, whilst those of A2 
lie predominantly in the nucleus of the solitary tract, the 
dorsal vagal nucleus and the intervening area (Nieuwenhuwys,
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1985). A6 NA cells are found within the locus coeruleus, it 
is a densely packed accumulation of cells, and some evidence 
suggests that all of the cells situated in the central part 
of this structure are noradrenergic (Swanson, 1976). The A6 
cell group can be described in terms of three extensions, 
caudolateral, ventral and rostral. It is the rostral 
projection that is of relevance to the PVN. It consists of 
cells lying in the caudolateral part of the mesencephalic 
central grey (A6cg). This A6cg group is usually combined with 
the A4 group and the ventral extension of A6 (A6sc or 
subcoeruleul group) and classified as the noradrenergic locus 
coeruleus complex (LCC).
DORSAL BUNDLE
The LCC is quantitatively the most important site of NA 
projection, containing about half the total number of NA 
synthesising neurons in the brain. The major efferent of this 
system was called the dorsal noradrenergic bundle (DNAB) by 
Ungerstedt (1971) [see figure 1], but it is a secondary and 
much smaller efferent that is of interest here. This is the 
projection that forms the rostral limb of the dorsal 
periventricular pathway, which ascends to the diencephalon 
within the ventromedial part of the periaqueductal grey, 
forming part of the dorsal longitudinal fasiculus complex. 
Rostrally this pathway continues into the diencephalic 
periventricular fibre plexus. Lindvall and Bjorklund (1974)
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suggested that fibres from this projection innervate the PVN. 
However subsequent analysis by Sawchenko and Swanson (1981) 
has shown that it is only the parvocellular part of this 
nucleus that receives any sizeable input from the LCC.
VENTRAL BUNDLE
The efferents of the dorsal medullary (A2) and lateral 
tegmental (Al, A5, A7 ) noradrenergic cell groups were 
described by Ungerstedt (1971) as giving rise to a long, 
ascending fibre system called the ventral noradrenergic bundle 
(VNAB) [see figure 2]. The VNAB ascends through the reticular 
zone of the brain stem and continues rostrally within the 
medial forebrain bundle. According to Ungerstedt (1971) the 
VNAB has widespread terminal areas including the reticular 
formation, the entire hypothalamus (particularly dorsomedial, 
periventricular, infundibular, supraoptic and paraventricular 
nuclei), the preoptic area and bed nucleus of the stria 
terminalis. However, more recent studies (Lindvall and 
Bjorklund, 1974, Swanson et al. 1981) have shown that the VNAB 
and DNAB as described by Ungerstedt are not as clearly 
distinct from each other as he proposed. They form one 
complex which has been termed the 'central tegmental tract' 
in which ascending fibres are mixed with descending ones and 
axons of the 'lateral tegmental group' feed into it at 
successive levels through radially coursing transverse fibres. 
However, the non-coerulean NA projections to the hypothalamic
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cell masses originate exclusively from the caudal medullary 
Al and A2 cell groups (Ricardo and Koh 1978, Sawchenko and 
Swanson 1981, 1982a).
The regions innervated by each of the Al, A2 cell groups have 
been sub-divided as follows
Al innervation.
(i) Bed nucleus of the stria terminalis.
(ii) Medial preoptic area.
(iii) Anterior, lateral and posterior hypothalamic areas.
(iv) The dorsal hypothalamic area, the dorsomedial nucleus and 
the median eminence.
(v) The magnocellular and parvocellular portions of the PVN. 
In the magnocellular portion of PVN the projection from Al 
terminates predominantly in areas that show high levels of 
vasopressin-like immunoreactivity.
A2 innervation.
i) Medial preoptic area.
ii) Anterior, lateral and posterior hypothalamic areas and the 
dorsomedial nucleus.
iii) The parvocellular portion of the PVN.
A large part of the long, ascending projections from Al and 
A2 are bilateral, but with an ipsilateral predominance.
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ADRENERGIC INNERVATION OF PVN
Adrenaline (ADR) represents the final stage in the synthesis 
chain of the catecholamines, in which noradrenaline is 
converted by the enzyme phenylethanolamine - N - methyl - 
transferase (PNMT). [See figure 5]. As it is a catecholamine 
ADR can be visualised by the fluorescence methods that apply 
to NA and dopamine (DA) but no distinction can be made between 
these compounds. However, antibodies against the enzyme PNMT, 
which is present only in ADR synthesising neurones have 
enabled selective anatomical tracing of PNMT containing 
neurones. These studies purport to show the distribution of 
ADR neurones in the brain.
Three PNMT containing cell groups have been identified, all 
situated in the caudal rhombencephalon. In concordance with 
the nomenclature of Dahlstrom and Fuxe (1964) these groups are 
referred to as Cl, C2 and C3. They are named in order of 
magnitude. Cl, the largest group, contains about 69% of the 
total number of PNMT immunoreactive cells (Howe et al. 1980). 
It is located between the lateral funiculus and the inferior 
olivary complex in the ventrolateral myelencephalon. Group 
C2, comprising 22% of PNMT reactive cells, is located in 
intimate association with the NST. Some cells falling within 
the boundaries of this nucleus, and others directly adjacent
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FIGURE 5.Synthesis pathway of the catecholamines 
Figure from Nieuwenhuys (1985).
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to it. Group C3/ which is the remaining 9%, lies adjacent to 
the dorsal raphe region, its cells interspersed amongst the 
fibres of the medial longitudinal fasiculus. Groups Cl and 
C2 are not, as suggested by Hokfelt et al (1974), located 
within the NA groups Al and A2 but lie rostral, although 
adjacent, to these areas. It is interesting to note that, 
whilst the cells of Cl and C2 are clearly labelled by 
antibodies to PNMT most of these cells do not show 
catecholamine histofluorescence (Howe et al 1980).
From the general region of areas Cl - C3 an ascending tract 
of PNMT-reactive fibres can be traced through the reticular 
formation, the ventral tegmental area and into the lateral 
hypothalamus (LH). These fibres follow the VNAB almost 
exactly. Terminal fields of PNMT containing neurons appear 
to be distributed quite widely throughout the CNS, innervating 
in particular; the dorsal motor nucleus of the vagus (DMV), 
the NST, LC, ventral periaqueductal grey, the dorsomedial 
nucleus of the hypothalamus, some thalamic midline nuclei and 
a particularly dense field in the PVN. Exactly which group 
of cells (C1-C3) projects where is hard to define but 
Sawchenko and Swanson (1982a) suggest that Cl projects to 
magno- and parvocellular portions of PVN whilst C2 also 
projects to the parvocellular portion.
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PVN AFFERENTS
There appears to be very little input to the PVN from the 
telencephalic limbic areas, apart from a few prelimbic 
cortical afferents (Luiten et al. 1987). In addition to the 
catecholaminergic afferents already discussed the major 
afferents appear to be from the dorsolateral septum and bed 
nucleus of the stria terminalis, as well as from the 
subfornical organ and the organum vasculosum lamina terminalis 
(Sawchenko and Swanson 1983). The routes from higher limbic 
centres such as the hippocampus, amygdala and prefrental 
cortex, to the PVN are indirect. These areas undoubtedly 
influence 'emotional state' and behaviour, involving adrenal 
hormone release. It is probable that the ventral 
premammillary nucleus (PMV) acts as a relay station between 
these structures and the PVN (Luiten et al. 1987).
INTRAHYPOTHALAMIC PROJECTIONS OF PVN.
From the parvocellular area of PVN there are some projections 
to the medial and ventral peripheral zones of the LHA. 
Further, some efferents project to the medial aspects of VMH 
and a well developed output is present to the dorsomedial area 
(DMH). A projection is present to the perifornical column 
throughout the hypothalamus from anterior to posterior and 
there is a dense projection to the periventricular layers of 
the third ventricle, to the arcuate nucleus and the median 
eminence (Luiten et al. 1987).
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It appears that all hypothalamic nuclei concerned with the 
control of food intake and metabolism receive input from PVN. 
Furthermore, the PVN must be considered one of the main 
hypothalamic outflow stations. Despite the presence of dense 
projections from other hypothalamic nuclei, particularly DMH, 
to the PVN, reciprocal pathways are quantitatively limited. 
This is taken to imply that PVN exerts its wide ranging 
influence on food intake and autonomic activity not as a 
result of intrahypothalamic integration and processing but 
as a result of extensive PVN output. (Gold et al. 1977, Weiss 
and Leibowitz, 1983).
PVN EFFERENTS
Hypothalamic outflow via the neuroendocrine system is 
undoubtedly dominated by the PVN projections to adeno- and 
neuro-hypophesis. Corticotropin releasing factor (CRF) 
neurons in the parvocellular PVN, via their projections to the 
median eminence, constitute a major pathway in the expression 
of motivational drive and emotional state (Bassett 1984). 
These releasing factors can activate secretion of 
adrenocorticotropic hormone (ACTH) from the posterior 
pituitary, which in turn leads to corticosteroid release from 
the adrenal glands (Merchenthaler, 1984, Merchenthaler et al. 
1984). Further, Leibowitz and her colleagues have
demonstrated the interaction of steroid hormones and NA within
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the PVN (see p. 37 below) and shown that the presence of these 
hormones is necessary for aspects of PVN function. Thus a 
feedback loop exists between PVN neurons releasing CRF and 
levels of circulating steroid hormones.
The outflow pathways from PVN to the autonomic nervous system 
form two main streams of fibres. One tract maintains a 
periventricular position whilst the other runs lateral over 
the substantia nigra and finds a position on the floor of the 
brainstem. These two pathways provide synaptic endings in the 
periacqueductal grey (PAG) and Edinger-Westphal nucleus, 
ventral mesencephalic tegmentum, pedunculo-pontine tegmental 
nucleus and parabrachial nucleus, locus coeruleus and the 
raphe nuclei. Continuing to the lower brainstem, PVN 
projections form highly organised terminations in the nucleus 
ambiguus (AMB) and DMV, NST, and area postrema. Via these 
nuclei the PVN has a direct and powerful influence on the 
parasympathetic cell groups of the autonomic nervous system 
(Rogers and Hermann 1985, Rogers and Nelson 1984).
Descending through the lower medulla many fibres move 
laterally in the dorso-lateral funiculus. These PVN efferents 
can be followed over the entire length of the spinal cord, 
giving off collaterals that branch extensively in the 
intermediolateral column of the thoraco-lumbar segments. 
After entering the intermediolateral cell group (IML) most
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fibres continue medially and terminate finally in area 10 of 
Rexed (the midline extension of IML) which consists of 
pre-ganglionic sympathetic neurons (Luiten et al. 1984).
Comparing the anatomical data provided by Luiten and his 
colleagues, generated using the 'phaseolus vulgaris' 
leuco- agglutinin (PHA-L) tracing methods (Gerfen and 
Sawchenko 1984) with the immunohistological data from Swanson, 
remarkable similarity is apparent. The PVN projection to the 
parasympathetic cell groups in the lower medulla shows high 
levels of vasopressin like immunoreactivity, whilst in the 
sympathetic PVN-IML projection the immunoreactivity was 
exclusively to oxytocin indicating that these two compounds 
may be parasympathetic and sympathetic transmitters 
respectively.
ARE PNMT CONTAINING CELLS ADRENALINE NEURONS?
Since the discovery and mapping of PNMT-containing neurones 
the assumption has been made that these cells are specifically 
adrenergic. However, a recent review by Ivan Mefford (1987) 
suggests that this assumption may be erroneous. Several 
manipulations of ADR and PNMT in brain are difficult to 
rationalise in terms of classical catecholamine neurons
(i) Lesions made with the specific neurotoxin 6-OHDA fail to 
cause degeneration of PNMT containing cells in the
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hypothalamus (Fuller 1982).
(ii) It has not proved possible to demonstrate co-localisation 
of PNMT with other catecholamine synthesising enzymes 
(tyrosine hydroxylase [TH] or dopamine-B-hydroxylase [DBH]) 
within the hypothalamus.
(iii) Transection of fibres from Cl, C2 causes a depletion of 
ADR but no lowering of PNMT activity in hypothalamus (Langer 
et al. 1980).
(iv) Chronic administration of monoamine oxidase inhibitors 
(MAOI) causes a disproportionate increase in ADR compared to 
NA (Mefford 1987).
(v) Acute stress causes a marked depletion of ADR whilst 
having a considerably smaller effect on NA (Roth et al. 1982).
In order to account for these differences, special properties 
have been ascribed to ADR neurones. However Mefford 
proposes an alternative explanation. He suggests first, that 
the majority of PNMT neurones in the hypothalamus are not 
capable of specific uptake, storage, or * de novo' synthesis 
and are thus not catecholaminergic neurones ; and second, that 
ADR formed in the hypothalamus by PNMT is a post-synaptic 
catabolite of NA and diffuses out of the PNMT neurone. It 
acts either as a local diffuse transmitter or hormone, 
possibly interacting with glial systems, or it can be taken 
up into NA neurones and act as a co-transmitter with NA. 
Finally, in the medulla, PNMT exists with TH and DBH, and ADR
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is produced but stored and released as a co-transmitter with 
NA.
This hypothesis raises many questions about the monoamine 
involvement in hypothalamic function and serves to indicate 
the difficulty in separating the NA and ADR actions in the 
PVN. These questions are further addressed in the discussion 
section.
NORADRENALINE AND PEEPING
In 1962, Grossman reported that hypothalamic injection of NA 
could elicit feeding in satiated rats. The effects of 
injections of NA were examined using operant techniques; rats 
were trained to press one lever for food reward and another 
for water reward on a variable interval, 30 second schedule 
of reinforcement. The injection of NA at perifornical sites 
in satiated animals significantly increased the rate of lever 
pressing for food reward, whilst the rate of pressing for 
water was unaffected. This finding stimulated considerable 
research into the possibility that central adrenergic systems 
might mediate natural hunger. A mapping study performed by 
David Booth (1967) indicated that the most effective sites for 
eliciting NA induced eating were in the anterior hypothalamic 
areas. The lateral and caudal hypothalamus were in general 
ineffective, while injections into certain extra-hypothalamic 
sites, such as the nucleus accumbens, the subfornical area and 
the olfactory tubercle were effective in eliciting feeding.
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Support for NA involvement in feeding regulation was provided 
by the results of Slangen and Miller (1969) who demonstrated 
that eating was stimulated by intrahypothalamic injection of 
drugs which enhance endogenous NA release and further, that 
the introduction of NA a-receptor blocking drugs led to 
a suppression of NA induced feeding. Further evidence for the 
site specificity of NA involvement was the response to NA 
injections into the mesencephalic reticular formation which 
suppressed operant responding for food reward (Grossman, 
1968). The response to hypothalamic injections was also found 
to be dependent upon the internal state of the animal. Coons 
and Quatermain (1970) confirmed the results reported by 
Grossman (1962) but found that the facilitatory effect of the 
NA was prevented by 6 or 24 hour periods of food deprivation 
prior to testing on both fixed ratio and variable interval 
schedules. The results suggested that "the facilitatory 
action of NA on operant responding for food reward may have 
been dependent upon a low rate of responding and was reversed 
by conditions which created a high rate of responding" 
(Matthews et al. 1986).
The data presented above served to indicate the involvement 
of NA in some aspects of feeding behaviour and moreover, 
indicated that a possible locus for this involvement might be 
the hypothalamus. In order to clarify further the anatomical 
basis, pharmacology, and specificity of NA involvement in
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feeding or its regulation, detailed studies of all these 
aspects were required. Over the last fifteen years Sarah 
Leibowitz, working at the Rockefeller University in New York, 
has carried out an exhaustive and consistent programme of 
research aimed at understanding the mechanisms underlying 
feeding in the rat. The work of Leibowitz and her colleagues 
is central to this thesis and is thus considered below as a 
separate chapter.
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SARAH F. LEIBOWITZ
The major research effort into the actions of NA microinjected 
into the PVN has come from Dr. Sarah Leibowitz and her 
colleagues. Initially, NA was injected at a variety of brain 
sites and in various doses and the behavioural response 
observed. Three major effects were noted; i) adrenergic 
stimulation of the 'perifornical' hypothalamus, at the level 
of the anterior hypothalamus, had profound effects on 
ingestive behaviour. Feeding was promoted by stimulation of 
alpha NA receptors and suppressed by stimulation of beta NA 
receptors; ii) Injection of NA into other structures, from 
the pons to the caudate, revealed a consistent pattern with 
respect to ingestive behaviour. From the rostral midbrain to 
the preoptic area, the medial portion of the brain appeared 
sensitive only to alpha stimulation, whilst the lateral areas 
appeared sensitive only to beta stimulation; iii) Injection 
of dopaminergic agents at these sites had no effect on 
ingestive behaviour (Leibowitz, 1973). From these data she 
hypothesised a reciprocal feeding mechanism: feeding was
elicited by the action of NA at medial a-receptors and 
inhibited by the action of NA at lateral G-receptors, the 
effective location of these mechanisms being hypothalamic, 
this hypothesis was subsequently demonstrated (Leibowitz 
1975a).
The pattern of feeding and drinking produced by'NA injections
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was examined further (Leibowitz 1975b). This examination 
produced six major components to the response; (i) The feeding 
and drinking responses to NA injection were dose dependent;
(ii) The drinking response (l-4ml) had a latency of around 1.5 
min. and lasted for 2-3 min. It was followed closely by 
eating (2-4gm) that lasted for about 20 min. (Data for 40nm 
NA in 0.5ul injection). (iii) The drinking response was 
clearly time related whilst satiation appeared to be important 
for termination of the feeding response, (iv) These responses 
were similar in appearance to normal pre-meal drinking and 
subsequent feeding, (v) The NA elicited responses could not 
be observed following LH stimulation by NA and only feeding, 
without the pre-prandial drinking was observed from VMH 
injection, vi) In contrast to drinking induced by peripheral 
G-adrenergic stimulation, that induced by NA was not abolished 
by nephrectomy. These results together with previous findings 
(Booth 1968, Slangen and Miller 1969, Leibowitz 1973) 
convinced Leibowitz that NA played a vital role in the 
regulation of feeding behaviour and that this effect was 
primarily mediated via a medial hypothalamic site. Thus, she 
undertook an extensive mapping study of the hypothalamus to 
identify the site which produced the greatest feeding response 
to microinjection of NA (Leibowitz 1978a). This study 
identified the PVN as the most responsive site to NA 
injection, in the satiated rat. In mildly hungry rats NA was 
shown to potentiate ongoing feeding, the most potent site
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again being the PVN. Potentiation in these animals was 
observed along the periventricular hypothalamus adjacent to 
the third ventricle. Injection of NA into the LH of these 
hungry animals resulted in a suppression of feeding. This 
finding, in parallel with those discussed in the earlier part 
of the introduction, further implicated the PVN in the control 
of feeding. Further work (Leibowitz, 1978b) demonstrated 
that the effects of NA injection were consistent despite 
variation in the time of injection - 4 hrs. into the light 
cycle, or 4 hrs. into the dark - or the baseline food intake 
or diet. Moreover, a response could be obtained from very low 
(4.2ng) doses of NA. Injections of NA or DA into the lateral 
hypothalamus suppressed feeding, as did injection of 
amphetamine. (For a review of the mechanisms and sites of 
actions of anorectic drugs see Leibowitz 1978c). When 
catecholamine re-uptake blockers were injected the suppressant 
effect of LH stimulation was reliably strengthened; G- but not 
a- blockade inhibited the suppression of feeding. These data 
provided further support for a lateral, G-adrenoceptor 
mediated feeding inhibitory mechanism (Leibowitz and Rossakis 
1978) .
That NA microinjected into the PVN resulted in feeding 
behaviour was now an accepted result but it remained to be 
demonstrated that the endogenous compound acted in the same 
way at this site. It was necessary to show that the actions
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of endogenous NA could result in feeding behaviour. Whilst 
it was difficult to measure spontaneously released levels of 
endogenous NA it was possible to use pharmacological 
manipulations to induce the release of the endogenous 
transmitter. Many antidepressant compounds were believed 
to exert their effects through actions on endogenous 
catecholamine systems. One such drug, tranylcypromine, acts 
as a monoamine oxidase inhibitor, granule depleting agent, and 
partial re-uptake inhibitor. Injection of this compound into 
the PVN, it was hypothesised, would result in the release 
of endogenous catecholamines from their storage granules and 
a reduction in the rate at which the catecholamines thus 
released would be inactivated. This would result in high 
levels of catecholamine availability at receptor sites. 
Within the PVN the predominant catecholamine is NA and it was 
argued that injection of tranylcypromine would mimic the 
effects of injection of exogenous NA as a result of increased 
endogenous NA release (Leibowitz et al. 1978a). [Recent work 
by Irie and Wurtman (1987) examined the release of NA from a 
slice preparation following electrical stimulation. Both 
spontaneous and evoked release were greater in a DMI 
containing than free media. This suggests that without DMI, 
the NA released from the slices was largely taken up into 
nerve terminals or glia. Furthermore, high levels of 
stimulation (1800 pulses in 10s trains, 60mA with 10 sec. 
intervals) release only 8.79 +/-0.25 % tissue content of NA.
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This is not very much, certainly far less than a 40nM
injection. Overall these experiments suggest that only about 
5% of NA in terminals is available for release. Given these
data it is a considerable assumption that pre-synaptic
manipulations can be exactly equivalent to pharmacological 
manipulations.] The results of Leibowitz et al. (1978a) 
experiment demonstrated that the injection of tranylcypromine 
into the PVN resulted in feeding behaviour, albeit on a
palatable diet, but that this feeding was less potent than 
that produced by exogenous NA. Two other aspects of these 
experiments indicated that endogenous NA was responsible for 
the feeding response; (i) local pre-treatment with NA 
synthesis inhibitors blocked the response to tranylcypromine 
induced feeding but not that induced by exogenous NA, and (ii) 
the feeding to both exogenous NA and tranylcypromine could be 
selectively blocked by local injection of NA 
alpha-antagonists. It is of great interest to note that the 
most potent blockade of the tranylcypromine feeding response 
was obtained with the a-antagonist phenoxybenzamine, not 
phentolamine. Phenoxybenzamine had previously been reported 
as effective in the blockade of feeding induced by exogenous 
NA microinjection (Leibowitz 1975a). Other monoamine 
antagonist drugs were not effective in inhibiting this 
response; these were the G-blockers propranolol and sotalol, 
DA blockers haloperidol and fluphenazine, the serotonin 
blocker cinanserin, and the cholinergic blocker atropine
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sulphate. All these compounds were administered in 
concentrations previously demonstrated to be effective in 
providing receptor blockade without affecting feeding baseline 
levels.
Thus NA induced feeding in the medial hypothalamus was 
elicited most potently from the PVN, could result from 
exogenous microinjection or drug-induced release of the 
endogenous transmitter, and was susceptible to blockade by <%- 
adrenergic antagonists but not by other antagonists active at 
other monoamine receptors. The use of the a-blocking agent 
phenoxybenzamine in these experiments has caused some 
difficulty in subsequent analysis of the results. 
Phenoxybenzamine is an irreversible antagonist selective for 
the a-1 subtype. Repeated injections of irreversible 
antagonists, as in Leibowitz et al. (1978a), would lead to an 
increasingly severe blockade in each trial for each individual 
dose. The a-1 selectivity of this compound, unlike 
phentolamine, would lead to a preferential depletion of this 
receptor subtype.
Further experiments involving antidepressant drugs which block 
NA re-uptake and perhaps enhance release, demonstrated that 
they elicited eating when injected into PVN. This eating 
correlated positively with the eating produced by injection 
of exogenous NA. Again this feeding could be blocked by
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pre-treatment with synthesis inhibitors or a-receptor blockers 
(Leibowit z 1978b).
The involvement of NA mechanisms within the PVN with the 
feeding response having been demonstrated, the next area for 
investigation was the anatomical basis of the endogenous NA 
involved. Electrolytic lesions in the dorsal and ventral 
midbrain tegmentum produced a variety of effects relating to 
feeding and drinking, and also greatly altered the responses 
to feeding-associated drug manipulations within the 
hypothalamus (Leibowitz et al 1980). Therefore, Leibowitz and 
Brown (1980a) applied the techniques of: (i) selective lesions 
of catecholamine containing neurons with 6-OHDA; (ii) 
fluorescence histochemistry and (iii) brain cannulation to 
analyse the NA projections to PVN and their function in 
stimulating feeding. It must be remembered that much of the 
anatomical data previously referred to in this thesis was not 
available at this time. Leibowitz and Brown conclude that 
"mldbrain lesions are found to have dramatic effects on the 
responsiveness of the hypothalamic PVN to adrenergic drug 
manipulations. Associated with these effects are damage to 
specific ascending catecholamine projections and degeneration 
of catecholamine varicosities within the PVN. The convergence 
of hlstochemlcalf pharmacological and behavioral evidence 
supports the hypothesis that brain synthesised catecholamines, 
specifically In the PVN have a function In stimulating feeding
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behaviour; that the neuroanatomlcal substrate for this 
stimulatory function Includes noradrenergic or adrenergic 
fibres of the dorsal CTT which originate from pontine (A3 or 
A6) or medullary (Al) cell groupsf course In the dorsal 
tegmentum Immediately dorsal to the superior cerebral 
pedunclesf and then project ventrorostrally through the medial 
TR system Into the ventral tegmentum; and that these 
adrenergic projections contribute to the feeding stimulatory 
effect of antidepressant drugs'* [p. 308] Leibowitz and Brown 
demonstrated that damage to either the Al - À2 system or the 
A5 - A6 system affected the feeding response to adrenergic 
manipulations within the PVN, both systems being involved in 
some part. Further experiments (Leibowitz and Brown 1980b), 
demonstrated the involvement of the dopaminergic A8 and A9 
systems in the feeding inhibition response to certain agents. 
However, accurate, quantitative data on the amount of NA 
depletion within the PVN produced by these lesions, were not 
described.
These results increased the evidence suggesting that the PVN 
was an area of the hypothalamus of major importance in the 
regulation of food intake and that this regulation involved 
NA from the ascending dorsal and ventral bundle systems. 
Electrolytic lesions of the PVN itself result in overeating 
and obesity (Leibowitz et al. 1981) as do coronal or 
parasagittal knife cuts in the vicinity of the PVN (Grossman
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1975, Sclafani and Berger 1977). However, injections of the 
neurotoxin 6-OHDA into the PVN produced little change in 
feeding behaviour [Fahrbach and Leibowitz unpublished (in 
Leibowitz et al. 1981)p.l039], although more recently 
published results show a deficit in ingestion of energy-rich 
carbohydrate diets in the early dark period, or in response 
to food deprivation (Shor-Posner et al. 1986). Many other 
compounds have been demonstrated to affect feeding when 
administered into the PVN; GABA (Grandison and Guidotti 1977), 
G-endorphin (Leibowitz and Hor 1980), enkephalins (McLean and 
Hoebel 1980), serotonin and cholesystokinin (McCaleb and Myers
1980). The response to manipulations within the PVN was 
clearly complex, but NA systems continued to provide the best 
avenues for further exploration.
Peripheral administration of the a-adrenergic agonist 
clonidine has been demonstrated to induce feeding in a variety 
of animals, as has intercerebroventricular, anterolateral 
hypothalamic, or PVN injection (see McCabe et al. 1984). 
Feeding induced by peripherally administered clonidine can be 
blocked by peripheral administration of the a-2 selective 
antagonist yohimbine but not the a-1 selective antagonist 
prazosin (Schlemmer et al. 1981). This indicated that 
clonidine exerted its effects through an a-2 receptor 
mechanism. An examination of the effects of microinjecting 
selective a-1 and a-2 blockers into the PVN was performed
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(Marino et al. 1983). These experiments demonstrated that 
" the general a-adrenergic antagonist phentolamine was found 
to essentially abolish (-82%) the NA eating response, 
Clonidine Induced feeding was also significantly attenuated 
by phentolamine. Tests with the specific a-1 antagonists, 
corynanthlne and prazosin, failed to reveal any blocker
Induced attenuation of NA and clonidine feeding In
contrast the a-2 antagonists yohimbine and rauwol seine 
significantly attenuated, by 50-75%, both NA and clonidine 
Induced feeding" [p. 467]. A separate experiment in the same 
report showed that PVN injection of the a-2 antagonist 
yohimbine significantly suppressed the effects of systemically 
administered clonidine by 40-80%.
Leibowitz and her colleagues hypothesised that the feeding 
elicited by PVN microinjection of NA or clonidine was mediated 
via the a-2 receptor and attempted to define whether or not 
this receptor was pre- or post-synaptic. High levels of a- 
receptors had already been demonstrated within the PVN 
(Leibowitz et al. 1982) but their precise location was not 
defined. The a-2 receptor had recently been demonstrated to 
occur post-synaptically as well as pre-synaptically (Paciorek 
et al. 1984, Unnerstall et al. 1984, Pimoule at al. 1985). 
It is possible that they may even predominate in the 
post-synaptic location (Starke 1981a, 1981b, Cerrito and
Preziosi 1985, Gothert 1985). Also the actions of clonidine
35
were believed to be post -synaptic as well as pre-synaptic 
(Spyraki and Fibiger 1982). Thus as clonidine displays a 
selectivity for the a-2 receptor Leibowitz and her colleagues 
suggested that NA injected into the PVN was acting through a 
post-synaptic a-2 receptor to stimulate feeding behaviour. 
The following evidence in support of this hypothesis is cited 
in Leibowitz et al. (1982): (i) eating induced by PVN NA is
antagonised by a-2 adrenergic, in contrast to a-1 adrenergic, 
receptor blockers (Marino et al. 1983). (ii) Eating elicited 
by peripheral doses of clonidine occurs at doses below 
lOOug/kg that are believed to act upon a-2 rather than a-1 
receptors, (iii) Eating produced by peripheral clonidine can 
be blocked by PVN injection of the a-2 antagonist yohimbine 
(Marino et al. 1983) but remains unaffected by PVN 
injection of the selective catecholamine neurotoxin 6-OHDA 
(Leibowitz, Shor-Posner and Azar, unpublished, cited in Marino 
et al. 1983 p.467). Eating induced by ventricular NA 
injection is essentially abolished by electrolytic PVN lesions 
(Leibowitz et al. 1983). (iv) Eating induced by PVN injection 
of NA occurs independently of presynaptic stores of endogenous 
NA (Leibowitz and Brown 1980a). That is, disruption of NA 
afferents to PVN or local administration of a- 
methyl-p-tyrosine significantly enhances NA induced eating (a 
post-synaptic response) while attenuating the eating response 
to PVN injection of antidepressant drugs (a pre-synaptic 
response). (v) In contrast to clonidine"s hypothesised
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pre-synaptic pattern of action associated with a decrease of 
NA turnover (Langer 1977), clonidine's effects in the PVN 
include a reduction of NA levels and an apparently stable NA 
turnover (Jhanwar-Uniyal et al. 1983).
The hypothesis presented, that NA induced feeding in the PVN 
was mediated via a post-synaptic a-2 receptor was further 
tested using a range of a-adrenergic antagonists (Goldman et 
al. 1985). Again the conclusion was made that the feeding 
elicited by NA or clonidine injected into PVN was the result 
of these compounds acting at a post-synaptic a-2 adrenergic 
receptor. Leibowitz and her colleagues have performed many 
further experiments to determine the role of the PVN in the 
regulation of feeding behaviour which will be reviewed briefly 
below, but it is the conclusion that this feeding results from 
an action at post-synaptic a-2 receptors that is of major 
importance to this thesis.
The feeding that can be elicited by microinjection of NA into 
the PVN can be suppressed by compounds other than a-adrenergic 
antagonists. The peptidergic transmitter neurotensin has been 
demonstrated to have a suppressant effect on NA elicited 
feeding in PVN (Stanley et al 1985a). Similarly, compounds 
other than NA can elicit feeding when microinjected to this 
site. The most potent feeding response so far tested is 
produced by microinjection of neuropeptide Y (Stanley et al.
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1985b). Interestingly this peptide has been demonstrated to 
co-exist with NA in certain ascending fibres (Lundberg et al 
1984). The demonstrations that such a variety of compounds 
can influence feeding when microinjected into PVN serve to 
demonstrate the complexity of such a fundamental response as 
food intake.
Leibowitz and her co-workers have recently attempted a more 
complete analysis of the feeding behaviour seen as a result 
of NA injected into the PVN and attempted to describe the role 
that the intact structure plays in normal feeding. , After PVN 
NA injection rats demonstrate a clear preference for high 
carbohydrate diets, (Leibowitz et al. 1985). This effect is 
robust and occurs with both chronic and acute NA infusion. 
Similarly, 6-OHDA infusion into PVN results in an initial 
increase (24hrs) in food intake, particularly carbohydrate, 
followed by a long term deficit in carbohydrate intake (-42%). 
Although these rats maintained a normal diurnal feeding 
pattern they failed to exhibit the increased ingestion of an 
energy rich carbohydrate diet which rats normally show during 
the dark cycle (Shor-Posner et al. 1986). Indeed, rats with 
6-OHDA lesions of PVN displayed a syndrome of deficits 
concerned with the compensatory eating of energy rich foods 
after periods of deprivation or rapid energy expenditure, 
suggesting that the PVN a-2 noradrenergic system might be 
involved in such compensatory mechanisms. The feeding to
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microinjected NA was found to be dependent upon the integrity 
of the adrenal system, and further study demonstrated that 
it was the presence of corticosterone that was a
requirement in producing this effect (Roland et al. 1986).
Corticosterone levels have been demonstrated to show a 
circadian rhythm which closely resembles the periodicity of 
natural feeding in the rat, being at a peak just after the 
onset of the dark cycle. Radioligand binding studies by 
Jhanwar-Uniyal et al. (1986) demonstrated a similar pattern 
of periodicity in the number of a-2 binding sites in rat PVN. 
A monophasic peak of PVN NA receptor binding is detected at 
the onset of the dark cycle, when corticosterone levels are 
highest and feeding is initiated. Leibowitz suggests that 
there may be an interaction between circulating corticosterone 
levels and a-2 noradrenergic receptor binding in the PVN and 
that this may be of importance in the initiation of natural 
feeding behaviour.
The work of Leibowitz and her colleagues forms an impressive
and powerful argument indicating the involvement of the PVN
in the control of feeding in the rat. Pharmacological, 
biochemical and behavioural data have been combined to present 
a strong case in support of this theory. It is not my
intention to dispute the conclusions drawn by Leibowitz from 
her programme of experiments, but rather to offer an 
alternative interpretation of some of this data and, more
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importantly, to show how the pharmacological and behavioural 
manipulations she has used in this paradigm may be applied 
to provide an explanation of how NA is transmitted within 
this nucleus and possibly the brain as a whole.
THE PVN AS A FEEDING REGULATORY CENTRE
The evidence that the PVN can influence feeding behaviour is 
very strong, although it must be remembered that feeding is 
not a simple reflexive type of behaviour: many physiological 
measures, such as blood glucose levels, insulin levels, 
glycogen stores, fat stores and energy requirements must be 
calculated. However, any purely physiology driven model of 
feeding is obviously inadequate. A multitude of other 
variables must be considered: the location and availability 
of food, palatability, other ongoing activity, and the motor 
control of feeding related behaviour. Even such factors as 
habit and 'what the rat next door is doing' may influence 
feeding in the laboratory rat. Yet it is clear that injection 
of NA into PVN results in feeding behaviour in a satiated 
animal. Thus the questions to be addressed regarding the PVN 
and feeding regulation are threefold: (i) why the PVN, what 
aspects of PVN anatomy and chemistry make it suitable for such 
a complex regulatory function ; (ii) how does the PVN exert 
influence over such physiological mechanisms j and (iii) do 
the results of laboratory manipulation of PVN by
microinjection and other techniques indicate the role of this
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nucleus under normal conditions ?
To answer the first question, it is necessary to reconsider 
the anatomy of the hypothalamus in general terms. It 
is also necessary not only to study the mechanisms of visceral 
or sensorimotor control systems but also their 
integration and consider what is meant by a regulatory system. 
Behavioural responses are initiated by both internal and 
external signals and the problem faced by the scientist was 
summed up by C. J. Herrick who observed " The living body. . .its 
continual welfare is conditioned upon a nicely balanced 
adjustment between Its own activities and those of surrounding 
nature, some of which are beneficial and some harmful. The 
great problem of neurology Is the determination of the exact 
part which the nervous system plays In this adjustment" 
(Herrick 1918 p. 13). The hypothalamus as a whole has long been 
regarded as playing a particularly important integrative role 
in the expression of adaptive behaviour related to homeostasis 
(Hess 1947; Ranson and Magoun 1939). Homeostasis, the 
maintenance of a constant internal environment, is of 
fundamental importance in the survival of an organism. Two 
points are of particular relevance here; first the 
hypothalamus is the most rostral part of the CNS in which 
lesions can abolish the performance of integrated adaptive 
responses; second, all levels of the CNS contribute to the 
expression of adaptive behaviour. The goal of the
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neuroscientist working in this area is expressed by Swanson 
as being " to clarify the precise role of specific parts of the 
hypothalamus In different types of response, and to determine 
how these [centres] are related to the rest of the CNS, In 
essence,,.,to establish the neural basis for Hess's 
observation that electrical stimulation of the hypothalamus 
can lead to Integrated, goal-oriented behavioural responses" 
(Swanson and Mogenson 1981 p.2). Whilst raicroinjection 
of NA into the PVN may not be stimulatory in Hess's terms 
it still results in the generation of goal-oriented 
behavioural responses, namely feeding and furthermore this 
occurs in a satiated and thus, prior to injection,
'unmotivated' anima1.
It is apparent that any regulatory mechanism must have two 
features; first it must be supplied with the relevant afferent 
information concerning the existing state of the organism and 
second it must have efferent connections such that it can 
effect changes to this state. The hypothalamus is perfectly 
equipped for this role. Certain discrete hypothalamic nuclei 
are completely without a blood-brain barrier giving these 
areas access to circulating blood glucose, osmolarity, and 
insulin and other hormones. Such areas include the 
sub-fornical organ, the median eminence and the nucleus 
circularis, and each may be involved in a different aspect of 
physiological homeostasis. Other hypothalamic nuclei are
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involved in cyclic regulation, the supra-chiasmatic nucleus 
in long term cycles and the medial pre-optic area in short 
term circadian rhythms, The hypothalamus is located above the 
neurohypophysis to the pituitary and controls the release of 
many hormones and releasing factors; an important component 
of hypothalamic efferent activity. The PVN has a central 
location within the hypothalamus, and the afferent projections 
to this nucleus suggest that it may receive information as to 
the state of the periphery from the vagus and NST. Similarly 
the efferent connections of PVN indicate a possible role in 
the regulation of autonomic activity and hormonal balance. 
Whilst it is not possible to state for certain the function 
of a brain area based on a knowledge of its anatomy and 
connections, such information is a powerful indicator. 
Certainly the anatomy of the PVN is consistent with this 
region having a major role in energy balance and homeostasis. 
Thus the PVN fulfils the "why this area" question.
The second question about the involvement of the PVN in the 
control of feeding was, how does it exert its influence? 
Again the anatomy of this region provides the major clue. The 
major PVN efferents are; (i) to brainstem nuclei and spinal 
cord and (ii) to the neurohypophysis and pituitary. It has 
therefore, two means of influencing the state of the 
periphery, via direct neuronal influence on the autonomic 
nervous system and by the manipulation of circulating hormone
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levels. The empirically derived information that lesions of 
the PVN, or microinjection of NA, affect food intake is not 
sufficient to prove that feeding regulation is the function 
of PVN under normal conditions, although it may be taken as 
an indication of such. The anatomy indicates how the PVN 
might exert control over feeding behaviour by altering the 
state of physiological components in the periphery but there 
is a second possible mechanism. The microinjection of NA into 
the PVN might give rise to the brain state 'hunger' which 
itself triggers feeding behaviour without there being a 
physiological requirement. Indeed, the feeding behaviour 
elicited by NA is prominent in satiated animals which by 
definition have no physiological need. However, the fact that 
there is a preference for certain macronutrients, particularly 
carbohydrate indicates that the animal feels some sort of 
physiological need. In contrast, the fact that the rat is 
satiated prior to the test (during which the characteristics 
of the diet do not change) should by definition exclude the 
possiblity that feeding is triggered by a 'physiological' 
deficit in some macronutrient; maybe NA induced feeding is 
the result of a particular brain state in the animal. There 
still remain certain physiological requirements however, such 
as the presence of adrenocorticosteroids for feeding to NA to 
be expressed. To attempt to explain feeding caused by PVN 
manipulation in terms of either brain state or physiology 
contradicts the function of the hypothalamus. The
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hypothalamus is a complex integrator receiving and integrating 
information of both cognitive and physiological import. 
It is composed of nuclei themselves serving an integratory 
function. Some of these have predominantly efferent 
influences whilst others have afferent but all are 
predominantly concerned with the integration of multiple 
inputs which bear on the maintenance of homeostasis.
%
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Earlier the concept of why the PVN should affect feeding 
behaviour was examined with respect to the anatomy of this 
nucleus. This has suggested why the PVN might be involved in 
the regulation of food intake as a result of it's anatomical 
organisation but the experiments of Sarah Leibowitz beg a 
different answer to the question "why the PVN?". This is 
"why?" in terms of; what physiological or 'mental' processes 
does the PVN modulate such that manipulations of this nucleus 
result in changes in feeding behaviour ?
It is clear that Leibowitz herself conceives the PVN as being 
an important component in the normal, day-to-day control of 
food intake in the rat. The integration of high a-2 binding 
capacity, a peak in the diurnal pattern of corticosterone 
levels and concurrent NA release is seen as the 'normal ' 
signal that in a rat initiates food intake at the beginning 
of the dark cycle. Furthermore, as this signal is also
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associated with a preference for carbohydrate intake, dietary 
selection of this macronutrient is also at a peak at this 
time. As the dark cycle progresses, a-2 binding capacity and 
levels of corticosterone begin to fall and the rat reduces 
meal size and preference for carbohydrate. The demonstration 
by Smyth et al. (1984) of a positive correlation between 
hypothalamic NA levels and blood glucose levels can be seen 
as direct support for this argument at the biochemical/ 
physiological level. If this is indeed the case then the 
state into which the injection of NA puts the animal must be 
'hunger', because such an injection would create a state 
within the brain indiscriminable from that experienced under 
'normal' conditions of hunger. However, this does not appear 
to be the case as rats after intra-PVN injections of NA 
display certain differences from normal, food deprived 
controls. If rats which have been injected with NA into the 
PVN are prevented from gaining access to food for 1 hour, the 
subsequent feeding is suppressed compared to animals with 
immediate access to food following an identical injection 
(Swiergel and Peters 1987). Similarly, rats are less willing 
to work for food on an operant schedule following PVN NA than 
mildly food deprived animals (Matthews et al. 1985) and are 
more sensitive, or 'finicky', to the palatability of the diet 
than controls (Sclafani and Toris 1981). Furthermore, 
Swiergel and Peters (1987) have demonstrated that following 
PVN NA injections rats will gnaw at wood chips, but only if
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these are presented in the animals' normal food hoppers and 
shaped like food pellets. Food deprived animals did not gnaw 
these chips, neither did sham injected animals. It seems most 
probable that the injection of NA into PVN is in some way 
acting on processes which are indirectly involved in normal 
regulatory feeding, but it is clearly not the 'whole story' 
of normal food intake.
If the PVN is a brain area concerned with the regulation of 
feeding and energy balance it is interesting to ask how and 
on which processes it exerts it's influence. If it is not as 
Leibowitz suggests responsible for the brain state 'hunger' 
then feeding must be brought about by some PVN regulated 
process, acting on the physiology of the rat, which results 
in it 'believing' itself to be, however temporarily, in need 
of food. In these circumstances the term 'hungry' is used to 
represent a state in which the ingestion of food is currently 
top in a hierarchy of freely selectable behaviours. There are 
two possible mechanisms whereby the physiology of the rat 
might be affected by manipulations of the PVN. First, the PVN 
is involved in components, particularly endocrine, of the 
response to stress. It is widely held that stress and feeding 
are in some way linked (Robbins and Fray 1980) and thus the 
PVN might exert an influence over food intake through an 
indirect 'stress induced eating' mechanism. Second, the PVN 
by its spinal connections is only one or two synapses from the
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liver where it may influence the control of glycogen stores 
and manipulation of these reserves could rapidly alter blood 
glucose levels and thus indirectly affect food intake. These 
two hypotheses must be examined in detail in order to assess 
their impact on the role of the PVN in the regulation of food 
intake.
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PVN CONTROL OF LIVER FUNCTION
As has been suggested previously in this introduction, the 
hypothalamus is the CNS region most involved in the regulation 
of the sympathetic and parasympathetic nerves. In addition 
to the control of endocrine status, the hypothalamus acts via 
these nerves to control the response to physiological 
emergency requirements, and to maintain homeostasis. If the 
hypothalamus is the CNS homeostasis regulator, the liver amy 
be the peripheral effector mechanism through which it might 
exert its control. In the maintenance of glucose homeostasis, 
for example, the liver plays a significant role. It acts as 
a major temporary store capable of removing large quantities 
of glucose from the circulation in times of excess and 
releasing it in times of need. This glucose is stored in the | 
parenchymal hepatocytes in the form of glycogen. The 
conversion of glucose to glycogen is controlled by the enzyme 
glycogen synthetase, whilst that of glycogen to glucose is 
controlled by glycogen phosphorylase. These are not the only 
two enzymes involved in the conversion but represent the rate 
limiting steps in the process (Shimazu and Fukuda 1965). Thus 
whilst the optimal level of blood glucose may be 'determined' 
or 'defined' by hypothalamic mechanisms, it is the liver which 
physiologically regulates actual plasma glucose concentration.
The nerves innervating the liver fall into three main 
categories, sympathetic, parasympathetic and afferent
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components (for full review see Sawchenko and Friedman 1979). 
The sympathetic fibres to the liver are derived from the 
splanchnic nerves; the pre-ganglionic fibres reaching the 
celiac ganglia through the greater and lesser splanchnic 
nerves. The post-ganglionic fibres originate in the celiac 
ganglia and form the celiac plexus. The pre-ganglionic fibres 
of the parasympathetic system also reach the celiac plexus, 
via the anterior and posterior vagus. Extending from the 
celiac plexus into the hepatic portal region is the hepatic 
plexus containing post-ganglionic sympathetic and 
pre-ganglionic parasympathetic fibres. The post-ganglionic 
parasympathetic fibres arise in the ganglion cells located 
closer to the liver in the hepatic hillus (Shimazu 1983). 
There is good evidence that individual hepatic parenchymal 
cells receive innervation from both sympathetic and 
parasympathetic branches of the peripheral nervous system, 
although the density of this innervation is species dependent. 
In the rat the number of synapse-like contacts is low but 
there are many gap junctions between neighbouring hepatocytes 
and synaptic innervation may be widely propagated (Hartmann 
et al. 1982). Afferent innervation of the liver may be 
important in terms of its osmoreceptive, chemoreceptive and 
baroreceptive functions (Sawchenko and Swanson 1979). Whilst 
the afferent pathways are poorly defined there seems little 
doubt that the liver is supplied with information from a 
variety of peripheral receptor mechanisms. This afferent
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information courses along fibres forming a proportion of the 
splanchnic and vagus nerves, Because of the intimate
involvement of the liver in the metabolism of ingested 
nutrients, signals from hepatic chemoreceptors are presumed 
to inform the CNS about the caloric content of ingested food, 
probably through afferent fibres of the vagus (Mei 1978). 
This information is presumed to reach the hypothalamus 
(Schmitt 1976, Jeanningros and Mei 1980) which is thus 
constantly informed about glucose status and hepatic 
carbohydrate metabolism.
Since the first investigations of Bernard (see above p.l) it 
has been assumed that it is the sympathetic nervous system 
that is responsible for initiating hyperglycemia by promoting 
the mobilisation of liver glycogen, and that this depends 
almost entirely on neuroendocrine mechanisms, with mediation 
of adrenaline released from the adrenals and glucagon from the 
pancreas (Frohman 1971). However, evidence that hepatic 
glycogenolysis is under direct control of the sympathetic, 
hepatic innervation was demonstrated by Shimazu and Fukuda 
(1965). They demonstrated significant increases in the 
activity of the enzymes responsible for glycogen breakdown 
(glycogen phosphorylase and glucose-6-phosphatase) with a 
concomitant decrease in liver glycogen content, following 
electrical stimulation of the peripheral end of the splanchnic 
nerve. Since these effects persisted after removal of both
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adrenals and pancreas, which also receive sympathetic
innervation, they concluded that the release of either 
adrenaline or glucagon was not necessary for the rapid 
increase in hepatic glycogenolysis in response to splanchnic 
nerve stimulation. Thus, these effects were directly 
dependent upon sympathetic nerve stimulation. Subsequent 
research has shown that a 300% increase in glycogen
phosphorylase activity can occur within 30 seconds of 
splanchnic nerve stimulation, and that this increase can be 
counteracted by concurrent vagal stimulation (Shimazu and 
Amakawa 1968). These data clearly suggest a mechanism by 
which the CNS might mediate glucose output from the liver via 
direct neuronal intervention.
In an extensive review of the reciprocal innervation of the 
liver Shimazu (1983) draws attention to the need for detail 
in assessing the significance of the intrinsic innervation of 
this organ. It is therefore unfortunate that in his 
exploration of the effects of hypothalamic stimulation on 
liver function his analysis of the hypothalamus is relatively
crude. Shimazu divides the hypothalamus into a medial
'satiety' region (VMH) and a lateral 'feeding' region (LH). 
However, stimulation of the VMH as a whole may involve 
stimulation of PVN and associated fibre systems as well as 
VMN, and the results of such stimulation are very similar to 
the results obtained from splanchnic nerve stimulation.
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Electrical stimulation of the VMH causes a rapid rise in 
circulating glucose and a marked decrease in liver glycogen 
as a result of increased glycogenolysis; this result has been 
consistently confirmed (Frohman and Bernardis 1971, Gisel and 
Innes 1979, Shimazu 1983). In order to identify exactly which 
hypothalamic site is involved in this sympathetic outflow a 
more anatomically detailed study is required. It is of 
interest to note that Weingarten et al. (1985) have conducted 
a study contrasting the metabolic effects of discrete 
electrolytic lesions of VMH and PVN. The rats from both 
lesion groups became obese when fed 'ad lib' but the VMH 
lesioned animals were hyperinsulinaemic and showed increased 
levels of gastric acid secretion whereas the PVN lesioned 
animals did not show any detectable metabolic disturbances. 
When maintained on a restricted diet, only the VMH lesioned 
animals became obese, revealing a fundamental difference in 
aetiology between the two obesity syndromes.
The information presented thus far in this introduction forms 
the basis of a possible, if speculative, hypothesis concerning 
the role of the PVN in the regulation of food intake. This 
hypothesis is as follows: stimulation of the PVN by NA 
causes depletion of liver glycogen as a result of increased 
sympathetic outflow. This depletion of its reserves causes 
the liver to generate a signal indicating rapid metabolic 
loss, which in turn acts to promote feeding. The assumption
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is made that the signal arising from the liver is of 
sufficient intensity to predominate over other afferent 
information indicating high levels of plasma glucose (see 
below) . There is an apparent paradox, in that electrical
stimulation of the VMH suppresses food intake, whereas NA
injection promotes feeding, and both mechanisms apparently 
involve increasing the rate of glycogen -> glucose conversion 
in the liver. However electrical stimulation of brain causes 
complex changes in behaviour in addition to such measurable
changes in the physiology of an animal. Eliot Valenstein
(1973), using the elicitation of feeding from LH stimulation 
as his paradigm, pointed out four aspects of electrical 
stimulation of the hypothalamus which diminish its impact as 
a measure: (i) In the rat there appeared to be a lack of
anatomical specificity; (ii) the responses often lacked 
specificity at the behavioural level; it was possible to 
elicit different behaviours from the same stimulus parameters 
and site, depending upon the presence or absence of goal 
objects. Such 'mixed' responses are very prevalent following 
hypothalamic stimulation;
(iii) the responses strengthened with repetition, indicating 
the possibility of a learning effect; and (iv) the elicited 
reponses were frequently abnormal in nature. Animals often 
ignored preferred foods in favour of those that had been 
presented in previous periods of stimulation.
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Robbins (1986) states "these observations do not encourage the 
notion of fixed circuitry in the hypothalamus responsible for 
particular forms of consummatory response which, when 
activated immediately turn on the appropriate response" 
(p.276). The complexities of interpretation of the results 
of electrical stimulation of the brain are such that the fact 
that VMH stimulation disrupts feeding behaviour is not a 
strong argument against the proposed hypothesis.
However, a second paradox also needs explanation: stimulation 
of the rate of glycogen -> glucose conversion would result in 
an increase in blood glucose level, normally seen as a satiety 
signal. It is necessary to examine the possible signals to 
feed reaching the hypothalamus; (i) the signals produced by 
food deprivation, might be expected to increase in intensity 
over a relatively long time course and need to be at a 
relatively high and sustained level to influence the CNS to 
initiate feeding behaviour; (ii) the signal produced by sudden 
depletion of liver glycogen might be both rapid in onset and 
intense, having a powerful and immediate effect. The signal 
from the liver may be sufficiently potent to overrule the 
signal from blood glucose monitors. This explains why 
preventing a satiated rat from feeding for 6 hours following 
VMH NA injection suppresses the expected feeding response 
(Coons and Quatermain 1970). The glucose liberated from the 
liver would, over this ensuing period, be converted back to
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glycogen inhibiting the signal from the liver. Evidence that 
signals from the liver can be the most potent in the 
determination of feeding behaviour is provided by the work of 
Friedman, Strieker and their colleagues. They demonstrated 
that 'hunger' can be controlled by metabolic products 
available to liver and not brain. They made rats 
hypoglycaemic by injection of insulin and then administered 
injections of several different nutrients. Injections of the 
sugars glucose, fructose and mannose all inhibited feeding. 
However, fructose cannot cross the blood-brain barrier and 
would thus occur in only very low concentrations in the CNS. 
In contrast, injections of a ketone which can be metabolised 
in brain but not in the liver failed to inhibit feeding 
(Friedman et al 1976, Strieker et al 1977).
The hypothesis that the injection of NA into PVN results in 
feeding because of glycogen -> glucose conversion in the liver 
has the power to incorporate and explain much of the available 
data.
(i) The behavioural specificity of the feeding response is 
explained; glycogen depletion from the liver requires energy 
intake to make up the deficit.
(ii) Following infusion of NA into the PVN rats preferentially 
select high carbohydrate diets, which would serve to replace 
glucose most rapidly.
(iii) Electrolytic lesions of PVN promote obesity in the
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absence of hyperinsulinaemia; one consequence of the 
impairment of control over liver glycogen might be the 
deposition of excess fat. Also the loss of an effective 
'glucose buffering system' might result in more frequent 
feeding bouts.
(iv) The latency to eat following intra-PVN infusion of NA 
(2-10 mins. ) is consistent with the time necessary to deplete 
liver glycogen; a 300% increase in glycogen phosphorylase 
activity can be achieved within 30 seconds following 
splanchnic nerve stimulation (Shimazu and Amakawa 1975).
(v) The imposition of a delay between infusion of NA and 
feeding, such as an operant task, reduces the amount of food 
consumed presumably as a result of re-conversion of glucose 
to glycogen (Booth et al 1986).
This hypothesis accounts for much of the apparently 
contradictory data surrounding feeding behaviour and 
manipulations of the medial hypothalamus, particularly the 
PVN. However, neither this hypothesis, nor the involvement 
of the PVN in stress related responses makes clear exactly 
what role this nucleus plays in the regulation of day to day 
feeding behaviour. What is apparent is the complexity and 
variety of signals that can result in feeding behaviour. Far 
from being the simple, ubiquitous behaviour originally 
supposed feeding is a complex, integrated behaviour becoming 
daily more explicable but still not understood.
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STRESS INDUCED EATING.
Eating can be influenced by a diversity of stimuli, not all 
of which are involved in the physiological regulation of 
energy balance. Certainly the internal signals arising from 
nutrient or caloric imbalances play a vital role, but even 
brief introspection reveals the involvement of myriad other 
factors. The taste, smell or appearance of food all influence 
ingestive behaviour and it is widely believed that 'stress', 
often in the form of emotional upset or boredom can also 
affect food intake. There is a popular concept of 
stress-induced eating whereby environmental and emotional 
stimuli, apparently unrelated to food, result in a syndrome 
of hyperphagia and obesity. Those stimuli that elicit eating 
and cannot be described as resulting from either 
food-deprivation induced physiological factors (stomach 
contraction or low blood glucose) for instance, or 
food-related stimuli (smell, palatability), have been 
referred to as 'nonspecific' stimuli by Pass et al. (1981). 
The factors responsible for 'stress-induced' eating are thus 
categorised as nonspecific, but some definition of 'stress' 
is also required. Definition of such a vague concept is hard 
but Valenstein (1976 p.113) suggests; "a state when the 
' adaptive' mechanisms (of an organism) are taxed beyond their 
normal range of functioning either because of the intensity 
or duration of the response required". There are a great many
58
nonspecific stimuli reported to result in stress-induced 
eating. Noises, lights, handling, •social influences and 
isolation are amongst those stimuli reported to result in 
stress induced eating in rats (for a full review see Robbins 
and Fray 1980). Other manipulations that are sometimes 
referred to as producing stress-induced eating, such as 
electrical stimulation of the brain (ESB), or pharmacological 
manipulation of transmitter systems can not be clearly 
categorised as nonspecific as their mode of action might be 
such as to result in a signal of food deprivation. The use 
of a term such as stress is in itself confusing, because this 
term has subtly different implications depending upon the 
context of its use, (for a discussion of what constitutes 
stress see Antelman and Chiodo 1983). One of the most 
intriguing of the nonspecific stimuli to elicit eating in rats 
is tail pinch (TP). First reported by Antleman and Szechtman 
in 1975, tail pinch has been widely used as a model
nonspecific stimulus. Tail pinch, a sustained, mild pinch to 
the tail resulted in eating, gnawing and licking in virtually
every rat tested (Antelman and Szechtman 1975). The pressure
used was such that the animals ate vigorously without
vocalising or showing other signs of distress. Initially the 
rats reared and began sniffing and exploring, orientation to 
the tail and grooming often occurred. However after several 
trials the eating became 'stimulus-bound' to the onset and 
offset of the pinch and the other competing responses were
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FIGURE 17.
A. Selective blockade of eating elicited by 40nmoles NA by prazosin 
and idazoxan. Prazosin (0.2nmoles) did not affect NA elicited 
eating but 40nmoles idazoxan significantly attenuated eating to 
NA. When 40nmoles cocaine was added to NA eating was unaffected, 
but 4 0nmoles idazoxan was completely ineffective in antagonisisng 
NA/cocaine eating. ( tsig. diff. to 40nmoles NA [hatched bar] 
p<0.05 at least.)
B. Comparative blockade of eating elicited by SOnmoles NA and 
SOnmoles NA/ 40nmoles cocaine. Blockade to 30nmoles idazoxan was 
attenuated when cocaine was added to NA. Blockade to 30nmoles 
phentolamine was unaffected by the addition of cocaine to NA. ( 
:sig. diff. to 30nmoles NA [hatched bar] p<0.05 at least.)
disproved :
(i) Ecole's proposal of Dale's principle, in brief that each neuron 
contains only one transmitter substance*^. Co-localisation studies 
using double labelling with specific antibodies categorically 
demonstrate the co-existence of different transmitter substances 
within neurons (Hokfelt et al. 1980).
ii) Ecoles principle, that a transmitter substance opens just one 
type of ionic gate, that being either excitatory or inhibitory, on 
the post-synaptic membrane. Considerable information is now 
available to demonstrate that the effects of a neurotransmitter on 
the post-synaptic cell depend upon the nature of that cell, the 
type of receptor, the presence of other inputs, and a great many 
other variables.
However, the assumption that within the CNS neurone-neurone 
chemical transmission occurs only through discrete synaptic 
contacts is still widespread. This 'classical' model of 
transmission has recently been challenged by an alternative 
hypothesis of 'paracrine' or non-synaptic transmission. This 
hypothesis suggests that transmitters may be released not into 
morphologically defined synaptic clefts but into the extra-cellular 
space. They then diffuse to their site of action, specificity 
being retained by the presence or absence of appropriate receptors 
rather than by anatomical constraints.
* Unfortunately an inaccurate reproduction of Dale's work - for full discussion see: Multiple Transmitter Status and "Dale'sPrinciple". Potter D. Furshpan E. and Landis S. (1981) Neuroscience commentaries 1, 1: 1-9.
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replaced by eating (Antelman and Szechtman 1975, Antelman et 
al 1975). Under TP rats demonstrate preferences for.certain 
foods, they will not drink plain water but will consume food 
pellets, milk and saccharin water. This apparent finickiness 
was suggested by Antelman et al. (1976 p.746) to result from 
"lowered sensory motor thresholds and responsivity to... 
environment". In contrast Marques et al. (1979) suggested that 
the finickiness resulted from a TP induced change in the 
valence of taste cues but there is little evidence that TP 
increases the aversive properties of unpalatable foods.
There is clearly an appetitive component to tail pinch as 
preloading the stomach with milk has been demonstrated to 
reduce TP induced milk drinking when saline preloading did not 
(Antelman et al. 1976). However, ingestion under TP was in 
addition to normal dietary requirements as repeated tail pinch 
(10 mins. every 4 hours for 5 days) resulted in hyperphagia 
and obesity (Rowland and Antelman 1976). Eating to TP could 
be increased by administration of the minor tranquilliser 
chlordiazepoxide (librium) in doses which had no effect on 
eating in control trials without TP (Robbins et al. 1977). 
It has been suggested that TP induced feeding may be a 
combination of two components, an aversive component and an 
arousing, appetitive component. The aversive component is 
masked or reduced by low doses of librium allowing the 
unmasking of the consummatory component (Robbins and Fray
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1980). The consummatory component of TP is dependent upon the 
salience of external stimuli, thus not only feeding but 
maternal behaviour, digging, sniffing, licking, and gnawing 
behaviours have been elicited under TP (Antelman and Caggiula 
1977, Szechtman et al. 1977). The consummatory responses 
performed under TP have been demonstrated to have genuine 
motivational effect, as rats under TP will learn a T-maze for 
the opportunity to gnaw on wood or food pellets (Koob et al. 
1976, Fray et al. 1978).
The early studies of Antelman and his colleagues on TP 
suggested that the arousal and motivational component of any 
TP induced behaviour was dependent upon the ascending DA 
fibres of the nigro-striatal bundle. Intra-peritoneal (i.p.) 
injection of the DA receptor blocking agents spiroperidol and 
pimozide significantly reduced TP-induced behaviour as did 
6-OHDA lesion of the nigrostriatal bundle (Antelman and 
Szechtman 1975, Antelman et al. 1975, 1976). However, these 
lesions which resulted in a 90% depletion of DA in the caudate 
blocked TP on only 44% of trials and even if haloperidol was 
administered post-lesion, TP induced feeding was blocked in 
only 5 out of 8 animals. Furthermore the lesions were 
produced by intra-cerebroventricular injection of the toxin, 
allowing the possibility of widespread depletion not only of 
DA neurones but also of NA and adrenaline containing neurones. 
Antelman also reported that even at high doses alpha-
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(phentolamine) and beta- (sotalol) adrenergic receptor 
antagonists failed to antagonise TP elicited eating. However 
Sahakian et al, (1981) selectively lesioned the DNAB with 
6-OHDA, lesions which produced almost total hippocampal and 
cortical NA depletion, and demonstrated an impairment in 
response to TP. Eating occurred in only 7 out of 20 animals 
with DNAB lesions, and the latency of these animals to eat was 
significantly lengthened. It is possible that some of the 
effect of TP is mediated through noradrenergic facilitation 
of the nigrostriatal DA system and NA and DA interact to 
produce the overall effect. That there is some interaction 
is demonstrated by the finding that DNAB lesions reduce DA 
turnover in the striatum (Robbins and Everitt 1982). The 
dorsal bundle projection provides comparatively little of the 
NA projection to the hypothalamus (see p.12 above) and thus 
it is unlikely that TP exerts its effects directly through 
effects on the hypothalamic NA projection from the DNAB 
particularly in the absence of TP blockade to i.p. injection 
of NA antagonists.
The role of the VNAB in TP behaviour was investigated by 
Sahakian et al. (1983). Lesions of the VNAB enhanced the 
acquisition of TP induced eating but had no effect on the 
behaviour once acquired. Food deprivation alters NA turnover 
in the medial hypothalamus as well as DA activity in the 
mesolimbic system. The majority of medial hypothalamic NA is
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provided by the VNAB. Increase in plasma glucose is 
positively correlated with NA concentration in the medial 
hypothalamus (Smythe et al. 1984) from whence Leibowitz 
(1975,1978a,b) has demonstrated feeding in response to direct 
microinjection of NA. Leibowitz has also demonstrated the 
involvement of circulating corticosteroids in the feeding 
response to NA injection, and that hypophesectomy or 
adrenalectomy blocks the NA elicited feeding response (Roland 
et al. 1986). This evidence clearly demonstrates that 
manipulations of medial hypothalamic NA affect feeding 
behaviour; TP is known to affect DNAB and VNAB activity, and 
these pathways provide innervation to the PVN.
Whilst the fact that TP has wide ranging effects on ascending 
catecholamine transmission might give some clues as to how and 
where the effects of TP are manifest, other clues might come 
from analysis of the type of stimulus TP provides. The term 
'stress-induced eating' has been mentioned above without 
explanation of the physiological effects of stress. Some 
examination of these effects provides further evidence that 
the medial hypothalamus, particularly the PVN might be 
involved in TP induced eating.
Physiological response to stress.
Many responses to stress are, in the first instance, endocrine 
in nature and it is these responses and their consequent
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physiological changes that are of interest. Whilst exposure 
to long term, or very high levels of stress can undoubtedly 
produce complex behavioural and physiological changes 
(Antelman and Chiodo 1983) it is the short term endocrine 
responses that are of interest here. These changes occur 
along two axes;
i). The sympathetic-adrenal medullary system.
Exposure to stress involves activation of CNS systems. One 
of the limbic components involved in response to this exposure 
is the hypothalamus, which generates responses along two 
neuronal outflows to the periphery. The first of these 
influences the sympathetic branch of the autonomic nervous 
system, which innervates the viscera and contains the 
transmitter NA. The second outflow projects as the splanchnic 
nerve and innervates the chromaffin cells of the adrenal 
medulla. When stimulated these cells release mainly 
adrenaline, but also some NA. This release of catecholamines 
predominantly affects the peripheral cardiovascular system, 
preparing the organism for 'fight or flight' (See Fig.6).
ii). The pituitary-adrenocortical system.
'Emotional stress' activates the PVN and supraoptic nucleus 
of the hypothalamus. This results in the release, from 
neurosecretory cells in the median eminence, of corticotropin 
releasing factor (CRF) which travels via the hypothalamic-
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FIGURE 6. The pituitary-adrenocortical system. Ach =
acetylcholine. 5-HT = 5 hydroxytryptamine. GABA = gamma 
aminobutyric acid. + = stimulation. - = inhibition.
Figure from Bassett (1984)
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hypophyseal portal system to the anterior lobe of the 
pituitary. Here it promotes the release of
adrenocorticotropic hormone (ACTH) which is transported in the 
blood to the zona fasciculata of the adrenal cortex. Here 
the ACTH stimulates the release of the glucocorticoid hormone 
corticosterone (Peron 1960) (see Fig.7). Thus situations 
involving stress are associated with elevation in both 
catecholamine and glucocorticoid levels, the levels of both 
rising simultaneously (Mason 1968). Whilst the pituitary- 
adrenocortical system is activated by a wide range of 
psychological stressors, "situations of uncertainty or 
unpredictability produce a far greater elevation of 
circulating glucocorticoids" (Bassett 1984).
In review, the important question is why does the infusion of 
NA into the PVN elicit feeding in a satiated rat? There are 
two possibilities: first that NA injected into PVN mimics or 
affects in some way the natural processes of energy depletion 
or repletion. The second is that feeding to such injections 
has nothing to do with 'feeding' in terms of homeostasis or 
energy balance but is an artefact produced by stimulation of 
part of the 'stress cascade'. If the first option is 
examined, the question to be asked is what part of the natural 
feeding process does the microinjection of NA mimic? The work 
of Weingarten et al. (1985) indicates that the effects are not 
mediated through insulin or gastric acid secretion. Further,
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there is poor operant responding for food reward following 
such microinjections. Examination of the anatomy of the PVN 
in conduction with the work of Shimazu and colleagues (1965, 
1968, 1983) on the regulation of liver function indicates that 
the PVN may be involved in some aspects of liver function and 
exert its influence on feeding through this axis. However, 
this is not incompatible with the second hypothesis, that 
feeding to PVN microinjection of NA occurs in response to 
stimulation of part of the 'stress cascade'. The stimulation 
of medial hypothalamic sites results in both the release of 
CRF leading to increased ACTH levels and release of glucose 
from the liver (resulting from glycogen conversion into 
glucose). This results in an increase in plasma glucose in 
the absence of intake, presumably to provide energy for 'fight 
or flight' . However it also results in a very rapid depletion 
of short term energy reserves which might in turn provide a 
stimulus to eat. Thus the feeding in response to PVN NA 
microinjection might be explained in terms of either of the 
two hypotheses. One series of experiments described in this 
thesis concerns the microinjection of NA antagonists into the 
PVN prior to stimulating the rat with TP. These experiments 
were performed in order to clarify the role of the PVN in 
stress induced eating.
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MECHANISMS OF CHEMICAL INFORMATION TRANSFER
The first part of the introduction to this thesis 
described some of the progress made in the understanding of 
feeding behaviour, particularly of the involvement of NA in 
the PVN. This second section is concerned, not with behaviour 
but the processes of neurochemical transmission which are 
believed to underlie the expression of behaviour. Much of the 
behavioural work described in the first section related to the 
effects of infusion of neurologically active substances into 
the CNS of conscious animals. The majority of the work 
described on feeding and the hypothalamus involved the 
infusion of NA or adrenergically active ligands into a variety 
of discrete hypothalamic sites. However, it is not just work 
on feeding that employs the techniques of microinjection; 
experiments on drinking, sleep, locomotor activity, sexual 
behaviour, maternal behaviour, learning and memory, and even 
visual performance have all employed them (see Myers 1978 for 
comprehensive but dated review). The infusion of exogenous 
substances into the CNS, by microinjection, microiontophoresis 
or pressure ejection are accepted techniques in research aimed 
at understanding the relationship between neurochemistry, 
anatomy and behaviour. This being the case it seems
particularly pertinant to examine the assumptions that 
underlie microinjections, for if the theoretical basis of a
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technique is unsound, then the results generated by its use 
must be re-assessed in the light of subsequent advances.
The debate on exactly how nerve cells communicate information 
has been active for a long time, and indeed the principle 
components of the argument have themselves changed in the 
light of continuing advances. Initially the debate was 
whether or not communication between nerve cells was 
electrical or chemical in nature. The electrical theory 
suggested that transmission was brought about by action 
currents originating from axon terminals and continuing in 
the post-junctional cell in a way similar to conduction along 
the axon. The attractiveness of this theory was enhanced by 
the experiments of Galvani, and later Matteucci, demonstrating 
that the current from a large mass of muscle may excite a 
nerve. However, in the physiological state, activation passes 
not from muscle to nerve but from nerve to muscle and 
activation of muscle does not occur when an active nerve 
supply is simply laid upon it. The current from the nerve is 
insufficient to depolarise the larger mass of muscle tissue. 
It became clear that the nerve impulse required amplification 
and that this was somehow provided at the junction between 
nerve and muscle by means of a chemical process. The theory 
that nerve cells communicate chemically had been around since 
the 1900's. Scott stated "J formed the hypothesis that 
nerve-cells are true secreting cells and act upon one another
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and upon the cells of other organs by the passage of a 
chemical substance, This hypothesis has to do with the 
stimulation of cells, and not with conduction which proceeds 
in the substance between the neurosomes.,.When the impulse 
reaches the nerve ending it causes, I believe, the discharge 
of some of the neurosomes which are very numerous in that 
situation. * (Scott 1905 pp.521-522). But it was only with the 
experiments of Loewi (1921) that any direct evidence for the 
existence of chemical messengers was obtained. There are a 
few exceptions to the rule of chemical transmission; # 
electrical transmission does occur though it is now referred 
to as ephatic transmission and the region at which it occurs 
is called an ephapse. Electrical transmission is not known 
to occur in the CNS of mammals (Bowman and Rand 1984). This 
thesis is predominantly concerned with information transfer 
in the CNS that is chemical in nature. The chemicals involved 
in information transfer are diverse, and their modes of action 
complex. Such compounds are referred to below as
neurotransmitters; an expanded justification for the use of 
this term is given in appendix 1.
A recent debate concerns whether or not chemical communication 
in the CNS is only of a 'classical' synaptic form or whether 
a non-synaptic or 'paracrine' system of transmission also 
operates. In recent years many of the 'fundamental
principles' of chemical transmission have been challenged and
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disproved:
(i) Ecole's proposal of Dale's principle, in brief that each neuron 
contains only one transmitter substance*^. Co-localisation studies 
using double labelling with specific antibodies categorically 
demonstrate the co-existence of different transmitter substances 
within neurons (Hokfelt et al. 1980).
ii) Eccles principle, that a transmitter substance opens just one 
type of ionic gate, that being either excitatory or inhibitory, on 
the post-synaptic membrane. Considerable information is now 
available to demonstrate that the effects of a neurotransmitter on 
the post-synaptic cell depend upon the nature of that cell, the 
type of receptor, the presence of other inputs, and a great many 
other variables.
However, the assumption that within the CNS neurone-neurone 
chemical transmission occurs only through discrete synaptic 
contacts is still widespread. This 'classical' model of 
transmission has recently been challenged by an alternative 
hypothesis of 'paracrine' or non-synaptic transmission. This 
hypothesis suggests that transmitters may be released not into 
morphologically defined synaptic clefts but into the extra-cellular 
space. They then diffuse to their site of action, specificity 
being retained by the presence or absence of appropriate receptors 
rather than by anatomical constraints.
* Unfortunately an inaccurate reproduction of Dale's work - for full discussion see: Multiple Transmitter Status and "Dale'sPrinciple". Potter D. Furshpan E. and Landis S. (1981) Neuroscience commentaries 1, 1: 1-9.
70
FIGURE 8. The concept of 'chemically addressed' transfer of 
information between neurones. The cells A and B release their 
transmitters A and B diffusely. These can only have effect at 
cells equiped with the appropriate receptors (a and b).
Figure from Iversen (1986)
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FIGURE 9. a-1 and a-2 adrenoceptors in the central nervous system. 
Schematic representation of a central noradrenergic neuron. 
Postsynaptic adrenoceptors are of both a-1 and a-2 sub-types. 
Figure from Langer et al. (1980b)

The debate over exactly how chemical transmission occurs 
within the CNS can be seen to have an important bearing on the 
theoretical basis of the microinjection technique, for whilst 
this technique has been used to evaluate the effects of many 
compounds within the CNS it clearly involves a major implicit 
assumption. This is that the direct injection of a compound 
into the CNS results in that compound having equal access to 
all the sites to which the endogenous ligand might bind.
In isolated tissue preparations, the concentration of a drug 
in the biophase is taken to be that in the surrounding 
physiological salt solution (under steady state conditions). 
However, 'in vivo' it is known that there are sites of loss, 
in intimate association with the receptors of certain 
transmitters, called re-uptake mechanisms. In such cases 
there may be marked differences in drug concentration between 
the solution and the biophase unless the site of loss is 
blocked. The biophase is thus the concentration of the 
transmitter available to act on a given receptor (Bowman and 
Rand 1981).
The assumption that direct injection of a compound gives it 
equal access to all receptors is thus clearly false if some 
receptors are closer to these sites of loss than others, 
because the re-uptake mechanism will act to cause a 
concentration gradient such that exogenous ligand is more 
available to receptors further from sites of loss. The
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structure of the synapse, and the presence of a re-uptake 
mechanism are the two crucially important components that 
must be examined to validate the assumptions made in using the 
microinjection technique.
The structure of the svnapse.
A synapse is a morphologically specialised, intimate contact 
between two neuronal elements. The pre-synaptic component of 
a synaptic junction is usually formed by the terminal swelling 
of an axon branch. Often referred to as 'bouton terminaux' 
these are characterised by the presence of accumulations of 
small vesicles containing the transmitter substance(s). The 
pre- and post-synaptic elements are separated by a synaptic 
cleft, typically about 20nm wide, with both elements showing 
morphological specialisation. On the pre-synaptic side, 
electron microscopy has distinguished diffusely outlined dense 
patches protruding from the membrane into the cleft. These 
protrusions are arranged into a structure described as the 
pre-synaptic vesicular grid. The post-synaptic membrane is 
characterised by local membrane thickening, either continuous 
or in discrete patches. Freeze-etching studies have revealed 
the presence of small protrusions from the post-synaptic 
thickening, which may represent the exposed component of 
post-synaptic receptor sites (Nieuwenhuys 1985). The
sequence of events comprising synaptic transmission is now 
accepted to be as followsi the arrival of an impulse causes
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the synaptic vesicles to move towards the cleft, guided by the 
vesicular grid. On reaching the pre-synaptic membrane, the 
membrane of the vesicle fuses with it, releasing it's contents 
into the cleft. This process is called exocytosis. The 
transmitter molecules diffuse across the cleft in the 
extra-cellular fluid and bind to the post-synaptic receptor 
sites. This receptor - ligand interaction results in a change 
in the status of the post-synaptic membrane, usually resulting 
from the opening of particular ionic channels; although this | 
may often be mediated by a 'second messenger' system such as 
a GTP-binding protein regulating intracellular pathways that 
result in changes of such specific effectors as ion channels 
in the membrane, or adenylyl cyclase metabolism (Neer and 
Clapham 1988). The synaptic cleft contains an extra-cellular 
matrix of greater density than that surrounding the cell 
(Nieuwenhuys 1985, Hunter et al. 1989), and this serves to 
impede the diffusion of transmitter molecules away from the 
functional zone and into the general extra-cellular space.
Re-uptake of released transmitter.
The best understood re-uptake mechanism is probably that for 
NA. Study of the peripheral sympathetic nervous system 
revealed that neurones were capable of taking up both 
endogenous and exogenous catecholamines by an active transport 
mechanism. Much of this work was pioneered by Leslie Iversen, 
and his findings for the rat heart preparation illustrate the
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potency of this mechanism well: "The isolated heart rapidly 
accumulated NA when perfused with a solution containing a low 
concentration of [^H]-noradrenaline (lOng/ml) . The uptake led 
to concentrations in the heart about 40 times greater than the 
perfusion medium, after perfusion for 20 minutes. This means 
that the NA uptake system is capable of clearing the entire 
extracellular space of the heart in approximately 10 seconds. 
If one considers that the uptake sites are restricted to the 
sympathetic nerve terminals in the heart, which occupy only 
a minor portion of the tissue volume, this performance is even 
more remarkable. There is no way of making an accurate 
estimate of the volume of extracellular space adjacent to the 
sympathetic terminals, but it seems likely that the uptake 
system could completely clear NA from this fluid volume in an 
interval of time measured in milliseconds rather than seconds" 
(Iversen 1971 p.573). This re-uptake system, known as 
uptake-1 is a rapid, high affinity system probably responsible 
for the majority of NA re-uptake, and is located in the 
membrane of adrenergic neurones. There is a second system, 
known as uptake-2 which has a lower affinity for NA than 
uptake-1 but a higher capacity and is located in post-synaptic 
cells and glia. Within the CNS these re-uptake processes 
appear very similar to those of the sympathetic nervous 
system. The kinetic constants and inhibitor specificities of 
the central and peripheral processes are very similar (Iversen 
1971). Iversen is aware of the possibility that the presence
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of a re-uptake mechanism would lower the concentration of 
compounds, for which it had an affinity, in the biophase: 
"under these conditions the concentration of agonist in the 
extracellular space adjacent to the receptor sites will be 
reduced to a value lower than that applied to the external 
medium, because of the continuous removal of the agonist from 
the biophase by uptake" (Iversen 1971 p.582.)
If they are to act upon intra-synaptic receptors, it can be 
seen that exogenously administered compounds have barriers to 
overcome. First, any compound administered directly into the 
extra-cellular fluid of the brain has to diffuse from a less 
dense into a more dense medium in order to penetrate the 
synapse. Second, if the exogenous compound is susceptible to 
re-uptake it has to diffuse into the synaptic cleft at a rate 
sufficient to overcome the rate of loss from re-uptake. It 
is however clear that exogenous compounds can and do have 
widespread effects following microinjection into the CNS, even 
those such as NA which are the endogenous ligand for the 
re-uptake mechanism. It is possible that these exogenously 
administered compounds are simply given in concentrations so 
great as to overcome both the restrictions on diffusion and 
loss from re-uptake. However there is a second possibility, 
and that is that some exogenously administered compounds exert 
their effects at receptors outwith the 'classical' synapse, 
called extra-synaptic receptors.
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Extra -Synaptic receptors.
There is a considerable amount of evidence available that the 
receptors for certain chemical messengers exist outside 
any form of synapse. Thus the receptors for hormones in the 
periphery, for example, receive their ligand from the blood 
supply. The more difficult question is, do certain 
synaptically released transmitters also operate in a 
'paracrine' fashion within the CNS? Using NA as an example 
once again, the question becomes; are there NA receptors 
present both inside and outside the classical synapse? A 
recent review by Miles Herkenham (1987) compares the data 
generated by localisation studies of receptors and 
transmitters in an attempt to illuminate this question.
Receptor mismatch data.
As explained above, the hypothesis most commonly held about 
chemical information transfer in the CNS is that it takes 
place through defined synaptic contacts. However Herkenham 
states "close transmitter/receptor matches are the exception 
rather than the rule for most well characterised 
neurO'-chemical systems. . . .mismatches are the general rule for 
these systems" (Herkenham 1987 p.2). It is not possible here 
to review the source evidence used by Herkenham but his 
conclusion as regards NA is definite: "Lumping all of the
adrenergic receptors together and comparing their distribution
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with the adrenergic innervation of brain leads to the
conclusion that the receptors are far more widely distributed 
than the nerve terminals, and that the patterns of adrenergic 
receptor distributions do not resemble the patterns of 
adrenergic fibre distribution" (p.12). There are a variety 
of explanations for this mismatch data:
(i) Mismatches represent technical failures in visualisation 
or incomplete knowledge of a family of receptors or
transmitters. For example, failure to detect transmitter in 
an area containing dense receptors may represent a lack of 
sensitivity for very low transmitter levels. The antibody
used may fail to recognise all molecular forms of the
transmitters that comprise a family of substances recognised 
by the receptor. However, the use of more sensitive 
techniques and antibodies directed against newly discovered 
transmitters have usually served to compound the mismatch hot 
diminsh it.
(ii) Many transmitters are located by labelling anti-bodies 
to the synthesising enzyme, but this enzyme is often present 
throughout the cell, not just in terminals. Furthermore, not 
all receptors occur in outer cell membranes, receptors may be 
in axonal transport, or even internal to the cell.
(iii) Biochemical explanations include incomplete labelling 
because of occupied receptors, non-functional, or "drug 
binding sites" and unrecognised low-affinity sites. The 
expression of certain receptors may be genetically linked to
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the expression of other receptors even if no ligand for these 
occurs at that site.
(iv) Many receptors, especially high affinity receptors, may 
be located not in a synapse, but at a site distant from the 
source of release.
Herkenham examined the first three explanations (i-iii) in 
detail but concludes that the extent of mismatch is such that
(iv), extra-synaptic receptors, must be the reason for many 
of the observed discrepancies between transmitter containing 
neurons and receptor localisation.
Whilst Herkenham might be overstating the case when he implies 
that all transmitters so far discovered may act in both a 
classical and paracrine manner it is clear that evidence for 
non-synaptic transmission of receptors exists, and that in 
such a system " connect ional specificity is replaced by 
chemical specificity" (p.27). Such a system had already been 
proposed by Iversen (1986; see Fig.8) and independently by 
Schmitt (1986) who states "alongside of, and in parallel with, 
synaptically linked, 'hardwired' neuronal circuitry, that 
forms the basis for conventional neurophysiology and 
neuroanatomy, and that operates through conventional synaptic 
junctions, there is a system that I call 'para synaptic'. In 
parasynaptic neuronal systems 'informational substances' may 
be released at points, frequently relatively remote from 
target cells, which they reach by diffusion through
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extracellular fluid. Such a system has all the specificity 
and selectivity characteristic of the conventional synaptic 
mode; in the parasynaptic case the receptors that provide the 
specificity and selectivity are on the surface of the cells 
where they can be contacted by, and bind to, the informational 
substance ligands diffusing in the extra cellular fluid" 
(p.240).
Data from the peripheral nervous system.
Much of the early research work into the actions of 
transmitters such as NA was conducted in the peripheral 
nervous system. Frequently, it has been determined that 
peripheral modes of action closely resemble those later 
discovered within the CNS. Thus the work of Iversen (1971) 
initially concerned the re-uptake of NA from the rat heart, 
but has been found to generalise well into the CNS. This is 
not to say that all features of NA neurones or receptors in 
the peripheral nervous system have a parallel in the CNS but 
evidence gained from peripheral research may provide clues to 
the mechanisms underlying the actions of NA in the CNS.
Certain experiments on vascular smooth muscle, indicated to 
Salomon Langer and his colleagues that there might be a 
difference between the effects of endogenously and exogenously 
administered NA (Langer et al. 1980a,1980b). Using prazosin, 
a highly selective a-1 antagonist, the effects of a-1 blockade
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were compared when the tissue was stimulated with NA from an 
endogenous source (electrical stimulation of the nerve) or 
from exogenous NA added to the perfusate. They discovered 
that the blockade of the response achieved by prazosin was far 
greater to the endogenously released NA than that to NA 
added to the perfusate. Both a-1 and a-2 sub-types of the NA 
a-receptor were known to be present post-synaptically in this 
preparation. Langer and Shepperson (1982) subsequently 
suggested that this result might be due to the a-1 receptor 
being synaptic and the a-2 post-synaptic receptor 
extra-synaptic, both acting to contract the muscle but having 
different primary sources of their ligand. In order to test 
this hypothesis they performed a series of blockade 
experiments using selective a-1 blockade with prazosin, 
selective a-2 blockade with M-7 and the combined a-1, a-2 
blocker phentolgmine. In these experiments they once again 
provided stimulation by both endogenous and exogenous NA, the 
preparation being was perfused cat spleen. The nerve/muscle 
junction in this preparation is not a synapse as such but a 
neuroeffector junction, which shares many of the properties 
of the synapse. The results of these experiments supported 
the hypothesis that the a-1 receptor predominated 
intra-synaptically whilst the a-2 was extra-synaptic. Langer 
and Shepperson state "prazosin a selective a-I adrenoceptor 
antagonist preferentially antagonised responses to neuronally 
released NA while it was less effective in blocking responses
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to exogenously administered NA" (p.slO) . They further explain 
that if the NA re-uptake mechanism were to be inhibited with 
cocaine then the selectivity of these two blockades would be 
markedly reduced as exogenous NA could now penetrate the 
neuroeffector junction without being rapidly removed by the 
re-uptake mechanism and further that the blockade to 
phentolamine would be unaffected by this re-uptake inhibition. 
In a review of the role of pre-synaptic receptors in the 
periphery. Langer (1981) presents a model of a smooth muscle 
neuroeffector junction and its noradrenergic innervation (see 
Fig. 9) and further suggests a possible extra-synaptic 
location for CNS ot-2 adrenoceptors (see Fig 10). Referring 
to the effects of re-uptake inhibition Langer claims that 
"when neuronal uptake is inhibited with cocaine, prazosin 
becomes more effective than in the absence of cocaine in 
blocking the response to exogenous NA" (p.343). The findings 
that the a-1 receptor may predominate intra-synaptically 
whilst the a-2 is largely extra-synaptic is supported by 
Yamaguchi and Kopin (1980) and more recently by Lucchelli et 
al. (1985) who also reported preferential antagonism by 
prazosin of NA released by nerve stimulation.
However, recent work by Woodman (1987) has indicated that the 
post-junctional location of a-1 and a-2 receptors may not be 
as easily separated as Langer suggests. Woodman used tyramine 
as a noradrenergic releasing agent, this having the advantages
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FIGURE 10. Postsynaptic a-1 and a-2 adrenoceptors in vascular 
smooth muscle. Schematic representation of vascular smooth muscle 
neuroeffector junction. Endogenous NA acts preferentially at a-1 
receptors intra-synaptically, whilst exogenous NA acts at extra- 
synaptic a-2 receptors.
Figure from Langer and Shepperson (1982)
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of not being impulse dependent, thus not involving 
pre-junctional a-2 receptors, and the release is from all 
available sites. His experiments on coronary vasoconstrictor 
responses in the dog indicate the involvement of both a-1 and 
a-2 post-junctional receptors in the response in this 
preparation to release from the sympathetic nerves. This he 
claims, refutes Langer's suggestion that hormonal or 
circulating NA is responsible for the activation of 
extra-synaptic a-2 receptors. It is possible that tyramine 
will release NA from sympathetic nerves both into 
neuroeffector junctions, and also a limited amount at sites 
not directly adjacent to a junction. In this case the 
diffusely released NA would still be free to act at 
extra-junctional a-2 receptors, indicating when the a-1 
receptors are antagonised with prazosin that there is an a-2 
component to the response to stimulation of sympathetic nerves 
with tyramine. The a-2 post-synaptic receptor is available 
to ligand from any source, diffusely released, hormonal, or 
synaptically/junctionally released but it is unlikely that 
synaptically released NA can escape from the re-uptake 
mechanism associated with the synapse. Thus Woodman's results 
are not incompatible with Danger's, they differ merely in 
interpretation. A second and important suggestion made by 
Woodman is that the relative contributions of a-1 and a-2 
receptors to an effect at any site must be determined at that 
site, attempts should not be made to overgeneralise across
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preparations.
Evidence From Ultra-Structural Studies.
The axons of many monoaminergic and peptidergic neurones in 
the CNS give rise to thin, unmyelinated and profusely branched 
axons. These axons exhibit varicosities throughout much of 
their extent, not merely in their terminal region. 
Ultrastructural studies have determined that these projections 
do not appear to make synaptic contacts, and yet they contain 
large numbers of vesicles which resemble those from which 
transmitter is released at synapses. Such observations led 
to the speculation that transmitter was released from these 
varicosities, not into synaptic specialisations but freely 
into the extra-cellular space (Nieuwenhuys 1985). In a review 
of the ultrastructural data Beaudet and Descarries (1978) 
outline the detailed studies which have been undertaken to 
identify synaptic terminals in monoamine neurones within the 
CNS. They " . . examined 1835 noradrenergic terminals in 12 
series of 3 thin sections each, selected as representative of 
all cortical layers. In this extensive samplingf 18% of the 
varicosities were viewed in more than one thin section, but 
only 61 (<5%) exhibited the structural features of typical 
synaptic terminals. . . The paucity of synaptic junctions formed 
by noradrenergic, . . varicosities in the cortex was particularly 
striking when comparing the labelled terminals with unlabelled 
nerve endings randomly selected in the surrounding neuropil
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but similarly sampled in serial thin sections: more than 50% 
of these possessed the morphological characteristics of 
synaptic terminals'* (p.856). Beaudet and Descarries were not 
the only workers to discover such an apparent shortage of 
morphologically discrete synaptic specialisations within the 
CNS. They cite nearly twenty other studies which reach a 
similar conclusion for NA, 5-HT or DA at different sites, in 
particular, Swanson et al. (1978) who found only 19% of NA or 
adrenergic vesicles within the rat PVN formed synaptic 
contacts with other neurons, whilst a further 5% made contact 
with blood vessels. Beaudet and Descarries do not, however, 
imply that all transmission of these amines is non-synaptic, 
neither could they determine whether the same neurone engaged 
in both non-synaptic and synaptic release. In addition to all 
the NA varicosities observed containing vesicles they observed 
that "release of the biogenic amines solely by varicosities 
making synaptic contact could hardly account for the amounts 
liberated from the superfused cortex during the resting state 
or upon electrical stimulation" (p.857). In this they are 
supported by the study of the changes in endogenous content 
of NA varicosities after stimulation, as observed by 
histofluorescent techniques (Arbuthnott et al. 1970). 
However, the findings of Beaudet and Descarries have been 
challenged by Molliver et al. (1985) who studied the 
ultrastructural specialisation of NA and 5-HT varicosities 
using the technique of immunohistochemical labelling
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techniques. They found that about 50% of the positively 
identified 5-HT and NA terminals displayed synaptic 
specialisations, and those that did not they argued were 
merely outside the section plane. Further, in neonatal rats 
monoaminergic fibres form numerous specialised synapses. The 
conclusion of this research is that cortical monoaminergic 
transmission occurs through specialised synapses. The 
argument that not seeing synaptic specialisations because, if 
you don't see them they are simply out of the plane of the 
section, is difficult to refute. Very recent work by 
Papadopoulos et al. (1989) claims an incidence of 86% of NA 
vesicles form synaptic contacts within rat cerebral cortex, 
and suggest that the results reported by Beaudet, Descarries 
and colleagues resulted from insufficient numbers of serial 
sections. They report that a given varicosity is present in 
up to 15 serial sections whilst the post-synaptic 
specialisation occurs in only two or three. Buma and Roubos 
(1986) have developed a technique whereby the process of 
exocytosis can be directly visualised and have presented data 
which shows non-synaptic release of a substance that is 
probably NA within the area postrema of rat brain.
Theoretical Considerations
If a theory is a means of explaining empirical data in a way 
that is parsimonious, complete and testable then the idea that 
non-synaptic transmission occurs alongside synaptic
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transmission within the CNS is an attractive theory, 
particularly so because it is possible to incorporate all the 
available empirical evidence regarding synaptic transmission 
and in addition, explain a considerable number of empirical 
findings difficult to resolve using only the concept of 
straight "point-to-point" transmission. These are as follows:
(i) It provides an explanation for the high number of 
compounds known or suspected of being transmitters within the 
CNS.
(ii) It suggests an extremely economical use of space within 
the CNS, by reducing the 'hardware' requirements. .
(iii) It allows for specificity to be maintained by the 
appropriate locating of receptors rather than complex 
topographical relationships between neurons.
The evidence presented above gives a strong indication that 
non-synaptic transmission occurs within the CNS of mammals. 
Unfortunately none of the experiments reported actively 
tests this hypothesis. It is the purpose of this thesis to 
demonstrate that it is possible using psychopharmacological 
methods to test the conclusions presented above using 
behavioural measures.
HYPOTHESIS
The hypothesis to be tested in this thesis is that 
non-synaptic transmission occurs within the CNS of rats in
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parallel with classical synaptic transmission at least within 
the PVN. The receptors for the non-synaptically released 
transmitter are located outwith the conventional synapse; the 
separation of the two systems being maintained by both the 
presence of a powerful re-uptake mechanism on the pre-synaptic 
terminal and the structure of the synapse. The actions of NA 
at extra-synaptic receptors are of behavioural consequence.
In order to use the available space at the optimum both 
synaptic and non-synaptic transmission should operate at a 
given location. However, in order to prevent excessive 
crosstalk between the two systems they must be kept separate,
I have hypothesised that the most efficient way for this to 
occur is simply for the receptor site for the non-synaptically 
released ligand to be moved outside the synapse. Overlap is |
thus prevented, as transmitter released within the synapse 
fails to diffuse out because of the re-uptake mechanism and 
the density of the intra-synaptic medium. Similarly 
non-synaptically released transmitter will not significantly 
affect receptors within the synapse because these two 
mechanisms operating in reverse will serve to protect the 
intra-synaptic receptor population. This arrangement also 
serves to preserve the 'economy' of the classical synaptic 
arrangement with regard to the re-use of transmitter and keeps 
the required concentration of non-synaptic transmitter to a 
minimum, (see Fig.24). Indeed it is possible to suggest that
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the sensitivity of intra- and extra-synaptic receptors might 
be considerably different.
Experiments were designed to test this hypothesis using as a 
model system noradrenergic transmission within the PVN. This 
system was chosen for several reasons:
i) The pharmacology of NA is probably better understood than 
any other central transmitter system and reliable 
pharmacological agents are available for manipulation of 
central NA systems.
ii) The evidence of Langer and others suggested that in the 
periphery there might be a spatial separation of post-synaptic 
NA 06-1 and a-2 receptors with regard to the synapse.
iii) Iversen has demonstrated the presence of a potent 
re-uptake mechanism on CNS NA neurones.
iv) Beaudet and Descarries (1978) and Buma and Roubos (1986) 
have presented evidence in support of non-synaptic release of 
NA in the CNS of the rat.
V) The work of Leibowitz has demonstrated a reliable behaviour 
associated with manipulation of post-synaptic a-adrenergic 
systems within the PVN.
Initially experiments would be performed to replicate the 
findings of Leibowitz and her colleagues, that the feeding 
behaviour elicited by microinjection of NA into the PVN 
results from action at the post-synaptic a-2 receptor. Such 
replication would serve to validate the methodology being
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employed in this laboratory. Subsequent experiments would 
examine the effects of inhibiting the re-uptake mechanism, 
either pharmacologically or by physical removal, on the 
pattern of response to selective pharmacological blockade. 
The prediction made was that the a-2 selective antagonist 
idazoxan would markedly reduce the feeding elicited by NA 
microinjections into PVN, as would the non-selective a-1, a- 
2 antagonist phentolamine. However, in the absence of a 
re-uptake mechanism the blockade to the a-2 selective 
antagonist would be considerably reduced because the 
intra-synaptic a-1 receptors were made available to the 
infused NA. In the absence of the re-uptake system the 
response to phentolamine, the combined a-1, a-2 antagonist 
would be unaffected.
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SCREENING OF PHARMACOLOGICAL AGENTS
EXPERIMENT 1
The purpose of the first experiment was to establish the 
effects of the pharmacological agents to be used in subsequent 
studies on baseline food intake and behaviour. If the 
re-uptake or receptor blocking agents themselves affected food 
intake, or otherwise affected normal behaviour then their use 
in a food intake study would be confounded,
METHOD
Animals
A total of 27 male hooded Lister rats, bred 'in house', were 
used each weighing approximately 320gms at the beginning of 
the experiment. The rats were individually housed and kept 
under a 12hr light/dark cycle. The were maintained 'ad lib' 
on SDS maintenance diet No.l chow pellets^ and tap water.
Surgery 
1 Cannulae.
Each animal was unilaterally implanted with a permanent, 
23gauge stainless steel guide cannula, 11.5mm long, normally
SDS Maintenance Diet No.l supplied by Special Diet Services Ltd, 1 Stepfield, Witham, Essex, CM8 3AB. Tel. (0376) 513651
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occluded by an indwelling 30gauge wire stylet. The cannulae 
were manufactured by removing the last 11.5mm of a 23gauge 
'monoject' syringe needle^. Using syringe needles has the 
advantage of ensuring a high degree of cleanliness and also 
complete uniformity of bore and bevelling. The stylets were 
made from 30gauge surgical steel wire placed inside the 
cannula, bent over and cut, leaving a 'L' shaped stylet with 
a projecting arm of about 4mm. Cannulae were implanted 
using a cannula guide, consisting of about 5cm of straight 
23ga tubing with 30ga tubing down the inside^, projecting 
exactly 11.5mm. The cannula guide was attached to the side 
arm of a Kopf stereotaxic frame^ .
2 Implantation.
The animal was removed from its home cage, injected intra- 
peritoneally with lOml/Kg Avertin anaesthetic^ and was then
Mononject, Sherwood Medical. 0.6x25mm 23xlga long bevel syringe needles.
Stainless Steel Tubing from; CNW 261/265 Aston Lane, Birmingham, West Midlands. B20 3HS.
David Kopf sterotaxic frame
Avertin anaesthetic - Concentrate solution lOOgm oftri-bromo-ethanol crystals + 62ml tertiary amyl-alcohol liquid, dissolved and stored in darkness. Anaesthetic soln. 62.5ml of 0.9% saline + 5.0ml absolute alcohol mixed overnight in a dark bottle
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returned to the home cage until reflex testing (tail flick) 
indicated it to be completely anaesthetised. The animal was 
then removed and the top of the head shaved with Oster small 
animal clippers*. It was placed in the stereotaxic frame, 
atraumatic earbars were used, and the skull exposed. Bregma 
was located and the co-ordinates for entry through the skull 
recorded. Next, three small stainless steel screws^ were 
inserted into the skull spaced at about 5mm around the 
cannula site, to anchor the implant. A hole was drilled 
through the skull using a dental drill® and dental bit*. The 
dura co-ordinate was established and the cannula lowered into 
position. Any bleeding was staunched with cotton wool swabs, 
and the skull surface was wiped down with physiological
with 1.25ml concentrate. Standard dose lOml/Kg.
6
Oster small animal clippers with size 40MN cutting head.
7
Stainless steel screws 0-80 x 1/16 SS Plastic Products USA.
8
NSK Volvere 5
Dental bit; Komet, GEBR. BRASSELER GmbH & Co. Size ISO 014, US No4.
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saline. When the skull was dry, acrylic dental cement^® was 
applied to the skull surface and built up as it hardened 
around the screws until the implanted cannula was firmly held. 
The cannula guide was then withdrawn and the stylet placed 
inside the implant. Exposed edges of the wound were dressed 
with PEP wound dressing powder^^ but not sutured as recovery 
was found to be optimal if the cut skin grew back around the 
edge of the cement. Care was taken not to overlap the wound 
with cement. The animal was then returned to it's home cage 
and allowed to recover.
The stereotaxic co-ordinates used resulted in the injection 
cannula terminating in, or directly adjacent to, the 
magnocellular portion of the PVN. The co-ordinates were 
according to the atlas of Pellegrino, Pellegrino and Cushman 
(1979): in the de Groot orientation, nose bar +5mm above the
interaural line, 0.6mm posterior to bregma, 0.5mm lateral and 
6.0mm below dura. These co-ordinates refer to the placement 
of the guide cannula, the injection cannula projecting 2mm 
past the end of the guide to penetrate the PVN. Termination
10
Simplex Rapid, Austenal dental Products, The crystal centre, Harrow. HA 1 2HG.
11
P.E.P. Powder, Intervet Laboratories, Milton Road, Cambridge.
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of the guide cannula within the PVN would be too disruptive 
to the target site.
Test Procedure
Rats were allowed at least 14 days recovery after surgery 
before testing was started. However, the animals were handled 
daily and the stylets changed from day 3 after surgery. The 
animals were tested in wire sided testing cages, 24 x 24 x 
39cms. These cages contained lab chow pellets in a food 
hopper, and water bottles. Animals were acclimatised to the 
cages with at least three pre-injection trials, in which the 
animals were placed in the cages for one hour, removed, mock 
injected and returned to the cages for a further 40 minutes. 
After acclimatisation the animals were tested following a 
similar protocol; they were placed in the cages for 1 hour, 
removed, the stylet extracted and the injection performed. 
The food and water were weighed and the animal returned to the 
test cage for a period of 40 minutes. At the end of the test 
the animal was returned to it's home cage and the food and 
water re-weighed. The cage floors were metal grids through 
which spillage could fall onto a paper catch-sheet. All food 
spillage was added to the unconsumed total.
Injection Protocol
All injections were made through 13.5mm 30ga injection 
cannulae placed inside the guide cannula. The injection
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cannulae were made by attaching a piece of 30ga steel tubing 
about 2cms long to a 50 cm length of polythene tubing^ ,^ the 
joint being sealed with 'Araldite' adhesive. The precise 
length of 13,5mm was ensured by cutting a collar of polythene 
tubing and placing it on the steel tubing such that exactly 
13.5mm projected. This tubing/cannula arrangement was filled 
with the drug to be injected and attached to a lOul syringe^' 
fitted to a 'Harvard' infusion pump^ *. In attaching the 
tubing to the syringe a small air bubble, about 1mm long, was 
allowed to enter the tubing. The position of this bubble was 
marked before the injection commenced, and the progress of the 
infusion could be monitored by watching the movement of the 
bubble along the tubing. This procedure ensured that problems 
of non-injection due to blocked cannulae could be quickly 
observed and rectified. The lOul syringes were always filled 
with absolute alcohol. All infusions were made over 1 minute, 
and the volume was always 0.5ul. Constant volume was 
maintained with all drugs because of the effects on diffusion 
of adjusting infusion volumes (Myers and Hoch 1978), The
12
Polythene tubing, I.D. 0.28mm O.D. 0.61mm (Ref. 800/100/100) from Portex, Hythe, Kent.
13
S.G.E. 7 Argent place, Ringwood, Australia. Ref. 10-A-RN-GP
14
Harvard Compact Infusion Pump. Model 975.
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animal was removed from the testing cage and held in the left 
hand, the stylet was removed, and the injection cannula 
lightly pushed down the guide cannula. When in place the pump 
and a stopclock were started. After 1 minute the pump was 
stopped and the cannula left in place for a further 30 seconds 
before withdrawal.
Drugs
The drugs used in this experiment were as follows:
i) [-]-norepinephrine bitartrate FSIGMAI^^.
ii) The a-1 antagonist prazosin hydrochloride FPFIZER! *^.
iii) The a-2 antagonist idazoxan FRECKITT & COLEMANI^ .^
iv) The mixed a-1/a-2 antagonist phentolamine hydrochloride 
FCIBAI ®^.
15
Sigma No. A-9512 Lot 65F-0359 Mol. Wt.319.3
16
Lot No. A.NO.11-8445
17
Batch No. 800285 Mol.Wt. 240.69
18
Batch No. 00177 Mol.Wt. 317.8
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V) The NA re-uptake inhibitor cocaine hydrochloride r SIGMAI *^. 
All drug solutions were made up in sterile physiological 
saline. Two of the drugs posed solubility problems. 
Phentolamine was only soluble at a maximum of 30nmoles in 
0.5ul. Thus in experiments using this compound the dose of 
NA was reduced to 30nmoles also. Prazosin was used at the 
maximum solubility obtainable after warming and sonication 
(approximately Img/ml). However, the volume of Prazosin was 
not increased to allow equimolar injections because of the 
distortions inherent in increasing microinjection volume 
(Myers and Hoch 1978).
Histology
In order to confirm the cannula placements, the rats were 
sacrificed under barbiturate anaesthesia^* and perfused 
intra-cardially with 0.9% physiological saline, followed by 
10% phosphate buffered formalin solution^\ The brains were 
removed and stored individually in jars of the formalin
19
Sigma No. C-5776 Lot 35F-0174 Mol.Wt. 339.8
20
Euthatal May & Baker (200mg/ml pentobarbitone sodium). 1ml/kg.
21
Phosphate Buffer - pH 7.4 O.IM Sodium Phosphate (dibasic Na2HP04) plus O.IM Sodium Phosphate (monobasic NaH2P04) Approx 4 to 1 dibasic to monobasic. Add Monobasic slowly to dibasic, pH will fall from 9 to 7.4. For 10% buffered formalin add 100ml conc. formalin soln. to 900ml phostphate buffer.
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solution for at least 48 hours before cutting. The brains 
were cut by fixing them to the stage of a bench microtome with 
Tissue-Tek^^ and freezing with compressed carbon dioxide. The 
section thickness was 4Ou and sections were mounted by 
floating them onto subbed^® ground glass slides^*. Sections 
were stained using a conventional cresyl violet staining 
procedure^* and coverslipped using DPX^ * mountant. All rats 
used in this experiment were found to have injection sites in, 
or directly adjacent to the PVN. Photographs of
representative injection sites are presented in Figure 11.
Statistics
The results of all the experiments were analysed using a 
repeated measures analysis of variance (ANOVA) computer
22
Tissue-Tek OCT 4583 embedding compound. Miles scientific,
23
23. 4gm Gelatin in 260ml dist. water @ 37'C + 0.4gm Chrome alum in 20ml dist. water. Dissolve both separately, mix and add 120ml 96% alcohol.
24
Chance Propper Ltd. 76-5limn Thickness 1012. Ground edges.
25
Cresyl Fast Violet (aqueous) 0.Igm + 5mls Glacial acetic acid + Distilled water to lOOmls. Correct pH to 3.5 using Sodium Acetate
26
D.P.X. Mountant BDH chemicals Product. No.36029
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FIGURE 11. Photomicrographs of a representative section showing the 
PVN and injection site. The top figure is low power (xlOO), the 
bottom one is the same section in a higher magnification (x400). 
Abbreviations: opt, optic tract; 3V, third ventricle; PVN,
paraventricular nucleus. The arrow heads indicate the injection 
site.

FIGURE lia. Representative sections showing typical injection 
sites which failed to elicit the l.Sgms. feeding response 
following injection of 40nm NA. All sites are at least 0.75mm
fi _ /from the borders of PVN. Typical "miss" sites were cXor%c*-^ l and 
caudal to PVN ending in VM thalamic nucleus. These errors 
probably occured as a result of guide cannula deflection during 
surgery.
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package ALICE running on the St. Andrews VAX A 11/780 
computer. Post-hoc testing between the groups was performed 
using the Newman-Keuls test (unless otherwise specified). In 
the cocaine dose response experiment the 200nmoles condition 
is excluded from the analysis as 7 of the 8 scores in this 
condition were 0 and would otherwise have confounded the 
ANOVA. Further explanation of this condition is presented on 
the appropriate results section.
RESULTS
Experiment 1; Independent effects of Idazoxan, Phentolamine, 
Cocaine and Prazosin.
This experiment was designed to establish whether or not the 
drugs to be employed in subsequent blockade experiments have 
an independent action on food intake when microinjected into 
the PVN. Each drug was tested on a separate group of rats.
(i) Idazoxan
The effects of a variety of a-2 antagonists in the PVN have 
been reported (Leibowitz 1978a) but not those of Idazoxan. 
This compound was chosen as a result of studies demonstrating 
that it has a greater a-2 specificity than previously used 
agents such as yohimbine, rauwolscine and corynanthine (Doxey 
et al. 1984). A second advantage of using this compound is
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that it is easily soluble and can be used in high
concentrations and low volumes, allowing direct comparison 
with the doses of NA previously reported, A total of 11 rats 
with implanted guide cannulae were used in this experiment. 
The animals were first injected with 40nmoles NA to establish 
a feeding response. The criterion for acceptance was that the 
animal ate at least l.Sgms of lab chow in the 40 minute test 
period following injection. This figure was chosen because it 
was above the greatest amount eaten by any rat when mock 
injected. The second injection administered was 0,9% 
physiological saline, the vehicle for both NA and Idazoxan; 
third and fourth injections were 80nmoles and O.lnmoles
Idazoxan, and the fifth injection was a further saline
injection. All injections were separated by a minimum of 48 
hours.
Overall significance was found in these data (F=5.82 df=5,50 
p<0.001; see figure 12). Post-hoc tests show that neither 
SOnmoles nor 0.1 nmoles Idazoxan had an independent effect 
upon ingestion when injected into the PVN. The only condition 
which differed significantly from the others was 40nmoles NA 
which had an effect significantly greater than Idazoxan
SOnmoles (p<0.0015), Idazoxan O.lnmoles (p<0.0005), first 
saline (p<0.001) and second saline (p<0.0011). The effect 
Idazoxan did not differ significantly from that of either 
saline injection.
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(ii ^ Phentolamine
Phentolamine is soluble in warmed, sonicated physiological 
saline up to a maximum of just over SOnmoles in O.Sul. For 
this reason the dose of NA used in this experiment was reduced 
to 30 nmoles in order to equate with the maximum available 
dose of Phentolamine, which was administered in doses of 1, 
10, and 30 nmoles to a group of 8 rats. Overall significance 
was found in these data (F=21.13 df«=6,36 p<0.001 see figure
12). NA was given as both first and last injection and each 
of these had significantly greater effects (p<0.001 in each 
case) than any of the Phentolamine conditions, none of which 
differed significantly from saline (p>0.05). However it was 
found that the two NA conditions differed significantly 
(p<0.003) and this is considered further in the discussion.
(iii\ Cocaine
Cocaine blocks the re-uptake of released NA into the 
pre-synaptic nerve terminal and might therefore cause an 
increase in NA availability at the post-synaptic membrane. 
In order to establish whether this is sufficient to generate 
the same feeding response as the injections of exogenous NA 
a dose response to Cocaine was established in a group of 8 
animals using three doses: 10, 100 and 200 nmoles. Overall 
significance was found in these data (F=8.24 df=4,28 p<0.001
see figure 12). There was no significant difference between
1 0 1
the two NA conditions (p=0.287) but both of these were 
significantly larger than any of the Cocaine or saline 
conditions (p<0.005 in each case). The two lower doses of 
Cocaine, 10 and 100 nmoles did not differ significantly to 
saline. The 200 nmoles dose produced a response lower than 
that of saline or any of the other drug conditions, in fact 
7 of the 8 scores in this condition were zero. The inclusion 
of this number of zero scores in an ANOVA would have 
confounded the assumptions about the shape of the data 
employed in this test and thus the results are reported to be 
significantly lower by inspection only. The inhibition by 
200 nmoles Cocaine of even small feeding bouts, commonly found 
in the saline control group, probably results from the local 
anaesthetic action of high doses of Cocaine. Five of the rats 
in this condition appeared incapable of voluntary movement 
during the test period, whilst the other 3 were severely 
impaired.
fivl Prazosin
A dose response to Prazosin was not established due to its low 
solubility. It was always used at the maximum available 
concentration after warming and sonication, this dose being 
independently tested in the animals prior to its use as a 
blocking agent. Prazosin was found to have no independent 
effect on food intake, in agreement with the findings of
102
Leibowitz's group (Leibowitz 1975a, 1978b, Goldman et al.
1985).
Of the four pharmacological agents screened (idazoxan, 
phentolamine, prazosin and cocaine), only cocaine was found 
to have an independent effect on food intake. At high doses 
cocaine suppressed food consumption by disabling the animal. 
The three antagonist compounds did not cause any observable 
change in the rats normal behaviour, or cause any change in 
food consumption as compared to vehicle injection.
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FIGURE 12. Mean (+/- SE) gms of food consumed in 40min following 
microinjection of 40 nmoles NA, and various doses of either 
phentolamine, idazoxan or cocaine in three separate groups of rats. 
NA was administered as first and last injection, except in the 
idazoxan group when 40nmoles d-amphetamine was the last injection. 
NA or d-amphetamine induced significantly more eating than saline 
in every condition (at least p< 0.05). No dose of phentolamine, 
idazoxan or cocaine induced significantly more eating than control.
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EXPERIMENT 2
The purpose of this experiment was to establish that a small 
injection of the catecholamine neurotoxin 6-OHDA made via a 
cannula implanted into PVN could, at least temporarily, 
deplete this site of NA. Such a lesion, if effective, could 
be used to inhibit the re-uptake mechanism on pre-synaptic NA 
terminals by the physical destruction of such terminals.
METHOD
Animals
A total of 31 male hooded Lister rats were used in this 
experiment. Of these 6 were unoperated control animals and 23 
underwent surgery. These all weighed approximately 300gms at 
the time of surgery, and were maintained in a the manner 
described for experiment 1,
Surgery
The co-ordinates for the cannula placement were adjusted in 
an attempt to avoid a blood vessel located just below dura and 
frequently ruptured when the guide cannulae were lowered into 
position. The new co-ordinates were according to the atlas 
of Paxinos and Watson (1982): flat skull position, nose bar
3.3mm below the interaural line, 1.8mm posterior to bregma, 
lateral 0.2mm, and 5.5mm below the skull surface. These 
co-ordinates again resulted in the injection canula 
terminating in, or directly adjacent to, the magnocellular
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portion of PVN. This change of co-ordinates apart, the 
cannulae were implanted in the same way as for experiment 1.
Test Procedure
The animals were allowed at least 14 days to recover from 
surgery and then underwent the acclimatisation procedure 
described previously. Using the injection protocol described 
for experiment 1 animals were screened with NA and saline 
injections and only those exceeding the criterion of l.Sgms 
of lab chow in the 40 minute test after NA infusion were
retained. Two animals failed to reach this criterion and
were discarded from the experiment. The remaining 21 animals 
subsequently underwent the 6-OHDA lesioning procedure.
6-OHDA Lesion
The rats were placed in the testing cages and allowed to 
acclimatise for 30 minutes then removed and injected
intra-peritoneally with pargyline r S I G M A I ^ ^ at a concentration 
of 50mg/kg/ml. The rats were then replaced in the testing 
cages for a further 30 minutes before receiving a
microinjection of 6-OHDA. Because 6-OHDA oxidises readily, 
it was made up freshly for each animal in ice cold 0.02%
27
Pargyline [SIGMA] (N-methyi-N-benzyT-2-propynylamine) No. P-8013 Lot. 33F-08051 Mol. Wt. 195.7
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ascorbate saline^ ®. The 6-OHDA was made up at 4mg/ml of the 
free base, as the hydrobromide salt rSIGMAI^  ^ was used, a 
correction factor of 1.48 was applied to the dry compound to 
account for the hydrobromide. The injected volume was O.Sul 
and the injection protocol the same as that described above. 
The rats were then replaced in the testing cages and food and 
water weighed 40 minutes later. Finally the animals were 
returned to their home cages.
Lesion assessment
The effects of the lesion were to be assessed by measuring the 
amount of NA present in the lesioned PVN at four time points; 
24 hours, 48 hours, 72 hours and 8 days post-lesion. The 
amount of NA present in the tissue of the PVN was assessed by 
high performance liquid chromatography with electrochemical 
detection (HPLC-ED) according to the method of Mefford (1981). 
In order to assess PVN NA levels by HPLC-ED the animal must 
be sacrificed, the brain quickly removed, micro-dissected 
on ice, and the tissue samples stored frozen at > -20'C until 
the assay. This is in order to prevent the breakdown of the
28
0.0002gms per ml ascorbic acid added to ice cold physiological saline.
29
6-Hydroxydopamine r SIGMA1 (2,4,5-TrihydroxyphenethylamineHydrobromide) No. H-6507 Lot. 43F-0909 Mol. Wt. 250.1
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catecholamines in the tissue by the monamine-oxidases present
HPLC
Catecholamines were separated and detected by reverse phase 
HPLC with electrochemical detection. An isocratic lOOmM 
citrate/acetate buffer (pH adjusted to 5.2 using sodium 
hydroxide) containing ImM ethylenediaminetetra-acetic acid 
(EDTA), lOOmg/L octanesulphonic acid and 10% methanol, was 
pumped at Iml/min using a Gilson 303 HPLC pump. Separation 
was achieved using a Sum C-18 Ultrasphere column (250 x 4.6mm; 
Altex). Catecholamines were detected using a Bioanalytic 
Systems LC4B electrochemical detector connected to a LC-17 
thin layer analytical cell. An oxidation current of 0.7 V 
(with reference to a silver / silver chloride electrode) was 
used to oxidise the catecholamines. The system was calibrated 
by injection of 2ng of each relevent catecholamine.
(i) Brain removal and micro-dissection.
The rats to be sacrificed were lightly anaesthetised 
with halothane^" and then decapitated with a guillotine. The 
brain was rapidly removed (<100sec) and placed on an aluminium 
plate 10cm x 10cm resting in a box of crushed ice. Two cuts 
were made in the coronal plane with a razor blade, slightly
30
Halothane Fluothane inhalation anaesthetic ICI lot UP 686
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anterior and posterior to the PVN, at the levels depicted in 
plates 24 and 27 of Palkowits and Brovmstein (1988). This 
left a coronal section about 1.5mm thick containing the PVN, 
which was placed flat on the plate and dissected down the 
midline. As the 6-OHDA had been injected unilaterally the 
side contralateral to the injection acted as a matched control 
to the lesioned side. However, two unoperated control rats 
were sacrificed at each time to provide absolute control 
levels of NA. The PVN was removed by means of three further 
cuts, the first a horizontal cut just dorsal to the top of 
the third ventricle, the second vertical cut made parallel 
with the midline at the level of the fornix and the final cut 
horizontal at the level of the supra-optic nucleus (see figure 
13). This left a block of tissue about 2mm x 2mm x 1.5mm 
containing the majority of the PVN. This block of tissue was 
wrapped in tin foil and frozen rapidly in a container of dry 
ice, before being stored in a deep freeze at -25'C until 
assay. Rats were sacrificed at 24, 48, 72 and 192 hours, 7 
animals in the first three groups, 8 in the last.
(ii) Assay with HPLC-ED
The HPLC-ED assay was performed at Edinburgh University, 
Department of Pharmacology by Dr. S. Butcher. The 
methodology was as described by Mefford (1981). Unfortunately, 
when the first series of tests were performed the aluminium
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FIGURE 13. Plate from Palkowits and Brownstein showing the lines 
of cut for dissection of the PVN.
#
silicate, used to bind the catecholamines during the washing 
stages, had become 'de-activated' and thus retained only very 
low levels of NA. This resulted in very poor recovery of 
NA from these samples and consequently the number of 
effective results was greatly reduced. Subsequent samples 
were analysed by direct injection of prepared tissue 
homogenate onto the HPLC column. The methodology was as 
follows :
Samples were stored at -20'C prior to analysis. They were 
then weighed before being homogenised in 400ul of 0.6M 
perchloric acid using a teflon-glass homogeniser. Samples 
were then centrifuged at 5000g for 2 minutes and 20ul aliquots 
of the resulting supernatent were injected onto the HPLC 
column using a Rheodyne 7125 injection valve.
Only the results for the 17 animals that gave acceptable 
levels of recovery are presented. The criteria for acceptance 
were: (i) that the results were from samples measured by 
injection of the homogenate, (ii) that one of the pair of 
samples is from the results generated using the aluminium 
silicate process, but resulted from a test in which the 
internal standard could be determined. No results are 
presented for pairs of samples tested by the silicate process. 
All samples were tested at random, and Dr. Butcher was unaware 
of the experimental procedure applied to each sample. However
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it is recommended that the data generated as a result of this 
experiment be taken as indicative of a trend only.
RESULTS
Experiment 2; 6-OHDA lesion control study
This experiment was designed to assess the effects of a small 
(0.5ul, 4mg/ml) injection of 6-OHDA into the PVN, on the level 
of NA in this nucleus. If the level were to be significantly 
reduced then it could be concluded that such an injection 
physically disrupted the NA projection to the PVN. Thus such 
a lesion might act as a means of permanently, or temporarily, 
inhibiting NA re-uptake into pre-synaptic terminals.
As explained in the methods section above this data should not 
be taken as absolute but indicative of a trend. The data 
was analysed as 4 lesion groups (24, 48, 72, 192 hours) with 
3, 4, 3, 3 subjects in each group respectively. The control 
animals were taken as a group (N=4) at time zero pre-lesion. 
The data was entered as a percentage score: NA lesion side / 
NA control side. The control animals were entered NA,Ihs / 
NA rhs. Analysis of the lesion groups over time reveals 
overall significance [F=5.178 df=4,12 p<0.02]. Post-hoc
testing with the Tukey test reveals that this difference lies 
between the 24hrs condition and the control animals (p<0.02) 
and 24hrs and 192hrs (p<0.04). These data are presented
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pictorially in figure 14. The data demonstrate that injection 
of this dose of 6-OHDA into the PVN produces a temporary 
depletion of within the PVN which has recovered within about 
8 days.
Ill
FIGURE 14. Mean (+/- SE) percentage NA loss from PVN following 
treatment with 0.5ul 6-OHDA (4 mg/ml free base). Values shown are 
for unoperated rats (percentage loss calculated as L/R x 100) and 
lesioned rats sacrificed at 24, 48, 72 hours or 8 days post-lesion 
(percentage loss calculated as lesioned side / non-lesioned side 
X 100 for each rat). Significant differences between the groups 
over time were found (F-5.178, df=4,12, p<0.02).
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EXPERIMENT 3
The pharmacological inhibition of the re-uptake mechanism for 
NA might result in there being more NA available in the 
synaptic cleft to bind to post-synaptic receptors. In order 
to examine whether or not this hypothesised increase in NA 
concentration has an effect on feeding behaviour the following 
experiment was performed. Two dose response curves were 
established, one to NA alone and the other to NA in the 
presence of 40 nmoles cocaine. This experiment would also 
demonstrate whether inhibition of re-uptake potentiates the 
effects of exogenous NA by slowing the rate of loss of NA from 
injection site.
METHOD
Two groups of 8 male hooded Lister rats were used. These 
weighed approximately 340gms before surgery and were implanted 
with guide cannulae in the manner described above, using the 
co-ordinates for experiment 2.
Testing.
The animals were acclimatised to the test procedure as 
described previously. One group received 0.5ul injections of 
NA in the following doses: 1, 10, 40, and 100 nmoles presented 
in a counterbalanced order, plus a saline control injection.
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The other group received the same doses of NA but prior to 
each dose they received a pre-injection of 40nmoles cocaine.
RESULTS
The results of this experiment, when combined with those 
generated from the use of cocaine alone are intended to 
demonstrate the effects of cocaine manipulations on NA induced 
feeding within the PVN. The data are presented in figure 15. 
The two curves do not differ significantly (Groups x 
Conditions interaction F=0.41 df=4,56 p<0.80). Thus in this 
preparation pre-treatment with cocaine does not affect the 
feeding response to exogenous NA. Whilst it is accepted that 
cocaine is a drug with a wide variety of effects within the 
CNS these experiments demonstrate that it has neither 
independent effects on NA elicited feeding within the PVN, 
nor does it affect the response to exogenous NA.
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FIGURE 15. Mean {+/- SE) gins of food consumed in 40min following 
microinjection of various doses of NA or the same doses of NA 
directly proceeded by 40nmoles cocaine. All doses of NA or 
NA/cocaine produce significantly more feeding than saline (at 
least, p<0.05). There is no significant difference between the NA 
and NA/cocaine groups at any dose.
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EXPERIMENT 4:
Selective blockade of NA elicited eating.
(i): 6-OHDA study.
This is the first part of a three part experiment, with each 
part performed on a separate group of animals. It was 
designed to identify the receptor sub-type apparently 
responsible for mediating the feeding response to infusion of 
exogenous NA and then to examine the effects of blocking NA 
re-uptake either by 6-OHDA lesion of pre-synaptic terminals 
or pharmacologically with cocaine
Method
A total of 8 male hooded lister rats, weighing about 350gms, 
were implanted with permanent cannulae as described above.
These animals were acclimatised to the test cages and given 
the following series of injections: NA 40nmoles, saline and 
NA 40nmoles / idazoxan 40nmoles, presented in a 
counter-balanced order. Following these injections the 
animals were injected with O.Sul 6-OHDA at a concentration of 
4mg/kg free base (as above p 106). The animals were retested 
24 hrs later with either NA 40nmoles or NA 40 / idazoxan 40 -J 
and the reciprocal condition applied 48 hours later. Finally 
these animals received a saline injection.
Twenty four hours after the last injection the animals were 
sacrificed and the PVN prepared for HPLC-ED assay as described
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above. This assay was once again performed by Dr. S. Butcher 
in Edinburgh. The results of all 3 sections of this 
experiment are presented together below (p.118).
(ii) Selective blockade cocaine study.
This second part of the experiment was intended to examine the 
effects of inhibition of the re-uptake mechanism 
pharmacologically, by means of cocaine. It was hypothesised 
that this would result in an inhibition of a-2 selective 
blockade as a result of enabling the exogenous NA to penetrate 
the synaptic cleft.
Method
A group of 8 male hooded lister rats were implanted with 
cannulae and acclimatised to the test procedure as in the 
previous experiments. These rat received the following 
injections in a counter-balanced order (all drugs 40nmoles 
except prazosin): NA, NA / cocaine, saline, prazosin / NA, 
idazoxan / NA, idazoxan / cocaine / NA. These injections were 
performed at 48 hour intervals and the rats were subsequently 
perfused intra-cardially with 10% phosphate buffered saline 
and the brains submitted for histological verification of the 
cannula position. The results of this experiment are presented 
below (p.118).
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(iii) Simultaneous blockade cocaine study.
The final part of this experiment was designed to determine 
whether or not simultaneous blockade of a-1 and a-2 receptors 
with phentolamine? and the subsequent inhibition of the 
feeding response to exogenous NA; was affected by the presence 
of cocaine. The hypothesis would suggest that the inhibition 
of re-uptake would have no effect on the blockade produced by 
phentolamine as the receptors within the synapse which are 
made available would also be blocked by this compound.
Method
A group of 7 male hooded lister rats (approx. 370gms) were 
implanted and acclimatised as described above. These rats 
received the following injections: NA, saline, phentolamine, 
NA / idazoxan, NA / cocaine / idazoxan, NA / phentolamine, NA 
/ cocaine / phentolamine. All injections were at a dose of 
SOnmoles in O.Sul as this corresponds to the maximum 
solubility of phentolamine. Following the injection series 
the animals were perfused intra-cardially with 10% phosphate 
buffered formalin, their brains removed and submitted for 
histological verification of the cannula position. The results 
are presented below, see figure 16.
Histology
The brains were cut as described above for experiment 1, and 
the sections stained with cresyl violet- Sections were
116
FIGURE 16. Mean (+/- SE) gms food consumed in 40 mins following 
microinjection of 40nmoles NA, saline or NA preceded by 40nmoles 
idazoxan before and after administration of 6-OHDA (O.Sul, 4 mg/ml 
free base) ., Overall analysis showed significant differences 
between the conditions (F=20.484, df=6,60, p<0.001). No
differences were found between the effects of NA before and after 
6-OHDA (p-0.9977), but the effects of idazoxan were significantly 
different after 6-OHDA lesion (p<0.002).
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examined using a Leitz Diaplan microscope (eyepieces xlO, 
objectives xl.6, x2.4). All animals reported had injection 
sites in or directly adjacent to the PVN. Representative 
sections are presented in figure 17.
It should be noted that the histological verification of 
injection sites is, in these experiments, a secondary 
requirement. Each animal receives both control and test 
injections, the use of a repeated measures design means that 
if a certain animal performs the behaviour then the 
manipulations of that behaviour within that animal are 
internally valid. Thus the screening for effect of NA and the 
subsequent manipulations are more important than the exact 
location of the injection. However, the strength of the 
response to NA was clearly related to the proximity of the 
injection site to the PVN as previously reported (Leibowitz 
1978a), and it was thus considered important to maximise the 
behavioural effects by injecting as accurately as possible 
into PVN.
RESULTS 
Experiment 4
fit:Selective blockade and re-uptake inhibition bv 
means of a 6-OHDA lesion.
The purpose of this experiment was to examine the effects of 
re-uptake inhibition on the selective blockade established to
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exogenous NA by idazoxan. The results were analysed by ANOVA 
and post-hoc testing using the Tukey test [F=20.484 df=6,60
p<0.001]. Prior to the 6-OHDA lesion idazoxan significantly 
reduced the effects of exogenous NA (p<0.0001). This 
replicates the findings of Goldman et al. (1985) that the 
feeding response is mediated by the a-2 receptor system. NA 
conditions before and after the 6-OHDA lesion do not differ 
significantly (p-0.9977), neither do the saline conditions 
pre- and post-lesion (p=0.9997). However, the NA / idazoxan 
conditions before and after the 6-OHDA lesion do differ 
significantly (p<0.002). The NA / idazoxan condition 
post-lesion does not differ from either NA alone condition 
(pre- p=0.9137, post- p=0.9972). Thus the 6-OHDA lesion can 
be seen to have had a profound effect on the blockade 
established by idazoxan to the actions of exogenous NA.
Experiment 4
(ii): Selective blockade and re-uptake inhibition bv 
administration of cocaine.
This experiment examined the effect of selective a-1 and a-2 
blockade with and without cocaine. Overall significance was 
found in these data (F-9.05 df-5,35 p<0.001) ANOVA, post-hoc
Newman-Keuls. There was no significant difference between NA 
and NA / cocaine (p=1.0; see also expt.l iii) or between NA 
and NA / prazosin (p=1.0); both of these conditions were 
significantly different to saline (p<0.0005 and p<0.001
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respectively). However, there was a significant difference 
between NA and NA / idazoxan (p<0.02), the addition of 
idazoxan having a significant blocking effect on the actions 
of NA. There is no significant difference between saline and 
NA / idazoxan (p=0.21). When cocaine was added to the NA / 
idazoxan condition this blockade was abolished. NA / idazoxan 
/ cocaine does not differ significantly from NA alone (p=1.0) 
but is significantly greater than NA / idazoxan (p<0.005). 
This demonstrates that the actions of infused NA appear to act 
through a-2 receptors when tested by selective blockade (see 
Goldman et al 1985) but re-uptake inhibition by cocaine 
attenuates a-2 blockade.
Experiment 4
fiii): Simultaneous blockade and re-uptake inhibition 
bv administration of cocaine.
This final part of the experiment was designed to examine 
whether simultaneous blockade of a-1 and a-2 receptors was 
affected by re-uptake blockade with cocaine. The data 
provided significant differences between conditions overall 
[F=21.13 df“6,36 p<0.001]. The actions of infused NA were
significantly inhibited by the actions of phentolamine (NA vs 
NA / phentolamine p<0.001) or by the addition of idazoxan (NA 
vs NA / idazoxan p<0.01). However, the effects of blockade 
by phentolamine were significantly greater than the effects 
of blockade by idazoxan (NA / phentolamine vs NA / idazoxan
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p<0.05). The blockade exerted by idazoxan was abolished by 
the addition of cocaine, the effect of NA / idazoxan / cocaine 
being significantly greater than NA / idazoxan (p<0.0002) 
while NA / idazoxan / cocaine did not differ from NA alone 
(p>0.05). However, the addition of cocaine to NA / 
phentolamine had ^  significant effect on phentolamine 
blockade (NA vs NA / phentolamine / cocaine p=0.33). These 
data are presented pictorially in figure 18.
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FIGURE 17.
A. Selective blockade of eating elicited by 40nmoles NA by prazosin 
and idazoxan. Prazosin (0.2nmoles) did not affect NA elicited 
eating but 40nmoles idazoxan significantly attenuated eating to 
NA. When 40nmoles cocaine was added to NA eating was unaffected, 
but 40nmoles idazoxan was completely ineffective in antagonisisng 
NA/cocaine eating. ( :sig. diff. to 40nmoles NA [hatched bar] 
p<0.05 at least.)
B. Comparative blockade of eating elicited by SOnmoles NA and 
SOnmoles NA/ 40nmoles cocaine. Blockade to SOnmoles idazoxan was 
attenuated when cocaine was added to NA, Blockade to SOnmoles 
phentolamine was unaffected by the addition of cocaine to NA. ( 
:sig. diff. to SOnmoles NA [hatched bar] p<0.05 at least.)
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EXPERIMENT 5
In the introduction evidence was presented for the involvement 
of NA and DA in promoting eating in response to tail pinch. 
The evidence for the involvement of NA in feeding behaviour 
was also extensively reviewed, particularly with reference to 
the actions of NA within the PVN. The PVN was identified, not 
only as a site clearly involved in the feeding response to NA, 
but also as a nucleus with considerable influence in the 
mediation of both neurocrine and endocrine responses to 
stress. The following series of experiments were performed 
to examine the hypothesis that the feeding response to tail 
pinch is in part the result of an increase in endogenous NA 
release within the PVN. This was examined by means of 
bi-lateral infusions of NA selective antagonists into the PVN 
prior to the application of tail pinch, in animals already 
identified to respond to the pinch.
METHOD
Animals
Two groups of male hooded lister rats were employed in this 
study. Group 1 consisted of 12 rats each weighing approx. 
350gms at the time of surgery. Group 2 consisted of a group 
of 7 older rats each weighing about 450gms. at the start of 
the experiment. All rats were single housed and maintained 
under a 12 hour light/dark cycle with 'ad lib' access to SDS
121
No.l chow pellets and tap water. All animals were tested 
whilst food and water satiated.
Tail-pjnch Protocol
The animal to be tested was removed from it's home cage and 
placed in the testing arena, the floor of which was entirely 
covered with lab chow pellets. The arena itself was a four 
sided frame surrounding an area 60cm square and with sides 
40cm high. Three of the sides were aluminium, the fourth was 
clear perspex. The arena was uncovered, see figure 19.
(i) Habituation: Animals were placed in the test arena for an 
habituation period of 120 seconds during which time they were 
free to explore. This habituation was performed on alternate 
days for 5 trials, one per day, at which time the animals were 
judged to have acclimatised to the handling and experimental 
conditions.
(ii) Testing: Following the habituation trials animals were 
placed in the arena as before and allowed 120sec habituation. 
At the end of this time a pneumatic cuff, made of brass and 
padded with sticking plaster, was placed around the animal's 
tail approximately 1 inch (2.5cm) from the tip, see figure 20. 
Pressure was applied to the tail by means of a cylinder of 
compressed air forcing the plunger within the cuff against the 
rat's tail. The pressure of the pinch was regulated by means 
of a control valve attached to the cylinder. The pressure 
started at 10 psi and was raised by 5 psi after three
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FIGURE 18. Photograph of the Tail Pinch arena. The compressed air 
cylinder, and controls for the pneumatic cuff are also shown.

FIGURE 19. Photograph of the pneumatic cuff used for Tail Pinch. 
The air tube is protected at the cuff-end by a metal spring to 
prevent it being punctured by a bite.
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consecutive trials on which the animal did not eat. No 
pressures below 10 psi were considered as the pinch was 
dislodged by almost any movement of the animals tail at such 
low pressures. Pinch pressure was maintained for 120 sec 
unless the animal started to feed during the pinch, in which 
case the clock was re-started for 120 sec from the initiation 
of the feeding bout. Feeding was defined as a period of 3 sec 
of continuous chewing and swallowing of a pellet. Simply 
shredding the food pellets was not counted. The time at which 
feeding was started was recorded and represents the latency. 
Other salient behaviours were recorded idiosyncratically for 
each animal. If the pneumatic cuff was dislodged, the clock 
was stopped and the cuff replaced, in some cases at low 
pressures it was lightly held in place with sticking plaster 
if frequently removed.
The objective of the pre-testing of animals with tail pinch 
was to obtain a population of rats which ate on three 
consecutive trials. Once an animal reached this criteria TP 
was suspended until after surgery. The results of the 
pre-trials are presented below on p.123.
Surgery
The surgical procedure was similar in all respects to that 
described for experiments 1 - 4  excepting that these animals 
were implanted with bi-lateral guide cannulae. This was
123
achieved by affixing two cannula guides to the stereotaxic 
arm. However, the physical dimensions of these guides 
required that the lateral co-ordinate be increased to 0.3mm 
lateral. Injections were thus 0.1mm more lateral than in 
previous experiments.
Injection Protocol
The injection protocol was similar in most respects to that 
used in experiments 1 - 4  except that two injection cannulae 
were used, both injections being performed simultaneously. 
The Harvard pump employed during these experiments was 
designed to mount two syringes simultaneously and no 
significant change in protocol was required.
Drugs.
The drugs used in ths experiment were as follows:
(i) [-]-norepinephrine bitartrate fSIGMA1.
(ii) The combined a-antagonist phentolamine hydrochloride 
rCIBAI.
(iii) The DA antagonist haloperidol rSIGMAI^^.
(iv) The noradrenergic H-antagonist propranolol rSIGMA1. All 
drug solutions were made up in sterile physiological saline, 
except haloperidol which was made up in 0.02% ascorbate 
saline.
31
Haloperidol, Sigma No. H-1512 lot 76F-0016 mol wt. 375.9
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Cannula placement screening.
In order to determine whether the implanted cannulae were 
located correctly, the animals were screened by injection of 
40nmoles NA unilaterally down each of their cannulae. Thus 
each animal received two injections separated by 48 hours, one 
into the left cannula and one into the right. The criteria 
for acceptance of the cannula placement was that the animal 
ate l.Sgms or more in the 40 minute test period following the 
injection. Thus animals could be classified in terms of 
cannula placement: bi-laterally correct; left correct; right 
correct; neither correct. No saline injection was 
administered at this stage in order to minimise the overall 
number of injections performed. The results of this screening 
are presented below on pl27.
Central drug injections
The purpose of this experiment was to determine whether 
central injection of adrenergic or dopaminergic antagonists 
into the PVN could affect the eating response to tail pinch.
The tail-pinch protocol was as described above, except that 
the animal received a bi-lateral injection (0.5ul) of one of 
the following drugs into the PVN 30 minutes before tail-pinch: 
NA (40nm), propranolol (40nm), phentolamine (30nm), or saline.
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Latency to eat was recorded and the results are presented 
below on pl28.
Intra-peritoneal drug injections
A group of 8 rats, all of which had been demonstrated to eat 
to tail-pinch post-surgery, were injected with either 0.02% 
ascorbate saline (1ml/kg) or haloperidol (4mg/kg/ral) 30 
minutes prior to tail-pinch testing. This dose of
haloperidol has previously been demonstrated to be 
non-sedative (Taha and Redgrave 1980). All animals received 
both injections in a randomised order. The results for this 
experiment are presented below on pi28.
Cold Water Stress
As a final experiment the effect on feeding of a known 
stressor, cold water immersion, was examined. The 19 rats 
were randomly assigned to groups; group A (N=10) received an 
injection of 30nmoles phentolamine into the PVN, whilst group 
B (N=9) received a saline injection. Following these
injection animals were returned to their home cages for 30 
minutes before being removed and placed into the Morris water 
maze (Morris 1978), which was filled with cold water (4'C), 
for 45 seconds. Food and water in the home cage was weighed 
at this time. The rat was then removed from the water maze 
and returned to it's home cage, and a measure was taken of 
food and water consumption 1 and 3 hours after the exposure
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to cold water. The results for this experiment are presented 
on p.129.
RESULTS
(i) Baseline TP testing
Of the 12 animals tested (group 1) 8 ate on 3 consecutive 
trials by the eighth trial. Of the animals which ate; 3 ate 
when a pressure of 10 psi was applied, the remaining 5 rats 
ate at a pressure of ISpsi. ANOVA of log latency scores for 
each animal was not significant. There was no decrease in 
latency over the first 3 consecutive trials (F-1.52, df=2,21 
p>0.25). Of the rats which did not reach criterion, 1 never 
ate, 1 ate on three trials and 2 ate on four trials but never 
on consecutive days.
(ii) Post-operative TP testing
Both groups of rats were tested post operatively (N=19) and 
the latency for the first three trials was analysed by ANOVA. 
There was no significant difference between the three trials 
(F=1.15, df=2,21 p>0.25). Comparison of the pre- and post­
operative trials shows no significant differences (F=1.17, 
df=5,42 p>0.25). It thus appears possible to establish a 
baseline latency for the onset of TP induced eating. No rat 
that failed to eat consistently in the pre-operative screening 
ate consistently post-operatively.
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(iii) NA screening procedure
The criteria of consuming l.Sgms of lab chow within 40 minutes 
was applied as for experiments 1-4. Of the left cannulae 13 
from the 19 animals were correct. Of the right cannulae 15 
of the 19 were correct. A total of 10 animals were found to 
have bi-laterally correct cannulae. When the second criterion 
of eating on three consecutive trials was applied 6 animals 
fulfilled all the requirements and these 6 animals were 
subsequently used in the microinjection experiments.
(iv) Microinjection studies
None of the noradrenergic agents phentolamine, propranolol or 
NA had a significant effect on TP induced eating. ANOVA of the 
pre-operative, post-operative and drug microinjection trials 
revealed no significant differences (F=1.77, df=4,25 p>0.25).
Table 1. 
Condition Pre-op. Post-op. Phen. Prop. NA SalNo. rats eating 8/12 8/12 6/6 6/6 6/6 6/6Latency(secs) 64.2 55.7 44.6 75.8 63.7 88.8
SEM 8.0 7.4 18.5 15.4 15.6 11.4
(v) Intra-peritoneal drug injection study
None of the 8 animals injected i.p. with haloperidol ate under 
TP. However 6 of these 8 animals ate when injected i.p. with
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vehicle (ascorbate saline). Injections were performed in a 
counterbalanced order.
(vi) Cold water swim
Food consumed 1 and 3 hours after exposure to cold water was 
calculated. No significant difference was found between the 
phentolamine microinjected animals and saline injected 
controls (Student's t test t=-1.32, df=14.6, p=0.21).
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EXPERIMENT 6
Experiments 1 - 4  were designed to examine the hypothesis that 
there is a separation of post-synaptic alpha-receptors within 
the PVN. The a-2 receptor was hypothesised to be 
predominantly outside the 'classical' synapse, whilst the a- 
1 receptor was intra-synaptic. The results of these
experiments appeared to justify further examination of this 
hypothesis. In order to examine whether extra-synaptic a-2 
receptors and 'paracrine' release of NA might be a 
generalisable principle it was necessary to look at the 
effects of NA at a different site and generating a different 
behaviour. The site chosen for further investigation was the 
ventral striatum, and the behaviour to be examined was 
locomotion. In order to explain the reasoning behind both 
this choice of site and behaviour, some analysis of the 
anatomy and function of the ventral striatum is required.
This is presented below.
VENTRAL STRIATUM 
General Anatomy
The striatum is both a prominent and easily localised
component of the basal telencephalic grey matter in all
!mammals. It is a mosaic of two interlocked but neurochemically j 
distinct compartments known as patches and matrices. The 
patches demonstrate high opiate receptor binding and 1enkephalin- and substance-P like immunoreactivity. The j
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matrices have high acetyl- cholinesterase activity and are 
dense with fibres displaying somatostatin like 
immunoreactivity (Gerfen 1984). Graybiel (1983) suggests 
that this patch and matrix organisation may be a sub-cortical 
arrangement similar to the layers and columns organisation of 
the neocortex and be important in the organised channelling 
of information through this tissue. The lateral ventricle and 
subcallosal fasiculus clearly define the dorsal extent of the 
striatum. However, few such landmarks are available to 
demarcate the ventral extent of this structure. At many 
points in the basal forebrain it is extremely difficult to 
distinguish neo-striatal elements from areas such as the 
nucleus accumbens septi and the olfactory tubercle. Indeed 
it has been suggested (Heimer and van Hoesen 1979) that it is 
appropriate to view these latter structures as part of the 
ventral striatum. Consequently, in this chapter the term 
'ventral striatum' includes the nucleus accumbens, the 
olfactory tubercle and the ventral subcommissural part of the 
main body of the striatum. These structures are continuous 
with each other through 'striatal' cell bridges and are 
characterised by a 'striatal' pattern of connections. 
However, they are distinguished by certain hodological 
features which differ from the rest of the striatum. The 
boundary between the ventral olfactory tubercle and the 
underlying olfactory cortex seems sharp and clearly defined 
in both acetylcholinesterase (AChE) and Nissl-stained
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preparations in the rat. In contrast, the dorsal boundary 
between the tubercle and the nucleus accumbens is difficult 
to define particularly at more rostral levels. Many cell 
bridges provide a continuity between tubercle and accumbens 
which reaches the surface between the fibre bundles of the 
deep olfactory radiation (Heimer and van Hoesen 1979).
Anatomical connections
(i) Afferent connections.
The ventral striatum, as defined above, is largely 
characterised by the same pattern of connections as the dorsal 
striatum. That is, the major afferent pathways to the 
accumbens and tubercle originate in dopaminergic cells in the 
midbrain, non-specific thalamic nuclei and cerebral cortex. 
However there are also significant differences between the 
inputs to dorsal and ventral striatum. In particular, the 
dorsal striatum appears to receive no input from the amygdala 
whereas the ventral striatum receives a major amygdaloid 
projection, originating from the basolateral and basomedial 
amygdaloid nuclei. Afferents from the piriform cortex 
terminate in the olfactory tubercle and ventral part of the 
accumbens and afferents from the hippocampus (originating 
predominantly from the subiculum) terminate in the medial zone 
of the nucleus accumbens (Bjorklund and Lindvall 1986). 
Recently the projection from subiculum to the nucleus
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accumbens has been identified as glutaminergic (Totterdell and 
Smith 1986).
(ii) Efferent connections.
The efferent projections of the ventral striatum again show 
similarities with those of the dorsal striatum; neither 
striatal area having reciprocal connections with the cerebral 
cortex. Fibres from the nucleus accumbens ascend to the 
anterior septum, hippocampal rudiment, the anterior part of 
the dorsal striatum and the lateral septal nucleus. 
Descending fibres run to the globus pallidus and the medial 
and lateral pre-optic areas. There also appears to be a 
sparse projection to the PVN. Some labelled nucleus accumbens 
fibres remain in the MFB before becoming diffusely scattered 
in the ventral tegmental area, or spreading laterally to the 
substantia nigra where they distribute medially into the pars 
compacta and dorsally and medially into the pars reticulata 
(Conrad and Pfaff 1976).
Organisation of Striatal Circuitry
(i) Dopamine.
The AlO group of the mesencephalic DA cell group, mainly 
located in the ventral tegmental area (VTA), projects to the 
entire subcommissural part of the ventral striatum as well as 
to much of the caudate/putamen (Bjorklund and Lindvall 1986). 
The substantia nigra in contrast projects DA fibres
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FIGURE 20. Comparison of areas within striatal complex receiving 
afferents from nigral and DA neurons of AlO cell group (left) and 
from different parts of cortical mantle and amygdala (right). 
Figure from Bjorklund and Lindvall (1986)
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FIGURE 21. A. Anatomical relationship between cerebral cortex, 
striatal complex, thalamus, and ventral mesencephalon. Left-tilted 
hatching - areas innervated by substatia nigra; right-tilted 
hatching - areas innervated by DA neurons of AlO cell group.
B. Some major pathways and transmitter characteristics related to 
DA projection from VTA and medial substatia nigr to ventral part 
of striatal complex and to limbic cortex.
Both figures from Bjorklund and Lindvall (1986).
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predominantly to the caudate/putamen. Reciprocal connections 
occur with the dorsal striatum projecting to the substantia 
nigra, and the ventral striatum projecting to the VTA. 
However, as mentioned above the nucleus accumbens also 
projects to the substantia nigra which thus seems to represent 
a convergence point for outflow from both dorsal and ventral 
striatal complexes, Recent immuno-histochemical studies 
suggest that a second transmitter substance, cholecystokinin 
is co-localised in the same neurons as DA in elements of the 
mesolimbic pathway of the rat (Hokfelt et al. 1980).
(ii) Limbic and non-limbic organisation.
The functional organisation of striatal circuitary is thought 
to be regionally dissociated into two parts. The ventral or 
’limbic' region mediates the involvement of the striatum in 
affective behaviour. The dorsal 'nonlimbic' region is 
involved in sensorimotor function. The organisation of 
striatal input and output systems supports this view. The 
dorsal striatum receives neocortical inputs from sensorimotor 
areas and projects to the dorsal pallidum and substantia 
nigra. The ventral striatum receives 'limbic' inputs from 
amygdala and allocortex and projects to ventral pallidum and 
lateral hypothalamic and pre-optic areas. These systems 
interact by the convergence of output pathways to the 
thalamus, and midbrain tegmentum as well as the ventral 
striatal output to substantia nigra which provides the
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nigro-striatal 'feedback' loop to the dorsal striatum (Gerfen
1984) .
Behavioural Manipulation
Attempts to define the functions of the ventral striatum in 
behavioural terms have generally taken one of two forms. 
Either the lesioning of this area or the administration of 
pharmacological compounds by direct injection. The lesion 
studies themselves can be sub-divided into two categories: i) 
non-selective lesions of ventral striatum, ii) 6-OHDA lesions 
of the monoaminergic innervation of the ventral striatum. 
Certain studies have included both lesion and pharmacological 
components. A brief review of some of these studies, 
predominantly those that are concerned with locomotor 
behaviour, is presented below.
6-OHDA lesion
Ipsilateral rotation can be generated in rats by unilateral 
lesion of the ascending nigro-striatal DA pathway, followed 
by injection with amphetamine and contra-lateral rotation by 
injection with L-dopa. These drug induced rotational 
behaviours can be modified by changing activity in the 
mesolimbic DA system, such as 6-OHDA lesion of the nucleus 
accumbens. Thus demonstrating the possibility that both 
mesolimbic and nigro-striatal DA systems are involved in the 
control of motor behaviour (Kelley and Moore, 1976). More
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specifically Fink and Smith (1980a) demonstrated that 6-OHDA 
lesions of the mesolimbic DA system impair normal exploratory 
behaviour in rats. This impairment was largely corrected by 
intra-peritoneal injection of the direct DA agonist 
apomorphine. The deficits induced by such lesions did not 
appear to be the result of global motor deficits or changes 
in emotionality (Fink and Smith, 1979). The restoration of 
exploratory behaviour was not the result of increased general 
activity induced by apomorphine and could itself be 
antagonised by administration of the DA antagonist pimozide 
(Fink and Smith, 1980b). Furthermore, the increase in 
locomotion generated by intra-peritoneal administration of 1.5 
mg/kg d-amphetamine in the rat, was completely abolished by 
DA depletion of the ventral striatum. They state "that we 
were able to produce an abolition of the amphetamine -induced 
locomotion by severe denervation that was restricted to the 
mesolimbicocortical DA system and to adjacent medial and 
ventral striatal terminal fields is decisive evidence that 
these terminal fields were necessary for this response" (Fink 
and Smith, 1980c p. 122). However, it is important to note 
that denervation of the nucleus accumbens alone is not 
sufficient for a large decrease in the locomotor response to 
this dose of d-amphetamine (Fink and Smith 1980c). 
Furthermore, the lesions made by Fink and Smith which they 
claim to be selective for the DA innervation of the ventral 
striatum have been criticised as being too extensive and
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causing damage in the caudate/putamen. When selective 6-OHDA 
lesions of the DA terminal fields in the nucleus accumbens 
alone were examined exploratory deficits were not observed, 
and the range and extent of locomotor and drug induced 
behavioural deficits was greatly reduced (Winn and Robbins
1985).
Neurotoxin lesions
Kainic acid lesions restricted to the dorsal striatum and ; 
which left the ventral striatum intact, increased the 
locomotor response to amphetamine. This indicated that the 
neuronal elements of the ventral striatum were capable of 
mediating amphetamine induced locomotion (Mason et al. 1978).
Electrolytic lesions
Small electrolytic lesions confined to the ventral striatum 
result in animals showing a decrease in d-amphetamine induced 
locomotion. This is consistent with the suggestion that 
ventral striatal DA innervation may be more important to 
amphetamine-induced locomotion than dorsal striatal DA 
innervation (Neill et al. 1974).
Overall the lesion studies have demonstrated that the ventral 
striatum may have a role in the control of some aspects of 
locomotor and exploratory behaviour. However it is most 
important to note that the majority of 'lesion' studies of the
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ventral striatum are NOT lesions of generalised striatal cells 
or cells + fibres but are in fact lesions of ascending 
monoaminergic projections. Whilst DA is clearly an important 
transmitter in this region, the complexity of striatal 
organisation implies it has a variety of processing tasks to 
perform and involves a number of different transmitter 
systems. Thus demonstrations of the effects of manipulation 
of DA levels show only part of the functions of this region.
Micro-iniection studies
The direct injection of pharmacological agents into the CNS 
is a potent means of establishing behavioural or physiological 
consequences dependent upon transmitter action in discrete 
sites. In parallel with the lesion studies, microinjection 
of compounds into the ventral striatum appears to have been 
mainly directed at understanding the actions of the monoamine 
transmitters, particularly DA, at this site. Pijneburg et 
al. (1973) established that the micro-injection of ergometrine, 
a potent DA agonist, into the cerebral ventricles induced 
strong and long-lasting locomotor stimulation. The most 
potent locus of this behaviour was found to be the nucleus 
accumbens and these actions could be inhibited by subsequent 
doses of DA antagonists. Recent studies by Alexander Cools 
have suggested that whilst locomotor activity is clearly 
stimulated by injection of DA agonists into the ventral 
striatum, this activity is from DA actions in the olfactory
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tubercle and not the nucleus accumbens (Cools 1985,1986). 
Interestingly, Pijneburg et al. (1976) suggested that ventral 
striatal injection of NA also elicited locomotor activity but 
that this was less pronounced than that elicited by DA. They 
suggested the possibility that NA elicited locomotion was 
dependent upon the integrity of the meso-limbic DA system. 
In animals with DA depleting 6-OHDA lesions of the ventral 
striatum injection of NA fails to produce an increase in 
locomotor activity.
As suggested at the beginning of this chapter, in order to 
confirm the hypothesis about NA action and extra-synaptic a- 
2 receptors it is necessary to examine more than one site and 
one behaviour. Pijneburg et al. (1976) state that the 
injection of NA into the ventral striatum of nialamide pre­
treated rats causes an increase in locomotor activity. The 
ability to demonstrate an effect similar to that found in PVN 
but at a different site and with a different behaviour would 
add considerable weight to the suggestion that the effects 
demonstrated within the PVN were generalisable rather than 
site specific. Thus the hypothesis for the actions of NA in 
ventral striatum is; micro-injected NA in ventral striatum 
produces an increase in locomotor activity. This activity can 
be blocked by phentolamine and idazoxan but not prazosin. 
Blockade of NA re-uptake systems does not affect blockade by 
phentolamine but does affect blockade by idazoxan.
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The proposed experiments were as follows ;
(i) Micro-inject 40nmoles NA bi-laterally into the ventral 
striatum of rats and record subsequent locomotor activity.
(ii) If injection of NA at this site resulted in an increase 
in locomotion, attempt to block this with antagonists to NA 
a- receptors.
(iii) If such blockade could be established, the receptor 
apparently mediating this response could be identified. Were 
this to be of the a-2 sub-type pharmacological manipulations 
similar to those performed in PVN could be performed. 
EXPERIMENT 6
METHOD
Animals
A total of 32 male Hooded Lister rats were used. These 
animals had been bred 'in house' and weighed approx. 450 gms 
at the time of surgery. The animals were maintained 'ad lib' 
on SDS maintenance diet no.l lab chow and water, and kept 
under a 12 hour light/dark cycle.
Surgery
All the animals were bilaterally implanted with two permanent, 
23 gauge stainless steel guide cannulae which were normally 
occluded by indwelling stylets (11.5mm in length). The 
surgical protocol was as previously described in experiment 
1, except that the implants were bi-lateral, and the co-
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ordinates were changed. The co-ordinates used were according 
to the atlas of Pelligrino and Cushman; in the de Groot 
orientation: nose bar +5mm above the interaural line; 3.4 mm 
anterior to Bregma; 1.5mm lateral to the midline; and 6.0mm 
below dura. These co-ordinates resulted in injection sites 
in the ventral striatum.
General Test Procedure
Following at least 3 days recovery from surgery, rats were 
acclimatised to the test environment. This consisted of an 
array of 12 wire sided cages each measuring 25cm x 39cm x 
18cm, see figure 22. The room containing this array of cages 
was maintained under red light.Each cage contained four 
photoelectric cells, arranged in pairs, just above the floor 
of the cage. These were connected to a BBC microcomputer via 
a Paul Frey 'Spider' interface. Figure 21. Beam breaks were 
counted and saved to disc with the computer software filtering 
out repeated breaks of only one beam. The resulting counts 
were a reliable measure of locomotion. All animals were 
acclimatised for at least 7 days prior to drug injection. 
Stylets were changed each day and the animal handled with the 
infusion pump running to simulate the injection protocol.
In each test session, the animals to be tested were placed in 
the test cages for 1 hour prior to injection. They were then 
returned to their home cages before being microinjected
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FIGURE 22. Photograph showing three of the locomotor activity 
cages and the SPIDER interface.
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individually and then placed immediately into the test cage. 
Each test ran for 100 minutes and all tests were separated by 
a minimum of 24 hours.
Drug Injections
The drug injection procedure was similar to that previously 
described for experiment 1. The difference being that the 
infusions were, in this case, bi-lateral, and of lul over 2 
minutes. Injection of antagonist was performed 30 minutes 
prior to NA with the animal being returned to the home cage 
in between. Injection of cocaine was performed immediately 
prior to the injection of NA. All the drugs used were 
administered in a standard dose of 40nM\ul, and all were made 
up in physiological saline, (for details see expt. 1).
Histologv
In order to confirm the cannula placements the animals were 
sacrificed under barbiturate anaesthesia and perfused intra- 
cardially with 0.9% physiological saline and 10% phosphate 
buffered formalin. Sections were cut and stained as described 
for experiment 1. All animals presented in the analysis had 
bi-lateral injection sites within the ventral striatum. Table 
3a. shows the bi-lateral positioning for each animal.
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Pilot Study
This study was intended to determine whether injection of 40nM 
of NA into the ventral striatum would induce an increase in 
locomotion. The literature is unclear on the effects of such 
an infusion with Pijnenburg et al. (1976) finding no effect 
but Cools (1986) claiming a significant increase in 
locomotion. This experiment used 8 animals and doses of 20,
40, and 80nM/ul. Rats were split into 2 groups and injections 
were counterbalanced as shown below;
DAYl DAY3 DAYS DAY?
Group (A) 80nM Saline 40nM 20nM
Group (b) 40nM 80nM Saline 20nM
RESULTS
The results of this experiment are presented in figure 23. 
There is clearly an increase in locomotion as a result of 
injection of NA. However this increase is not easily linked 
to the dose of NA administered. It appears that an important 
factor in the size of the response to NA injection is whether 
or not there had been a previous infusion of NA. Second or 
more subsequent injections of NA produce a greater response 
than that produced to the same dose as a first injection. 
Histological examination of the injection sites did not reveal 
a clear answer. There is some indication that the deeper the
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injection the greater effect of NA, locations of the sites are 
presented in Table 3b.
EXPERIMENTAL PROCEDURE
The main experiment involved the use of 24 rats which were 
split into two groups, A and B in order to examine a wide 
range of drug manipulations without increasing the number of 
injections per animal. The injections given to each animal 
are presented in table 4. Procedures are summarised as 
follows.
(i) All rats from both groups were given bi-lateral NA (40nm 
in lul).
(ii) All rats from both groups were given bi-lateral
injections of both 40nm NA or vehicle (saline) separated by 
48 hours. The order of injection was counterbalanced both 
between and within groups.
(iii) Group B rats only (N=10) received injections of 
phentolamine/NA and phentolamine/saline. Injections were
separated by 48 hours and presented in a counterbalanced 
order.
(iv) Group A rats only (N=8) received injections of cocaine/NA 
and cocaine/saline. Injections were presented in a
counterbalanced order and separated by 48 hours.
(v) Group B rats received injections of idazoxan/NA or 
idazoxan/saline. Again injections were separated by 48 hours 
and counterbalanced.
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(vi) All rats (N=18) received microinjections of idazoxan/ 
cocaine/NA.
RESULTS
The pilot study had demonstrated that microinjection of NA, 
at a dose of 40nm in lul, into the ventral striatum produced 
an increase in locomotor activity. There was also the 
suggestion that a 'priming' effect; that is subsequent 
injection of an equal dose of NA being significantly more 
potent at eliciting this behaviour than the initial dose; 
occurred following injection of NA into the ventral striatum. 
The data for this study is presented in figure 24 a. showing 
the dose response curve and the modified curve if an allowance 
is made for the priming dose.
The suggestion that there was a priming effect was further 
examined in the main experiment. The injection of 40nm NA 
into the ventral striatum elicited an increase in locomotion 
when compared with saline (F=5.07, df=17, p<0.05). The effect 
of a second dose of 40nm NA administered 48 hours after the 
initial or priming dose was significantly greater than saline 
(F=14.94, df=17, p<0.002) and also significantly greater than 
the effects of the first dose of NA (F=9.74, df=17, p<0.05). 
However this priming effect is clearly complex, in both groups 
A and B whilst the majority of animals showed an increase 
following the second injection, one or two animals showed a
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NA DOSE RESPONSE
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FIGURE 24. Graph showing enhanced locomotion over 100 mins. as a 
result of NA microinjection into ventral striatum. Data shown 
represents the second dose of 40nm NA for group B. The increase 
in activity was significant (p<0.002, F=14.9)
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markedly reversed response. For this reason the complete data 
is presented in table 5. Figure 24 b. illustrates the 'primed' 
NA response compared with saline and the initial NA response 
combined over both groups.
Phentolamine blockade.
The combined a~l, a-2 antagonist phentolamine did not reduce 
the locomotor stimulant effect of NA. Phentolamine and NA is 
not significantly different to NA alone (F=0.413, df-9,
p>0.05). Phentolamine and saline does not differ 
significantly from saline alone (F=0.68, df=9, p>0.05).
Inspection of the data indicates that, as with the NA priming 
effects, the majority of the animals show an effect in one 
direction whilst one or two rats respond strongly the other 
way. The reasons for this are unclear.
Re-uptake inhibition with cocaine.
The combination of cocaine and NA did not differ significantly 
from NA alone (F=1.76, df=7, p>0.05). However cocaine alone 
did differ significantly from saline (F=6.7, df=7, p<0.05). 
This may have been the result of cocaine actions at NA or 
other monoamine sites in ventral striatum and will be 
considered further in the discussion.
Idazoxan blockade.
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FIGURE 25. Graph showing the priming effect of a second dose of 
40nm NA for all rats. The significance levels for these data are |
reported in the text.
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FIGURE 26. Graph showing the effects of NA a- antagonists, and 
cocaine on the locomotor response to microinjection of 40nm NA into 
ventral striatum. The significance levels for these data are 
reported in the text.
—I
m>
mz—4oozo
ido
o13OC13CO
>!z:o
G3
OOgtd
1— 4
MO
<!
Z
*—3
>
CO H  
53H-H >
X  >>  M  O
tdMOO
MIS13 O
tdZH
zC-H
M
O)—3
Oz
o
z>
In the light of the fact that phentolamine produced no 
significant blockade of NA induced locomotion, it was not 
expected that the a-2 selective antagonist idazoxan would 
produce blockade. No significant blockade was established 
(F=0.728, df=9, p>0.05). Once again two rats showed an
opposite trend to the other eight, and interestingly it was 
the same two animals as with phentolamine. One of these rats 
had cannulae ending in the pallidum, obviously incorrectly 
placed. However, the other had bi-lateral cannulae sited in 
ventral striatum. The results are not simply the result of 
incorrect cannula placing.
Combined cocaine, Idazoxan and NA injection.
As the idazoxan experiment produced no significant blockade 
the microinjection of cocaine in addition to idazoxan could 
not show attenuation of blockade. This combined injection did 
not differ significantly from NA alone (F-3.77, df-7, p>0.05).
The results of these experiments are discussed further below 
(pl59) however it is worth noting that whilst the mechanism 
by which it acts is unclear, microinjection of NA into the 
ventral striatum produces a significant increase in 
locomotion.
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TABLE 3a
Table for pilot study animals showing number of counts in locomotor cages over 60 min. following 
injection of NA. Site refers to the areas shown histologically to be affected by the injections.
+ OT
+ OT 
+ OT
+ OT
TABLE 3b
Table showing locations of injection site damage in animals used in main experimental groups.
Rat No. NA 20ul NA 40ul NA SOul Site
1 313 708 NAS
2 102 151 259 NAS
4 177 219 111 NAS
5 1019 1121 335 NAS
7 263 70 1377 NAS
8 636 288 938 NAS
9 740 78 1334 NAS
11 743 105 1871 NAS
Rat No. LHS. RHS.
41 NAS NAS
43 NAS + OT NAS + OT
44 NAS + OT NAS + OT
45 NAS + OT NAS + OT
46 NAS NAS
47 NAS NAS + OT
48 NAS NAS
49 NAS + OT NAS + OT
50 NAS + OT NAS + OT
51 PALLIDUM PALLIDUM
52 NAS + OT NAS + OT
53 OT NAS + OT
57 NAS NAS + OT
58 NAS + OT NAS
59 NAS + OT NAS + OT
60 NAS + OT NAS + OT
DISCARDED
TABLE 4
Data as total counts in 100 min. trial from main experimental 
groups A and B.
Group A.
Rat No. Cond .1 2 3 4 5 6 7 8 9 10
38/3 88 211 155 91 71 73
39/3 141 598 37 266 34 286
41/3 197 571 68 463 310 498
43/3 162 83 62 190 546 317
44/3 2584 2361 176 482 39 ' 846
45/3 232 420 29 744 341 312
46/3 690 1879 89 214 138 475
47/3 88 751 158 666 356 510
Group B.
48/3 136 480 60 326 36 288 88
49/3 120 176 18 13 20 262 33
50/3 265 633 43 383 51 406 65
51/3 461 244 232 1091 895 534 51
52/3 56 184 62 60 32 59 114
53/3 266 443 92 1523 7 718 33
57/3 184 492 73 277 175 228 78
58/3 800 1160 50 477 42 110 98
59/3 100 98 22 158 25 74 71
60/3 400 552 148 526 85 732 159
Conditions : 1= first dose of NA, 2= second <dose of: NA, 3= saline.
4= phentolamine + NA, 5= phentolamine + saline, 6= cocaine + NA, 
7- cocaine + saline, 8= idazoxan + NA, 9= idazoxan + saline,
10= idazoxan + cocaine + NA.
EXPERIMENT 7
This experiment was designed to examine the possibility of 
making a selective cell specific neurotoxic lesion of the 
parvocellular portion of the PVN. A variety of supposedly 
'fibre sparing' neurotoxic agents are available and are 
becoming widely used tools in neuroscience. These agents, in 
particular ibotenic acid (IBO) and n-methyl-d-aspartic acid 
(NMDA) are reported to cause death of cell bodies without 
damage to fibres 'en passant'. It is known that these toxins 
have their effect through receptors for excitatory amino acids 
(EAA's) although the exact classification of which toxin acts 
through which receptor is as yet unclear (Winn et al. in 
preparation). One frequently noted observation made regarding 
the use of certain excitotoxins is that magnocellular neurons 
are reliably and frequently spared in areas of otherwise 
complete cell death. One reason suggested for this is that 
magnocellular neurons may lack receptors for EAA's and thus 
remain unaffected by these toxins.
In the light of this observation it was considered a 
possibility that a neurotoxic lesion of the PVN might result 
in destruction of the parvocellular portion without causing 
significant damage to the magnocellular component. This would 
permit an examination of the contribution of the separate 
components of the PVN to the feeding behaviour elicited by 
microinjection of NA. Such a parvocellular depleting lesion
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has been obtained in the Syrian hamster (Hastings; pers. 
comm.) although the shape of the PVN differs slightly in this 
animal.
METHOD
Animals
A total of 10 male hooded Lister rats, bred 'in house', were 
used each weighing approximately 370gms at the beginning of 
the experiment. The rats were individually housed and kept 
under a 12hr light/dark cycle. The were maintained 'ad lib' 
on SDS maintenance diet No.l chow pellets and tap water.
Surgery.
The rats were anaesthetised with avertin and mounted in a Kopf 
stereotaxic frame. The surface of the skull was exposed and 
the location of bregma recorded. The co-ordinates were 
according to the atlas of Paxinos and Watson (1982): flat
skull position, nose bar 3.3mm below the interaural line, 
1.8mm posterior to bregma, lateral 0.2mm, and 8.5mm below the 
skull surface. A hole was drilled in the skull such that the 
30gauge injection cannulae could be lowered bi-laterally.
Injection protocol.
The injection was in principle very similar to that described 
for microinjections in previous experiments. Two 15mm long, 
30gauge injection cannulae were mounted on the stereotaxic
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frame. These were assembled and connected to the infusion 
pump in the manner previously described. Once the surface of 
the brain was exposed these cannulae were stereotaxically 
lowered into place and infusion of the neurotoxin commenced.
Results
Several concentrations of both ibotenic acid and NMDA were 
used; Ibotenic 0.12M, 0.06M, and 0.03M and NMDA 0.12M, 0.06M 
and 0.03M (all injections in O.Sul). Within approximately 30 
seconds of the commencement of infusions of either neurotoxin 
at either 0.05 or 0.12M, the rat began to hyperventilate and 
died in less than 1 minute even if the infusion was 
immediately stopped. At the concentration of 0.03M both 
toxins still resulted in hyperventilation but only ibotenic 
acid caused death. Unfortunately, whilst this dose of NMDA 
did not cause death, no lesion was found when the brains were 
examined histologically 14 days post-operatively. This 
experiment was not pursued further following this 
discovery.blockade (NA vs NA / phentolamine / cocaine p=0.33).
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DISCUSSION
Tail Pinch.
This experiment was concerned with the possibility that some 
component of tail pinch induced eating is mediated via a 
noradrenergic mechanism within the PVN. This hypothesis was 
based upon the evidence that the PVN has a major influence 
over the endocrine responses to stress (Bassett 1984) and that 
the microinjection of NA into PVN elicits feeding in the 
satiated rat (Leibowitz 1973,1975a,b,1978a). Furthermore 
Robbins et al. (1981) selectively lesioned DNAB with 6-OHDA 
and demonstrated an impaired response to TP.
In this laboratory, applying a pinch to rats' tails reliably 
elicited eating in satiated animals. Once such eating was 
established the latency of onset remained stable. This 
appears to be in contradiction with Antelman et al. (1975) who 
reported a steady decrease in latency with repeated trials, 
a feature which led both they and Koob et al. (1976) to 
postulate that TP is a learned response. However, Judith 
Clark (Pers. Comm, unpublished) has reported that at some 
pinch pressures rats with lesions of the lateral hypothalamus 
responded to TP on the first trial. The fact that a first 
trial response was possible, albeit in animals with CNS 
manipulations, suggested that direct physiological or 
psychological factors might induce this behaviour in 
circumstances where learning had not yet occured.
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The level of pinch pressure was found to be important. No 
responses were generated by pinch pressures of less than 10 
psi. and (unquantified) behavioural observation suggested a 
pressure of 5 psi, to have no effect different from the 
habituation conditions of having the cuff in place but no 
pressure applied. However, in contrast to the reports of 
Antelman's group (Antelman and Rowland 1976, Antelman et al. 
1975) the animals in this study were clearly aware of the cuff 
even if no pressure was applied. Frequent movements of the 
tail and cuff directed orienting and biting were observed even 
in the habituation stage. The effective pinch pressures for 
eliciting eating were found to be 10 or 15 psi. and the 
typical latency was around 60 sec. In agreement with other 
studies (Antelman et al. 1975, Koob et al. 1976) the eating 
bout finished exactly at the time pinch pressure was released. 
Animals were observed to allow food to fall from their mouths 
as the pinch ceased. The four animals which failed to eat at 
15 psi. still did not eat when the pressure was increased to 
20 psi. but they exhibited marked signs of distress; 
vocalisation, defecation and pinch directed biting; at these 
pressures.
As a result of their being two sets of independent criteria 
for these experiments the number of animals used in the 
central drug studies was reduced to six. Animals were
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required to have bi-lateral cannulae either of which 
independently supported feeding to the microinjection of NA 
and also to eat to TP on three successive trials. The 
microinjection of NA antagonists into the PVN prior to TP 
revealed the eating elicited by TP to be maintained in the 
absence of NA activation of PVN sites, Noradrenergic 
antagonists had previously been administered systemically by 
Antelman et al. (1975) without producing a blockade to TP 
induced eating. However, central injections often differ in 
effect from peripheral injections and in the light of the 
evidence linking stress and feeding to the PVN such an 
examination was considered worthwhile. Phentolamine the 
combined alpha-antagonist, administered at a dose previously 
shown to abolish feeding to PVN NA injection did not affect 
TP induced eating. Neither did the beta-antagonist 
propranolol. That the injection of these antagonists did not 
affect even the latency of TP induced eating can be taken as 
evidence that TP is not mediated via the PVN.
In order to compare the action of phentolamine in the PVN on 
TP and another form of stress induced eating, a second 
stressor known to elicit eating, was examined. Microinjection 
of phentolamine into the PVN failed to antagonise eating 
resulting from the stress of a cold water swim.
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Intra-peritoneal injection of the DA antagonist haloperidol, 
in a dose previously demonstrated not to inhibit normal 
feeding significantly attenuated the response to TP. Not one 
of the 10 animals injected with haloperidol ate to TP. This 
result replicates Antelman's (1974) finding.
In conclusion: TP induced eating is not attenuated by PVN 
microinjections of the NA antagonists phentolamine or 
propranolol, nor is the response altered by microinjection of 
NA, Thus despite the involvement of the PVN and NA both 
feeding and stress this system is not involved in TP induced 
eating.
Noradrenergic transmission within the PVN.
Injection of NA into the PVN of rats induced eating even 
though the animals were satiated. This feeding response was 
blocked by the administration of the alpha blocking agent 
phentolamine and by the selective a-2 antagonist idazoxan, 
although this blockade is not as great as that established by 
phentolamine. These effects replicate the work previously 
published by Leibowitz and her colleagues (Leibowitz 
1973,1975a,b 1978b, Goldman 1985). In the doses used here, 
neither of these agents had independent actions on food 
consumption. The blockade established to idazoxan was greatly 
attenuated by pre-injection of the re-uptake blocking agent 
cocaine, whereas that established to phentolamine was
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unaffected by this treatment. Injection of cocaine had no 
independent effect on food intake, nor did it affect the 
response elicited by NA. Similarly, lesion of NA terminals 
in the PVN by 6-OHDA had no effect on the eating elicited by 
microinjection of NA but significantly attenuated the ability 
of idazoxan to antagonise this effect of NA.
These data can be accommodated in an hypothesis which proposes 
that the a-1 and a-2 receptors differ in terms of their 
location on neuronal membranes. As discussed in the 
introduction the idea that post-synaptic receptor sub-types 
differ in location with regard to the synaptic specialisation 
is not new. It has previously been suggested in the periphery 
by Langer and his colleagues (Langer and Shepperson 1982, 
Langer et al. 1980a,b)and in the CNS by others (Lucchelli et 
al. 1985, Nieuwenhuys 1985). The suggestion here is that the 
a-2 receptor is predominantly extra-synaptic and more 
accessible because, at this site, it is the receptor for non- 
synaptically released NA and that a-1 and a-2 receptors may 
differ in location because the source and means of delivery 
of their ligand is different. This arrangement is illustrated 
in figure 27. According to this model the post-synaptic a-1 
receptor lies proximal to pre-synaptic elements and is 
therefore surrounded by a relatively dense medium (Nieuwenhuys 
1985) and associated with the re-uptake mechanism of the pre- 
synaptic element. The post-synaptic a-2 receptor may be
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located at a distance from any synaptic bouton and be 
unprotected by medium or the re-uptake mechanism of a pre- 
synaptic element. Johnson et al. (1986) have presented 
electrophysiological evidence in support of a similar system 
involving DA receptors in the caudate. They suggest that D1 
DA receptors are extra-synaptic and the D2 DA receptors are 
intra-synaptic. The implications of this suggestion will be 
discussed further below.
The present data might be incorporated in the hypothesis as 
follows :
(i) Microinjected NA is largely denied access to the a-1 
receptor by the powerful local re-uptake mechanism and 
therefore acts preferentially on the a-2 receptor.
(ii) Idazoxan is a very effective blocker of the eating 
induced by NA (though not as effective as phentolamine) 
because, with the re-uptake mechanism intact, exogenous NA has 
little opportunity to act through the a-1 receptor. Prazosin 
is ineffective because it blocks a receptor to which the 
microinjected NA does not have sufficient access.
(iii) When the re-uptake mechanism is blocked by cocaine the 
a-1 receptor is 'exposed' and exogenous NA can now act at both 
a-1 and a-2 making idazoxan much less effective. 
Phentolamine, which blocks both a-1 and a-2 receptors, 
continues to exert an almost total blockade of the effects of 
exogenous NA.
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FIGURE 27. Diagramatic representation of the difference in 
location of post-synaptic a-1 and a-2 receptors. The biophase for 
the a-1 receptor differs from that for the a-2 because of the 
presence of the pre-synaptic terminal bouton withits associated re­
uptake mechanism. Thus, NA released from axonal varicosities or 
exogenous NA microinjected in this general region will find the a- 
2 receptor more readily accessible. Inhibition of re-uptake or 
removal of pre-synaptic terminal boutons renders both a-1 and a-2 
receptors equally accessible.
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(iv) Removal of the pre-synaptic terminal with 6-OHDA does not J 
affect the eating response to NA (Goldman et al. 1985, Marino 
et al. 1983). However, 6-OHDA lesion does significantly 
attenuate the ability of idazoxan to block responding to 
exogenous NA, just as re-uptake inhibition by cocaine did.
Thus terminal removal and re-uptake inhibition have a 
functional equivalence in terms of selective blockade.
In order to explain the present data it is necessary to accept 
that both a-1 and a-2 have an equivalent or compatible 
function at the post-synaptic site. Stimulation of either 
type of receptor should generate the same response in terms 
of excitation or inhibition of the post-synaptic cell, even 
if the mechanism by which this is achieved differs. However, 
in contrast to the principle suggested by Eccles (1964) that 
a neurotransmitter released from a neurone has only one and 
the same effect on all the 'follower' cells, the co-existance 
of both excitatory and inhibitory receptors has been described 
(for review see Szabadi 1978). With regard to NA, it is known 
that the application of NA to central neurones by 
microelectrophoresis can evoke both excitatory and depressant 
responses (Krnjevic 1974). Beven et al. (1977) suggested that 
NA could stimulate both a- and B- adrenoceptors on cortical 
neurones, and that the a- receptors mediate excitatory, and 
the B- receptors mediate depressant responses. A similar 
organisation of receptors is an established property of smooth 
muscle cells where functionally antagonistic a- and B-
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receptors have been understood to exist for many years (for 
review see Furchgott 1972). The presence of antagonistic 
receptors on the same neuronal membrane has been suggested 
(Szabadi 1978) to create a degree of plasticity for synaptic 
transmission. However, Szabadi (1978 p.1895) further states 
that both receptors should occur within the same synapse, a 
suggestion that is hard to reconcile with present 
understanding. This point will be discussed further below 
(p.161).
Receptors may have a variety of descriptions depending on how 
they are classified: pharmacological (e.g. receptor binding 
studies), physiological (e.g. growth hormone responses to a- 
2 agonist infusion), or anatomical (e.g. pre-synaptic, post- 
synaptic) .
Two groups of workers in the early seventies independently 
arrived at the conclusion that there were two sub-types of NA 
a-receptor. Starke et al. (1975) discovered that NA overflow 
(presumably a pre-synaptic response) and the contraction of 
smooth muscle (presumably post-synaptic) showed different rank 
orders of potency for the agonists phenylephrine, 
oxymetazoline and naphazoline. Similarly Langer (1974) 
demonstrated that the a-selective antagonist phenoxybenzamine 
was some 30-fold less potent at inhibiting smooth muscle 
contraction than it was in promoting NA overflow. Langer
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categorised these two sub-types as a-1 and a-2 receptors. 
Initially these were considered anatomically discrete with the 
a-1 receptor occurring post-synaptically and the a-2 acting 
as a pre-synaptic autoreceptor. However, this description is 
simplistic and demonstrably not the case (see below).
One of the major techniques for the description of receptors 
in terms of : number, location, differentiation and
characterisation is direct labelling of the receptors with a 
radioactively labelled ligand. This technique, known as 
direct radioligand labelling, involves the binding of a 
compound with high specific radioactivity (usually [3H]) to 
the receptor recognition site (and often other associated 
proteins ) . This technique has been widely used in the 
description of NA a-receptors. Unfortunately, whilst simple 
in theory such a technique has many pitfalls and has prompted 
Perry and U'Prichard (1984) to write the following 'caveat'. 
"Because of the simplicity of the methodology, it has been 
widely used by investigators from all disciplines. 
Unfortunately, while subtle complexities of radioligand 
interactions with the a-receptor complex have been 
demonstrated, a lag in communication across disciplines has 
led, in some instances, to the less than optimal use and/or 
interpretation of radioligand binding assays. In many studies 
non--optimal preparation of tissue, improper selection of 
radioligand, blank to define specific binding, assay buffer,
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and/or other assay constituents fe.g. metal ions and 
nucleotides), as well as incomplete experimental design, have 
made published results from adrenergic radioligand binding 
studies difficult to interpret."
Receptor binding studies, such as those of Perry and 
U'Prichard (1984), have described a 'kinetic' model of a-1 and 
a-2 receptors. It is proposed that both a-1 and a-2 receptors 
exist in two (or possibly more) states; a high affinity state 
and a low affinity state and that these states are in 
equilibrium. In general it appears that a-agonists are 
selective for the high affinity state of the receptor whilst 
a-antagonists are more selective for the low affinity state. 
However, this is in many respects an oversimplification and 
each compound used should be verified in this regard.
Far from being relatively stable entities receptors are 
capable of significant changes in number and sensitivity. 
Changes have long been shown to occur after prolonged 
overstimulation, resulting in receptor loss (Cohen et al. 
1982) and by prolonged alterations in receptor occupancy, such 
as occurs in dopamine receptor blockade. This results in a 
state equivalent to denervation supersensitivity (Clow et al. 
1979). Such changes have most commonly been measured using 
receptor binding techniques and are referred to as 'up or down 
regulation'. However, studies performed on tissue cultures
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demonstrate that rapid changes in responses to agonists and 
antagonists (minutes) can occur in receptors; these changes 
being referred to as 'desensitisation'. To complicate the 
issue still further, in some tissues adrenergic receptor 
number shows a circadian rhythm, high at night and lower 
during daylight; for B-receptors in the pineal (Campbell et 
al. 1985) and a-2 receptors in PVN (Jhanwar-Uniyal et al. 
1986). High during the day and low at night for a-2 
adrenoceptors in the supraoptic nucleus (Jhanwar-Uniyal 1986). 
It is at present unclear whether or not these processes are 
related. For a complete review of circadian rhythms in 
mammalian neurotransmitter receptors see Wirz-Justice (1986). 
Desensitisation may occur by two processes. First, the 
receptor may migrate out of the membrane fraction into a 
'light density fraction' this process being rapid and 
apparently reversible (Chuang and Costa (1979) , Harden
(1983)). Second, the receptor may become uncoupled from its 
effector system, for example a- or B-receptors may become 
uncoupled from their respective N proteins. This would 
manifest itself in binding studies as a change from high to 
low affinity state (Campbell et al. 1987). This leads to the 
problem for a behavioural scientist of whether or not 
receptors that are labelled in binding studies can be 
construed as being part of the functionally relevant receptor 
population. For example in the Jahnwar-Uniyal paper described 
above, total binding to [^H]p-aminoclonidine ([^H]PAC) was
161
measured in a variety of areas at set times during the light 
and dark cycle. However, as discussed above, this a-2 
receptor agonist is probably selective for the high affinity 
state of the receptor complex, also it is not possible to 
determine the proportion of receptors bound which are of 
functional consequence, or even how many are pre- and how many 
post-synaptic. Thus in itself this data says little about 
the function of a-2 adrenoceptors at these sites.
Receptor/recognition sites that are labelled by radioligands 
represent only a single link in the transmitter - receptor - 
effector - cellular response chain. In some systems changes 
in total a-receptor binding have been observed, with no 
corresponding change in the proximal biochemical effect 
(inhibition of adenylate cyclase) (U'Prichard et al. 1982). 
In other systems, changes in the number of receptor binding 
sites and effector functioning are temporally dissociated (Su 
et al.1980). Thus to quote Perry and U'Prichard (1984) 
"Functional changes in operationally defined, physiological 
(X-receptors cannot always be inferred from the demonstration 
of changes in radioligand binding properties. " Indeed certain 
studies now report that whilst finding significant levels of 
binding of antagonists to certain receptors this is not of 
functional significance. McKernan and Campbell (1986) state 
"although phenoxybenzamine has partial inhibitory effects on 
ql-2 adrenoceptors 'in vivo' it does not appear to alter those
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that are functionally active, "(p.50). They explain that this 
lack of effect may be the result of irreversible blockade 
leading to the unmasking of 'spare' receptors already 
preformed in the membrane. Alternatively, receptors present 
inside the cell may be inserted into the membrane.
As stated above, in order to explain the current data it is 
necessary to assume that stimulation of both a-1 and a-2 post- 
synaptic receptors results in the postsynaptic cell responding 
in the same way, although the mechanisms involved may differ. 
There is considerable evidence in support of this assumption. 
The data cited by Szabadi (1978) indicates that there are 
receptors which produce opposite effects to stimulation by the 
same neurotransmitter.
Further to the classifications of receptors described above 
a number of receptor proteins have been isolated and 
characterised. These reports indicate that the structure and 
mechanism of receptors are interdependent (for review see 
Strange 1988). Receptors may be distinguished according to 
the speed of their response. Class 1 are fast responding 
whilst class 2 are much slower and longer acting. Examples 
of class 1 receptors are GABA, glutamate, glycine, and 
cholinergic nicotinic receptors. These receptors mediate very 
rapid (millisecond) alterations in the ionic distribution 
across the membrane. Class 1 receptors are linked directly
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to an ion channel and there is no evidence for the involvement 
of G proteins or 2nd. messengers (Strange 1987). Class 2 
receptors show slower responses (seconds) and have actions 
analogous to hormones at surface receptors. The monoamine 
transmitters are typical of this class. The receptor is 
coupled to a guanine nucleotide regulatory protein (G protein) 
acting as a transducer. The whole apparatus is associated 
with the membrane (Bourne 1986). The two best characterised 
effector systems are adenylate cyclase, and 
phosphatidylinositol biphosphate specific phospholipase C 
(Strange 1987). There are a variety of effector systems 
called into play in excitable cells many of which may be 
present in neurons, see figure 28. "Rigid use of the terms 
neurotransmitter and modulator will hinder a sound insight 
into the continuity between transmitters and hormones" (Fujita 
et al 1988 p.84).
A frequently cited objection to post-synaptic a-2 receptors 
having the same function as the a-1 is the evidence that 
post-synaptic a-2 are inhibitory whilst post-synaptic a-1 are 
excitatory (Aghajanian and Rogawski 1983) . However this paper 
states that "to date there has only been one single-cell 
electrophysiological study [Guyenet and Cabot (1981)] 
demonstrating the existance of functional post-synaptic 
a2-adrenoceptors in the CNS. " Sympathetic pre-ganglioriic 
neurons are inhibited by catecholamines acting via an a-
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FIGURE 28
Messenger substances released from neurons may induce a variety of 
actions.
a. Changes in ion fluxes generate slow depolarisation in some 
cases. A slow depolarisation may sometimes develop into an action 
potential, which is propagated to the secretory portion and opens 
the voltage dependent Ca^  ^channel.
b. Activation of the inisitol lipid cycle may induce various 
cellular responses, including the release of Ca^  ^ from the 
intracellular Ca^  ^store sites and cell growth.
c. Potentiation of ion pumps requires ATP supply and is responsible 
for electrogenesis.
d. Activation of cyclic AMP formation triggers various cellular 
responses in concert with Ca^  ^-dependent processes and turnover of 
the inisitol lipid cycle.
e. Activation of oxidative phosphorylation in mitochondria and the 
glycolysis system supplies ATP for various cellular responses.
f. Activation of cytoplasmic receptors alters the transcription of 
mRNA.
g. Action directly on the nucleus increasing the transcription of 
mRNA.
Figure from Fujita et al. (1988)
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adrenoceptor which shows the same rank order of potency as do 
pre-synaptic a-receptors. From this single item of 
data regarding a-2 receptors the following conclusion was 
levelled "a-1 adrenoceptors are located postsynaptically and 
mediate facilitation of excitation, a-2 adrenoceptors mediate 
inhibition both pre- and post'-synaptically and JB-adrenoceptors 
mediate inhibition post-synaptically,"
For NA it seems that it is the a- and i3- classes of receptor 
that have opposing effects, the present data is concerned with 
a-1 and a-2 receptors. The second messenger systems 
associated with adrenergic receptor sub-types have recently 
been presented by Strange (1988) and are reproduced below.
RECEPTOR SUBTYPE EFFECTORAdrenergic a-1 PIPg-PLCa-2 AC8-1 AC8-2 AC
Effectors; AC, adenylate cyclase; PIP2 -PLC, phosphatidylinositol biphosphate-specific phospholipase C.
Stimulation of 8-receptors serves to increase adenylate 
cyclase activity, whereas stimulation of a-2 receptors 
decreases adenylate cyclase activity and stimulation of a-1 
increases PIP2-PLC activity. Recent work by Gandhi and Ross 
(1987) has examined the function of a-adrenergic receptors on 
synaptic plasma membranes from rat brain cortex. They have 
indeed found that, with regard to the regulation of Ca^'^/Mg^'*' -
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ATPase in these membranes, that both a-1 and a-2 receptors 
have similar function.
In the light of Strange's (1988) data showing that 8-receptors 
increase adenylate cyclase activity whilst a-2 receptors 
decrease it, it is hard to see how both of these result in 
inhibition. It is possible to understand how the same 
transmitter substance released from two separate neurons with 
different origins might convey opposite information when 
released onto different receptor sub-types on the same post­
synaptic cell. It is not easy to understand why the same 
transmitter released from a single pre-synaptic location 
should have simultaneously opposing effects within the same 
synapse.
Communication
Delay
Action
Discrimination
Chemical agent has to:
Morphologicalcharacteristics
SYNAPTIC One to one
Short (100-200 ms)
Short and phasic
Topographicalorganisation
Cross the gap (5 - 20nm)
Axo-axonic synapse Post-junctional specialisation
Table adapted from Vizi (1984 vlQ).
NGN-SYNAPTIC One to many
Long (>1 sec)
Long and tonic
Depends on presence of receptors
Diffuse: 20nm to several micrometers
Free nerve endings Axonal varicosities No post-junctional specialisation
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The existance of a-2 receptors in both pre- and post-synaptic 
locations (the pre-synaptic receptor being an auto-receptor), 
does not affect this explanation of the data. The a-2 auto­
receptor may be positioned within the synapse to monitor 
released NA, and as such should be protected from exogenous 
NA as the a-1 receptor is. It is unlikely to be involved in 
accounting for the present data, particularly as it is already 
known that the a-2 receptors which are involved in the feeding 
resulting from NA stimulation of the PVN are post-synaptic.
The location of an auto-receptor within the synaptic cleft 
might be part of the explanation why cocaine does not itself 
elicit feeding. As re-uptake blockade causes the
concentration of NA within the cleft to rise, the stimulation %
of pre-synaptic auto-receptors inhibits further release.
Recent work in this laboratory has been unable to replicate 
the findings of Leibowitz's group that another NA re-uptake 
blocker, DMI elicits feeding. Despite initially promising 
pilot data, no significant increase in feeding has been 
elicited by microinjection of DMI (Winn; pers. comm.). One 
of the major drawbacks with the testing thus far performed on 
the proposed model was the failure to examine the effects of 
a-1 stimulation or blockade directly. The selective a-1 |
antagonists considered were prazosin and phenoxybenzamine. 
However prazosin was insufficiently soluble to allow 
equivalence of concentration and volume with doses of NA found 
to be effective, and phenoxybenzamine is irreversible and has
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some action at a-2 receptors (McKernan and Campbell 1986). 
Furthermore it is hard to see any merit in the use of an a-1 
antagonist in this preparation as the actions of NA at a-1 
receptors are only expressed detectably in the presence of a- 
2 blockade and combined blockade has been achieved using 
phentolamine. Interestingly, in a preparation where NA 
release may be predominantly stimulated from pre-synaptic NA 
terminals; the elicitation of feeding by microinjection of the 
anti-depressant TranyIcypramine; Leibowitz describes the most 
potent blockade of this effect as due to phenoxybenzamine 
(Leibowitz et al. 1978b). Recent work by Winn and Batchelor 
has, however, concentrated upon the possibility of direct 
stimulation of a-1 receptors with selective agonists. Such 
work is necessarily difficult to interpret in view of the 
proposed model. If the a-1 agonist is a molecule similar in 
shape to NA itself then it should also be rapidly removed from 
the biophase by the re-uptake mechanism, and would thus be 
unable to reach the a-1 receptor. By using two very different 
a-1 agonists Winn and Batchelor hope to have circumvented this 
problem. Whilst the a-1 agonist phenylephrine has no apparent 
effect on food intake, a second a-1 agonist methoxamine has 
an effect some fourfold that of an equivalent dose of NA. 
They suggest that this effect is possible because the shape 
of the methoxamine molecule renders it an unsuitable substrate 
fo the NA re-uptake mechanism (Winn and Batchelor; pers. 
comm.). A further experiment currently in progress will
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examine the effects of re-uptake inhibition on the ability of 
phenylephrine to stimulate feeding, the hypothesis predicts 
that in the absence of re-uptake phenylephrine will stimulate 
feeding.
Ventral striatum and NA.
The purpose of experiment 6 was to examine the hypothesis; 
that a-2 receptors are predominantly extra-synaptic whilst a- 
1 are predominantly intra-synaptic; at a different site and 
using a different behaviour. The same techniques of selective 
blockade were attempted as for the manipulations in PVN. In 
this regard the experiment was manifestly unsuccessful. The 
noradrenergic antagonists used had no significant inhibitory 
effects on the increase in locomotor activity stimulated by 
NA. However, this experiment has generated two interesting 
findings. First, that NA microinjection into the ventral 
striatum results in increased locomotor activity and second 
that this response shows a priming effect whereby a second 
injection, 48 hours after the first, results in an enhancement 
of the response. Whilst it is well known that dopamine 
microinjected into ventral striatum increases locomotor 
activity (Fink and Smith 1980a, 1980b, 1980c) there has long 
been debate as to whether or not NA injected into the same 
sites will produce locomotion (Pijnenburg et al. 1973, 
Pijnenburg et al. 1976, Cools 1986). The data from experiment 
6 clearly indicate that NA alone can increase locomotion but
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do not shed any light on the mechanisms underlying this 
increase. More experiments are clearly required to examine 
further the 'priming' effect and whether or not the locomotion 
in response to NA requires an intact dopamine system in 
ventral striatum.
Excitotoxic lesion of PVN
Successful lesion of the parvocellular portion of PVN would 
have made possible studies to determine the contribution of 
the different cytological components of the PVN to the feeding 
response to raicroinjected NA. Unfortunately the mechanism of 
action of the excitotoxins used rendered such a lesion 
impossible. The excitotoxins are believed to act by 
stimulating cells to such an extent that they die. The 
parvocellular cells in the PVN are known to play an important 
role in the regulation of cardiovascular function and 
attempted lesion of such cells resulted in the death of the 
animal. This was probably due to cardiac arrest brought on 
by overstimulation of the heart resulting from the hyper­
excitation of cells in the PVN. Doses of toxin low enough for 
the animal to survive the infusion were insufficient to 
generate a lesion. Thus it would appear that at present the 
development of a selective, neurotoxic lesion of the PVN in 
the rat is not possible.
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THEORETICAL IMPLICATIONS
The data presented in this thesis support the hypothesis that 
communication between neurons within the CNS occurs both at 
specialised synapses and via simple diffusion through the 
extra-cellular fluid. Whether, as suggested by Herkenham 
(1987), all transmitters use both systems, or as Strange 
suggests only the slower, class II receptor systems employ 
diffuse release (Strange 1988) the implications for the study 
and manipulation of CNS systems are considerable. The use of 
centrally acting drugs is widespread in the treatment of a 
variety of CNS disorders. If, as this thesis suggests, merely 
admitting certain substances to the CNS is not sufficient for 
them to reach all the receptors at which they might bind then 
the way in which many drugs are believed to act will have to 
be re-thought. The majority of anti-depressants do not act 
directly at receptors but through a combination of re-uptake 
inhibition and enhanced release of the endogenous transmitter. 
The behavioural effects of such compounds may become more 
explicable if an understanding is developed of how such 
actions might affect the balance between synaptic and non- 
synaptic communication. A model similar to that suggested 
here for NA has been suggested for dopamine by Johnson et al. 
(1986) based upon electrophysiological evidence. Furthermore, 
Walters et al. (1985) suggest that stimulation of dopamine D1 
and D2 receptors is synergistic and that a minimum level of 
stimulation of either receptor is required for the expression
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of the other sub-type. If dopamine receptors are located 
intra-and extra-synaptically in populations of predominantly 
D1 or D2 sub-types as would be suggested by the Johnson model 
then understanding how the ratio of stimulation of the two 
populations affects the post-synaptic cell might lead to great 
advances in both Parkinson's and schizophrenia research.
CONCLUSION
Chemical transmission of information within the CNS is 
achieved through both release at specialised synapses and non­
specific diffusion. This has been demonstrated behaviourally 
for NA within the PVN. The involvement of PVN NA in feeding 
resulting from tail pinch was not demonstrated. Direct 
injection of NA at another site can elicit a clear behavioural 
response, injection into the ventral striatum results in 
increased locomotor activity but the mechanisms underlying 
this response remain unclear.
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APPENDIX I 
CHEMICAL INFORMATION TRANSFER
There is currently much research into the nature of the 
chemicals that nerve cells use to communicate with, and 
influence each other by. This research covers a variety of 
techniques and disciplines, and has spawned a range of 
descriptive terms for the chemical substances under 
examination. Thus in addition to "neurotransmitter", the 
following terms have been proposed: Neurohumor, (non)synaptic 
neurotransmitter, neurohormone, classical/ genuine
neurotransmitter, possible/putative/suspected 
neurotransmitter, neuromediator, neuromodulator, 
neuroregulator, neuroactive principle, neurochemical, chemical 
messenger, neuroactive substance, and informational 
substance. This variety has come about as more and more 
information is generated about the range of chemical 
substances which can influence neuronal processes and the ways 
in which an individual chemical can have different effects 
depending upon a wide variety of release and receptor 
parameters. There is clearly an enormous overlap in the 
specificity of many of these terms; some have been coined to 
cover the actions of a class of chemicals in many situations 
while others refer to the specific actions of a limited group 
of similar compounds under particular conditions, From the 
above list it is possible to describe NA with all but one of 
the listed terms (one would classify it as a genuine rather
than putative neurotransmitter). It is clear that a 
definition of the terms used in this thesis, and explanation 
for their choice, is necessary.
There are conflicting requirements in the choice of term for 
identifing a compound with actions that affect the state of 
neuronal tissue. On the one hand, for clear, accurately 
defined, provable or disprovable statements to be made about 
the nature and actions of a compound the definition must be 
tight and constrained. In contrast, it is clear that little 
is known of the properties, actions and interactions of many 
of these compounds and for any definition to be valid it must 
be flexible. Thus it may be better, as Burnstock (1976) 
suggested, to apply the term transmitter to "any substance 
produced and physiologically released from nerve terminals to 
evoke post-synaptic response via surface receptors. " However 
two allowances must be made, first that a change in membrane 
state is a response, and second that the action may occur pre- 
or post-synaptically. Similarly Dismukes (1979) states that 
"Given the Incomplete state of knowledge, there is little 
advantagein attempting to distinguish modulators from 
transmitters," For the purposes of the present thesis 
definition of the following terms is considered important: 
neurohumor, neurotransmitter, nonsynaptic neurotransmitter, 
neurohormone. No discussion of the concepts and definition 
of neuromediation or neuromodulation will be attempted here.
for review of this topic see Dismukes (1979) and commentaries, 
Iversen (1979), Van Dongen (1981) and Nieuwenhuys (1985).
DEFINITION OF TERMS.
The following definitions are modifications of those proposed 
by Van Dongen (1981):
NEUROHDMOR
A compound [X] is a neurohumor of a neurone or group of 
neurones when the following criteria are confirmed:
1. X is present in the neurone.
2. X is synthesised in the neurone.
3. Stimulation of the neurone causes the release of X.
4. X interacts with specific receptors.
5. A system exists which terminates the action(s) of X at its 
target site (there may be more than one such system).
Van Dongen includes a further requirement, that ^direct 
application of X mimics the effect of increasing its 
endogenous concentration: this effect is identical in all
respects, including pharmacological.' However, this appears 
both unnecessessary and self- defeating and it is in many 
respects the purpose of this thesis to demonstrate that the 
application of exogenous ligands does NOT mimic the effects 
of increasing endogenous concentrations. It is also
difficult to determine whether the effects of application of 
X is 'identical in all respects' to increasing the endogenous 
levels, when as explained above, the exact effects of many 
compounds are not clearly understood.
NEUROTRANSMITTER
Compound X is a neurotransmitter of a neurone 
when:
1. X is a neurohumor.
2. X is released proximal to its site of action and is not 
transported to this site by CSF or blood.
This class of compounds may be sub-divided into two:
A. Svnaptic Neurotransmitter
Compound X is a synaptic neurotransmitter when:
1. X is a neurotransmitter.
2. X is present in the pre-synaptic component of a 
morphologically distinct synapse; X acts transsynaptically at 
receptor sites located in the post-synaptic membrane.
B . Nonsynaptic neurotransmitter
Compound X is a nonsynaptic neurotransmitter when:
1. X is a neurotransmitter.
2. X is present in and may be released from terminals without 
synaptic specialisations.
The categories synaptic and nonsynaptic neurotransmitter are 
in no way mutually exclusive and the same compound may be said 
to fit either of these definitions dependent upon the sites 
of release and action.
NEUROHORMONE
Compound X is a neurohormone when:
1. X is a neurohumor.
2. X is released from a site remote from its site of action; 
to which it is transported by the action of CSF or blood.
However even when the appropriate definition is applied it is 
not possible to be absolute as to the function of certain 
transmitters. As Fujita et al. state "neuronal secretions, 
including typical neurotransmitters, are largely common to 
paraneuronal secretions including local hormones 
(parahormones) and typical hormones or telehormones. It is 
impossible to distinguish neurotransmitters, parahormones, or 
telehormones, either by their chemical nature or by the 
mechanism of their secretion" (Fujita et al. 1988, p. 77).
The compound of primary importance in this thesis is NA which, 
as defined above, is a neurotransmitter in CNS. The terms 
synaptic and nonsynaptic will be applied to NA as appropriate, 
but no attempt will be made to describe NA as a mediator or 
modulator of neuronal function. Such terms are often 
idiosyncratic and would serve merely to distract attention 
from the aspects of NA transmission under examination.
